Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
CP-465022 maleate | 199656-46-7 | C26H24ClFN4O·C4H4O4 | 579 | |
CP-461 free base | 227619-92-3 | C25H21FN2O | 384.45 | N-benzyl-2-[(3Z)-6-fluoro-2-methyl-3-(pyridin-4-ylmethylidene)inden-1-yl]acetamide; UNII-824ZMS3BGL; OSI-461 free base |
CP-457920 | 220860-50-4 | C18H17N3O3 | 323.35 | N-benzyl-6-ethoxy-4-oxo-1H-1,5-naphthyridine-3-carboxamide; CP-457920; CP457920; CP 457920; UNII-13BME2F602; CP-457,920 |
CP-457677 | 214535-77-0 | C22H21FN2O3 | 380.41 | 2-(4-fluorophenoxy)-N-[[4-(2-hydroxypropan-2-yl)phenyl]methyl]pyridine-3-carboxamide; CP-457677; CP457677; CP 457677; UNII-5A83419M4U |
CP-456773 sodium | 256373-96-3 | C20H24N2NaO5S | 427.46 | sodium ((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonyl)amide; MCC950; MCC 950; MCC-950; CP-45677; CP45677; CP 45677; CRID-3; CRID3; CRID 3; CP-456773 sodium salt; Cytokine release inhibitory drug 3. |
CP-432 | 431990-08-8 | C23H26F3NO4S | 469.52 | 5-(3-((2S)-2-((3R)-3-hydroxy-4-(3-(trifluoromethyl)phenyl)butyl)-5-oxo-1-pyrrolidinyl)propyl)-2-Thiophenecarboxylic acid |
CP-409092 | 194098-25-4 | C17H19N3O2 | 297.35 | N-[4-(methylaminomethyl)phenyl]-4-oxo-1,5,6,7-tetrahydroindole-3-carboxamide; 4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxylic acid (4-methylaminomethylphenyl)amide; CP 409,092; CP 409092; CP-409,092; CP-409092; CP409,092; CP409092 |
CP-394531 | 305822-63-3 | C23H23ClO2 | 366.14 | (2R,4aS,10aR)-4a-benzyl-2-(chloroethynyl)-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-2,7-diol; |
CP-376395 HCl | 1013933-37-3 | C21H31ClN2O | 362.94 | CP376395 HCl;2-(Mesityloxy)-3,6-dimethyl-N-(pentan-3-yl)pyridin-4-amine hydrochloride;3,6-Dimethyl-N-pentan-3-yl-2-(2,4,6-trimethylphenoxy)pyridin-4-amine hydrochloride |
CP-331684 | 207922-70-1 | C17H21N3O4 | 331.37 | 2-[4-[2-[[(2R)-2-(6-aminopyridin-3-yl)-2-hydroxyethyl]amino]ethoxy]phenyl]acetic acid |
CP-320626 | 186430-23-9 | C23H23ClFN3O3 | 443.90 | 5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide; CP 320626; CP-320626 |
CP-316311 | 175139-41-0 | C21H29NO2 | 327.47 | CP-316311; Pyridine, 4-(1-ethylpropoxy)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)- |
Cp2C / CppC | 29789-88-6 | C18H26N6O15P2 (free acid) | 628.4 (free acid) | P1, P2- Di- (cytidine- 5')- diphosphate, sodium salt |
CP-283097 | 138047-56-0 | C21H25NO4 | 355.43 | UNII-WHL1Z3GN15;(3R,4S)-Rel-3,4-dihydro-3-(4-hydroxy-4-(phenylmethyl)-1-piperidinyl)-2H-1-benzopyran-4,7-diol |
CP22185 | 52758-03-9 | C17H19N | 237.34 | CP-22185;Sertraline hydrochloride specified impurity B;(1RS,4RS)-N-Methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine;1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, (1R,4R)-rel-;(1R,4R)-N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine |
CP-220629 | 162141-96-0 | C20H25N3O | 323.44 | UNII-BAV9N49AFE; CP-220629; BAV9N49AFE; SCHEMBL84865; CHEMBL75819; 1-cyclopentyl-3-ethyl-6-(2-methylphenyl)-4,5-dihydropyrazolo[3,4-c]pyridin-7-one |
CP21R7 | 125314-13-8 | C19H15N3O2 | 317.34 | 3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione |
CP-199330 | 158102-92-2 | C28H24ClF3N2O6S | 609.01 | CP-199330; UNII-V4WYK6T8QA; CHEMBL96206; V4WYK6T8QA; SCHEMBL8890632; BDBM50081532; N-[3-[[(3R,4R)-6-[(7-chloroquinolin-2-yl)methoxy]-4-hydroxy-3,4-dihydro-2H-chromen-3-yl]methyl]-4-methoxyphenyl]-1,1,1-trifluoromethanesulfonamide |
CP-195543 | 204981-48-6 | C24H19F3O4 | 428.4 | 2-[(3S,4R)-3-benzyl-4-hydroxy-3,4-dihydro-2H-chromen-7-yl]-4-(trifluoromethyl)benzoic acid; 2-(3-benzyl-4-hydroxy-chroman-7-yl)-4-trifluoromethyl-benzoic acid; CP 195543; CP-195543; CP195543 |
CP-195494 | 158103-57-2 | C26H22F4N2O5S2 | 582.59 | UNII-1D055URF6U; CHEMBL300701; CP-195494; (+)-CP-195494; 1D055URF6U; BDBM50070919 |
CP-122721 | 145742-28-5 | C20H23F3N2O2 | 380.40 | CP122721; CP 122721; UNII-R7OYP6N58F; (2S,3S)-N-(2-methoxy-5-(trifluoromethoxy)benzyl)-2-phenylpiperidin-3-amine |
CP-114271 | 162326-86-5 | C17H19F3N2O4S | 404.40 | UNII-CY8W406YBX; UL-TG 307; UL-TG-307; CY8W406YBX; Acetic acid, (4-((2R)-2-(((2S)-2-hydroxy-2-(2-(trifluoromethyl)-4-thiazolyl)ethyl)amino)propyl)phenoxy)- |
CP-105696 | 158081-99-3 | C28H28O4 | 428.53 | CP-105696; UNII-Z7354TW4BM; CP-105,696; CHEMBL51770; CP 105696; Z7354TW4BM; 1-[(3S,4R)-4-hydroxy-3-[(4-phenylphenyl)methyl]-3,4-dihydro-2H-chromen-7-yl]cyclopentane-1-carboxylic acid |
CP-100829 | 172618-05-2 | C14H7Cl2FN2O3S | 373.18 | X7Y3B8B649; 1H-Indole-1-carboxamide, 6-chloro-3-((4-chloro-2-thienyl)carbonyl)-5-fluoro-2,3-dihydro-2-oxo-; 1H-Indole-1-carboxamide, 6-chloro-3-((4-chloro-2-thienyl)hydroxymethylene)-5-fluoro-2,3-dihydro-2-oxo-, (Z)- |
CP 99994 dihydrochloride | 145148-39-6 | C19H24N2O.2HCl | 369.33 | (2S,3S)-N-[(2-Methoxyphenyl)methyl]-2-phenyl-3-piperidinamine dihydrochloride |
CP 809101 hydrochloride | 479683-64-2 | C15H18Cl2N4O | 341.2 | 2-[(3-chlorophenyl)methoxy]-6-piperazin-1-ylpyrazine;hydrochloride; |
CP 80633 | 135637-46-6 | C18H24N2O3 | 316.39 | 5-[3-[(1S,2S,4R)-Bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl]tetrahydro-2(1H)-pyrimidinone |
CP 80080 | 152247-02-4 | C20H16FNO4 | 353.34 | CP 80080; CP80080; CP-80080; CP-80,080; 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-(4-methoxyphenyl)-4-oxo- |
CP 775146 | 702680-17-9 | C26H33NO4 | 423.54 | 2-Methyl-2-[3-[(3S)-1-[2-[4-(1-methylethyl)phenyl]acetyl]-3-piperidinyl]phenoxy]-propanoic acid |
CP 6232 | 141562-38-1 | C24H27N7O10S2 | 637.65 | 7-((2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetamido)-3-(N-(1,5-dihydroxy-4-pyridon-2-yl)methyl-N-methyl)aminomethyl-3-cephem-4-carboxylic acid |
CP 615003 mesylate | 1259477-42-3 | C20H24FN3O3.CH4O3S | 469.53 | N-(3-fluoro-4-(2-(propylamino)ethoxy)phenyl)-4,5,6,7-tetrahydro-4-oxo-1H-indole-3-carboxamide mesylate |
CP 59430 | 86329-06-8 | C21H22N8O3 | 434.45 | 2-(4-(4-Azidobenzoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline |
CP 544326 | 752187-80-7 | C24H22N4O5S | 478.52 | 2-(3-((N-(4-(1H-pyrazol-1-yl)benzyl)pyridine-3-sulfonamido)methyl)phenoxy)acetic acid; CP-544326; CP544326; CP544326; Taprenepag; PF-0421732 metabolite |
CP 471474 | 210755-45-6 | C16H17FN2O5S | 368.38 | 2-[[4-(4-fluorophenoxy)phenyl]sulfonylamino]-N-hydroxy-2-methylpropanamide; CP 471474; CP-471474; 210755-45-6; CHEMBL323612 |
CP 46665 | 72618-10-1 | C35H66Cl2N2O2 | 617.82 | 4-Aminomethyl-1-(2,3-bis(decyloxy)propyl)-4-phenylpiperidine |
CP 465022 | 199655-36-2 | C26H24ClFN4O | 499.41 | 3-(2-chlorophenyl)-2-[2-[6-(diethylaminomethyl)pyridin-2-yl]ethenyl]-6-fluoroquinazolin-4-one; CP-465022; CP465022; UNII-4582JTR93Y |
CP 461 | 227619-96-7 | C25H22ClFN2O | 420.91 | N-benzyl-2-[6-fluoro-2-methyl-3-(pyridin-4-ylmethylidene)inden-1-yl]acetamide;hydrochloride; CAS: 227619-92-3 (CP-461 free base); |
CP 424174 | 210825-31-3 | C22H29ClN2O4S | 452.99 | N-[[[4-Chloro-2,6-bis(1-methylethyl)phenyl]amino]carbonyl]-3-(1-hydroxy-1-methylethyl)benzenesulfonamide |
CP 346086 | 186390-48-7 | C26H22F3N5O | 477.48 | N-[1,2,3,4-Tetrahydro-2-(1H-1,2,4-triazol-5-ylmethyl)-6-isoquinolinyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide |
CP 339818 hydrochloride | 478341-55-8 | C21H24N2.HCl | 340.89 | N-[1-(Phenylmethyl)-4(1H)-quinolinylidene]-1 pentanamine hydrochloride |
CP 316819 | 186392-43-8 | C21H22ClN3O4 | 415.87 | 5-Chloro-N-[(1S,2R)-2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide |
CP 31398 dihydrochloride | 1217195-61-3 | C22H26N4O.2HCl | 435.39 | N'-[2-[2-(4-Methoxyphenyl)ethenyl]-4-quinazolinyl]-N,N-dimethyl-1,3-propanediamine dihydrochloride |
CP 24,879 hydrochloride | 10141-51-2 | C11H17NO·HCl | 215.8 | p-(Isopentyloxy)-aniline; 4-(3-methylbutoxy)-benzenamine monohydrochloride |
CP 226269 | 220941-93-5 | C18H19FN4 | 310.37 | CP-226269; 5-fluoro-2-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-1H-indole |
CP 154526 | 257639-98-8 | C23H32N4.HCl | 400.99 | N-Butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride |
CP 135807 | 151272-90-1 | C19H21N5O2 | 351.40 | 3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-N-(3-nitro-2-pyridinyl)-1H-indol-5-amine |
CP 117227 | 154531-78-9 | C31H33N3O2 | 479.61 | CP 117227; CP-117227; CP117227; 1-Piperazineethanol, 4-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)-alpha-((5-quinolinyloxy)methyl)-, (S)- |
CP 115953 | 136440-70-5 | C19H13F2NO4 | 357.31 | 1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxyphenyl)-4-oxo-3-quinolinecarboxylic acid |
CP 101606 | 134234-12-1 | C20H25NO3 | 327.42 | CP-101606; Traxoprodil; 1-((1S,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl)-4-phenylpiperidin-4-ol |
CP 100356 hydrochloride | 142715-48-8 | C31H36N4O6.HCl | 597.10 | 4-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-N-2[2-(3,4-dimethoxyphenyl)ethyl]-6,7-dimethoxy-2-quinazolinamine hydrochloride |
CP 100356 | 142716-85-6 | C31H36N4O6 | 560.64 | 4-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-6,7-dimethoxy-2-Quinazolinamine; 142715-48-8(hydrochloride) |
COX-2-IN-1 | 787623-48-7 | C18H14ClF3N4O2S | 442.84 | 1-(4-Sulfamylphenyl)-3-trifluoromethyl-5-(7-chloroindol-3-yl)-2-pyrazoline; 4-[3-(7-chloro-1H-indol-3-yl)-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]benzenesulfonamide |
COX2-IN-1 | 134729-13-8 | C17H12FN3O2S | 341.36 | 1-(4-fluorophenyl)-5-(4-methylsulfonylphenyl)pyrazole-3-carbonitrile |
COX-2 Inhibitor II | 181696-33-3 | C16H12F2N2O3S | 350.34 | SC-791; IN1371; 181696-33-3; 4-[(5-Difluoromethyl-3-phenyl)-4-isoxazolyl]benzenesulfonamide; SCHEMBL214781 |
COX-2 Inhibitor I | 416901-58-1 | C18H16ClNO4S | 377.8 | Methyl [5-methylsulfonyl-1-(4-chlorobenzyl)-1H-2-indolyl]carboxylate; LM-1685 |
COX/5-LO-IN-1 | 154355-75-6 | C16H15FN2O2S | 318.37 | Urea, N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propyn-1-yl]-N-hydroxy-; 1-[4-[5-[(4-fluorophenyl)methyl]thiophen-2-yl]but-3-yn-2-yl]-1-hydroxyurea |
Cowaxanthone B | 212842-64-3 | C25H28O6 | 424.5 | 1,3-Dihydroxy-6,7-dimethoxy-2,8-diprenylxanthone |
Coumurrayin | 17245-25-9 | C16H18O4 | 274.3 | 5,7-Dimethoxy-8-(3-methyl-2-butenyl)-2H-1-benzopyran-2-one;5,7-Dimethoxy-8-(3-methyl-2-butenyl)coumarin; 5,7-dimethoxy-8-(3-methylbut-2-enyl)chromen-2-one |
Coumestrol | 479-13-0 | C15H8O5 | 268.224 | Cumoestrol; Cumoesterol; Cumostrol; Coumesterol; 3,9-dihydroxy-[1]benzofuro[3,2-c]chromen-6-one |
Coumermycin A1 | 4434-05-3 | C55H59N5O20 | 1110.08 | |
Coumarin Boronic Acid pinacolate ester | 190788-61-5 | C15H17BO4 | 272.1 | CBA pinacolate ester; CBE; Coumarin-7-pinacolboronate; 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-1-benzopyran-2-one |
Coumarin Boronic Acid | 1357078-03-5 | C9H7BO4 | 190.0 | CBA; B-(2-oxo-2H-1-benzopyran-7-yl)-boronic acid; (2-Oxochromen-7-YL)boronic acid; Coumarin-7-boronic |
Corypalmine | 27313-86-6 | C20H23NO4 | 341.4 | Tetrahydrojatrorrhizine |
Corynoxine B | 17391-18-3 | C22H28N2O4 | 384.47 | Corynoxine B |
Corynoxine | 6877-32-3 | C22H28N2O4 | 384.47 | |
Corynoxidine | 57906-85-1 | C21H25NO5 | 371.433 | Tetrahydropalmatine N-oxide; (7S,13aS)-2,3,9,10-tetramethoxy-7-oxido-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-7-ium |
Corynoxeine | 630-94-4 | C22H26N2O4 | 382.45 | |
Corynecin V | 40958-12-1 | C14H18N2O6 | 310.3 | |
Corynecin IV | 40958-11-0 | C13H16N2O6 | 296.3 | |
Corynecin III | 18048-95-8 | C13H18N2O5 | 282.3 | Methamphenicol |
Corynecin II | 35098-52-3 | C12H16N2O5 | 268.3 | |
Corynecin I | 4423-58-9 | C11H14N2O5 | 254.2 | Dechlorochloramphenicol, Didechloramphenicol |
Corymbosin | 18103-41-8 | C19H18O7 | 358.34 | 2-(3,4,5-Trimethoxyphenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one; 5-Hydroxy-7-methoxy-2-(3,4,5-trimethoxyphenyl)-4H-1-benzopyran-4-one; 5-Hydroxy-3',4',5',7-tetramethoxyflavone |
Corylin | 53947-92-5 | C20H16O4 | 320.34 | |
Corylifol C | 775351-91-2 | C20H18O5 | 338.4 | 2-(3,4-Dihydroxyphenyl)-7-hydroxy-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one |
Corylifol A | 775351-88-7 | C25H26O4 | 390.47 | 3-[3-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-4-hydroxyphenyl]-7-hydroxy-4H-1-benzopyran-4-one;Corylinin;3'-Geranyl-4',7-dihydroxyisoflavone |
Corydine | 476-69-7 | C20H23NO4 | 341.4 | Glaucentrin; Glaucentrine; d-Corydine |
Corydalmine | 30413-84-4 | C20H23NO4 | 341.4 | (-)-Kikemanine;(13aS)-5,8,13,13a-Tetrahydro-2,3,9-trimethoxy-6H-dibenzo[a, g]quinolizin-10-ol;Kikemanin;Kikemanine;Schefferine. |
Corydaline | 518-69-4 | C22H27NO4 | 369.44 | (13S,13aR)-2,3,9,10-tetramethoxy-13-methyl-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline; |
Corundum | 1302-74-5 | Al2O3 | 101.96 | abramantf36; abramaxf46; abramaxf54; alpha-corundum; aluminiumoxideceramic; aluminiumoxidewafer; Corundum(Al2O3); duralf30 |
Cortodoxone | 152-58-9 | C21H30O4 | 346.46 | (8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one 11 Deoxycortisol 11 Desoxycortisol 11 Desoxycortisone 11-Deoxycortisol 11-Desoxycortisol 11-Desoxycortisone |
Cortisone acetate | 50-04-4 | C23H30O6 | 402.48 | NSC 49420 |
Cortistatin 14 | 193829-96-8 | C81H113N19O19S2 | 1721.03 | |
Corticotropin-releasingfactor (cattle) (9CI) | 92307-52-3 | C206H340 N60 O63 S | 4697.33 | SER-GLN-GLU-PRO-PRO-ILE-SER-LEU-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-GLU-VAL-LEU-GLU-MET-THR-LYS-ALA-ASP-GLN-LEU-ALA-GLN-GLN-ALA-HIS-ASN-ASN-ARG-LYS-LEU-LEU-ASP-ILE-ALA-NH2 BOVINE; H-SER-GLN-GLU-PRO-PRO-ILE-SER-LEU-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-GLU-VAL-LEU-G |
Cortexolone 17 alpha-propionate | 19608-29-8 | C24H34O5 | 402.52 | [(8R,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate CB-03-01 cortexolone 17alpha-propionate |
Copper oxychloride | 1332-40-7 | ClCuO | 427.13 | BLITOX; FUNGURAM; CUPRIC OXYCHLORIDE; CUPRAVIT; CUPOX; CUPROKYLT; COBOX; COPRANTOL |
Corosolic acid | 4547-24-4 | C30H48O4 | 472.7 | 2-A-HYDROXYURSOLIC ACID; 2ALPHA-HYDROXYURSOLIC ACID; 2,3-DIHYDROXYURS-12-EN-28-OIC ACID; HYDROXYURSOLIC ACID; COROSOLIC ACID; Corsolicacid; Corosolic; (2a,3b)-2,3-Dihydroxy-urs-12-en-28-oic acid |
CORONATINE | 62251-96-1 | C18H25NO4 | 319.40 | |
Coronarin E | 117591-81-8 | C20H28O | 284.4 | 15,16-Epoxy-8(17),11,13(16),14-labdatetraene |
Coronarin D methyl ether | 157528-81-9 | C21H32O3 | 332.5 | 2(3H)-Furanone,3-[[(1S,4aS,8aS)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalen yl]methylene]dihydro-5-methoxy-,(3E)- |
Coronarin D ethyl ether | 138965-89-6 | C22H34O3 | 346.5 | (3E)-5-Ethoxy-3-{2-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedeca hydro-1-naphthalenyl]ethylidene}dihydro-2(3H)-furanone |
Coronarin D | 119188-37-3 | C20H30O3 | 318.5 | 15-Hydroxy-8(17),12-labdadien-16,15-olide |
Coronarin B | 119188-38-4 | C20H30O4 | 334.5 | 3H-1,2-Dioxepin-5-carboxaldehyde,7-(decahydro-5,5,8a-trimethyl-2-methylene-1-naphth alenyl)-4,7-dihydro-3-hydroxy- |
Coronarin A | 119188-33-9 | C20H28O2 | 300.4 | (2S,4R,4aS,8aS)-4-[(E)-2-(3-Furyl)vinyl]-4a,8,8-trimethyl-3-methy lenedecahydro-2-naphthalenol |
Coronaridine | 467-77-6 | C21H26N2O2 | 338.44334;g/mol | Coronaridine; Methyl ibogamine-18-carboxylate |
Coronalolide methyl ester | 268214-50-2 | C31H44O5 | 496.7 | methyl 3-((1aS,3aR,4R,6aS,6bS,7aR,10aR,10bR)-3a,6a-dimethyl-4-((R,E)-6-methyl-7-oxohept-5-en-2-yl)-10-methylene-9-oxododecahydro-1H-cyclopenta[7,8]cyclopropa[4,4a]naphtho[2,3-b]furan-10b(2H)-yl)propanoate |
Coronalolide | 268214-51-3 | C30H42O5 | 482.7 | 3-((1aS,3aR,4R,6aS,6bS,7aR,10aR,10bR)-3a,6a-dimethyl-4-((R,E)-6-methyl-7-oxohept-5-en-2-yl)-10-methylene-9-oxododecahydro-1H-cyclopenta[7,8]cyclopropa[4,4a]naphtho[2,3-b]furan-10b(2H)-yl)propanoic acid |
Coronalolic acid | 268214-52-4 | C30H46O4 | 470.7 | 3-[(1R,3aS,3bS,6R,6aR,7aS,9aR)-6-(3-Hydroxy-1-propen-2-yl)-3a,9a- dimethyl-1-[(2R,5E)-6-methyl-7-oxo-5-hepten-2-yl]decahydro-1H-cyc lopenta[a]cyclopropa[e]naphthalen-6a(7H)-yl]propanoic acid |
Cornuside | 131189-57-6 | C24H30O14 | 542.49 | 7-Galloylsecologanol |
Cornoside | 40661-45-8 | C14H20O8 | 316.306 | 4-hydroxy-4-[2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]cyclohexa-2,5-dien-1-one |
cornin | 548-37-8 | C17H24O10 | 388.37 | cornin; methyl (1S,4aS,7S,7aR)-1-(beta-D-glucopyranosyloxy)-7-methyl-5-oxo-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate; |
Corncob xylan | 9014-63-5 | Poly[b-(1,4)-D-xylopyranose]; XOS | ||
Corn steep liquor | 66071-94-1 | |||
Corn starch | 9005-25-8 | (C6H10O5)n | Starch - from maize | |
Corn Oil | 8001-30-7 | |||
corn gluten meal | 66071-96-3 | CORN GLUTEN MEAL; GLUTEN, ENZYMATIC HYDROLYSATE; GLUTEN HYDROLYSATE; corn; cornglutens; glutens,corn; ZEA MAYS (CORN) KERNEL MEAL; Gluten, corn | ||
CORM-3 | 475473-26-8 | C5H4ClNO5Ru | 294.61 | |
Corey lactone THP | 69222-61-3 | C13H20O5 | 256.29 | Corey lactone THP; (3aR,4S,5R,6aS)-Hexahydro-4-(hydroxymethyl)-5-[(tetrahydro-2H-pyran-2-yl)oxy]-2H-cyclopenta[b]furan-2-one |
Cordycepin 5-triphosphate sodium salt | 71997-32-5 | C10H12N5Na4O12P3 | 579.11 | 3-Deoxyadenosine 5-triphosphate |
CORDIERITE | 886436-25-5 | Al4Mg2O18Si5 | 584.95 | CORDIERITE; 12330-40-4 (Hydrate); Celcor; Celcor 9475; Cordierite (mg2(al4o3(sio3)5)); Dichroite; Pc-mas/f; Ss 400 |
Coptisine | 3486-66-6 | C19H14NO4 | 320.32 | Bis[methylenedioxy]protoberberine; 7,8,13,13a-Tetradehydro-2,3-9,10-bis(methylenedioxy)berbinium; |
COPROSTANE | 481-20-9 | C27H48 | 372.67 | BETA, ALPHA, ALPHA 20R-CHOLESTANE; COPROSTANE; 5BETA-CHOLESTANE; beta-Cholestane; Cholestane, (5beta)-; Pseudocholestane; coprostane crystalline; CHOLESTANE, (5a-)-(RG) |
Copper,bis[2-[[(1,1-dimethylethyl)imino-kN]methyl]phenolato-kO]- | 13986-34-0 | C22H28 Cu N2 O2 | 177.2429;g/mol | (6Z)-6-[(tert-butylamino)methylidene]cyclohexa-2,4-dien-1-one;13986-34-0;Copper,bis[2-[[(1,1-dimethylethyl)imino-kN]methyl]phenolato-kO]-;AC1NUE4G;SCHEMBL2498832;SCHEMBL14011732 |
Copper(II) vanadium oxide | 14958-34-0 | Cu(VO3)2 | 261.4254 | COPPER(II) VANADIUM OXIDE; COPPER VANADATE; COPPER (II) METAVANADATE; CUPRIC METAVANADATE; CUPRIC VANADATE; copper divanadium hexaoxide |
Copper(II) sulfide | 1317-40-4 | CuS | 95.60 | C.I. 77450; C.I. Pigment Blue 34; Copper Blue; Copper monosulfide; Copper sulfide (CuS); Copper(2+) sulfide |
Copper(II) sulfate pentahydrate | 7758-99-8 | 249.68 | CUPRI SULFAS PENTAHYDRICUS; CUPRIC SULPHATE HYDRATED; CUPRIC SULPHATE, PENTAHYDRATE; CUPRIC SULFATE, PENTAHYDRATE; CUPRIC SULFATE TS; CUPRIC SULPHATE 5H2O; CUPRIC SULPHATE 5-HYDRATE; CUPRIC SULFATE, 5-HYDRATE | |
Copper(II) sulfate | 7758-98-7 | CuSO4 | 159.6 | BLUE VITRIOL; FEHLING'S SOLUTION; FEHLING'S SOLUTION A; FEHLINGS SOLUTION, COPPER A; FEHLING'S SOLUTION NO 1; FEHLING'S REAGENT SOLUTION(A); FEHLING'S REAGENT I; FEHLING'S REAGENT I FOR SUGARS |
Copper(II) Oxalate | 814-91-5 | C2H2CuO4++ | 153.58100 | |
Copper(II) nitrate | 10402-29-6 | Cu(NO3)2 | 187.56 | Copper(II) nitrate; Copper(II) nitrate solution |
Copper(II) hydroxide | 20427-59-2 | CuH2O2 | 97.56 | Cupric hydroxide |
Copper(II) hexafluoroacetylacetonate hydrate | 155640-85-0 | C10H4CuF12O5 | 477.65 (anhydrous basis) | copper; (Z)-1,1,1,5,5,5-hexafluoro-4-oxopent-2-en-2-olate; hydrate; Copper(II)hexafluoroacetylacetonatehydrate; 155640-85-0; PC2093 |
Copper(II) fluorosilicate | 12062-24-7 | CuF6Si | 205.62 | Copper(II) fluorosilicate; Copper(II) silicofluoride |
Copper(II) chromate | 13548-42-0 | CuCrO4 | 179.54 | COPPER(II)CHROMATE(VI); Chromic acid (H2CrO4), copper(2+) salt (1:1) |
Copper(II) 4,4',4'',4'''-tetraaza-29H,31H-phthaloCyanine | 15275-52-2 | C28H12CuN12 | 580.02 | COPPER(II) 4 4' 4'' 4'''-TETRAAZA-29H 3&; copper(ii) 4,4',4'',4'''-tetraaza-29H,31H-phthalo; Copper(II) 4,4',4'',4'''-tetraaza-29H,31H-phthalocyanine |
Copper(II) 2-ethylhexanoate | 149-11-1 | C8H16CuO2++ | 349.95 | |
Copper(II) 1,2,3,4,8,9,10,11,15,16,17,18,22,23,24,25-hexadecafluoro-29H,31H-phthaloCyanine | 14916-87-1 | C32CuF16N8 | 863.92 | COPPER 1 2 3 4 8 9 10 11 15 16 17 18 22&; COPPER 1,2,3,4,8,9,10,11,15,16,17,18,22, 23,24,25-HEXADECAFLUORO-PHTHALOCYANINE; F16CuPc; Copper(ll) 1,2,3,4,8,9,10,11,15,16,17,18,22,23,24,25-hexadecafluoro-29H,31H-phthalocyanine; 1,2,3,4,8,9,10,11,15,16,17,18, |
Copper(I) trifluoromethanesulfonate toluene complex | 48209-28-5 | C9H8Cu2F6O6S2 | 517.37 | Copper(I) triflate toluene complex, CuOTf-toluene, Cuprous trifluoromethanesulfonate toluene complex, Trifluoromethanesulfonic acid copper(I) salt toluene complex |
Copper(I) Triflate Benzene Complex | 42152-46-5 | C8H6Cu2F6O6S2 | 251.67 | Copper(I)triflatebenzenecomplex; 42152-46-5; Trifluoromethanesulfonicacidcopper(I)saltbenzenecomplex; AC1MC1UT; benzene; copper(1+) |
COPPER(I) HEXAFLUORO-2,4-PENTANEDIONATE-CYCLOOCTADIENE COMPLEX | 86233-74-1 | C13H13CuF6O2 4* | 378.78 | COPPER I HEXAFLUOROPENTANEDIONATE CYCLOOCTADIENE COMPLEX; COPPER(I) HEXAFLUORO-2,4-PENTANEDIONATE-CYCLOOCTADIENE COMPLEX; Copper(I) hexafluoroacetylacetonate cyclooctadiene complex; copper(i) hexafluoroacetylacetonate; Copper(I) hexafluoro-2,4-pentanedion |
Copper(I) chloride | 7758-89-6 | CuCl | 99 | chloridmedny; Copper chloride (CuCl); copperchloride(cucl); coppermonochloride; CuCl; Cu-lyt; Cuproid; cuprouschloride(cu2cl2) |
Copper sulfide (Cu2S) | 22205-45-4 | Cu2S | 159.14 | copper(i); coppersulfide(cu2s); cuprasulfide; cuproussulfide(cu2s); dicoppermonosulfide; dicoppersulfide; COPPER(I) SULFIDE; COPPER SULFIDE |
Copper nitrite | 14984-71-5 | CuN2O4 | 155.557;g/mol | copper; dinitrite; Coppernitrite; 14984-71-5; Cupricnitrite; Dinitrousacidcopper(II)salt |
Copper nitrate basic | 12158-75-7 | Cu2(OH)3NO3 | 480.22 | Tetrakupfer(II)hexahydroxynitrat; Basic copper nitrate; Copper nitrate basic; Cupric nitrate,basic; Cupric hydroxide nitrate; Dicopper nitrate trihydroxide; Trihydroxo(nitrato)dicopper |
Copper methylsulfonate | 54253-62-2 | 253.73 | ||
COPPER I / II HEXAFLUOROPENTANEDIONATE - VINYLTRIMETHYLSILANE COMPLEX | 139566-53-3 | C10H13F6O2CuSi | 0 | COPPER I / II HEXAFLUOROPENTANEDIONATE - VINYLTRIMETHYLSILANE COMPLEX |
Copper dilaurate | 19179-44-3 | C24H46CuO4 | 462.16564;g/mol | copper;dodecanoate;Copperdilaurate;19179-44-3;CopperLaurate;SCHEMBL191539 |
Copper chromite | 12018-10-9 | Cu2Cr2O5 | 311.08 | |
copper 5-oxopyrrolidine-2-carboxylate | 15454-74-7 | C10H12CuN2O6 | 319.758 g/mol | |
Copovidone | 25086-89-9 | Poly(1-vinylpyrrolidone-co-vinyl acetate); PVP/VA copolymer | ||
CoPo 22 | 606101-83-1 | C22H22N4O2 | 374.44 | ASN 06744166; N-(2-((3-Cyano-5,7-dimethylquinolin-2-yl)amino)ethyl)-3-methoxybenzamide; N-[2-[(3-cyano-5,7-dimethylquinolin-2-yl)amino]ethyl]-3-methoxybenzamide |
copanlisib hydrochloride | 1402152-13-9 | C23H30Cl2N8O4 | 553.445 | Aliqopa; Copanlisib dihydrochloride; UNII-03ZI7RZ52O; 03ZI7RZ52O; BAY 80-6946 dihydrochloride; BAY-80-6946 dihydrochloride |
Copanlisib | 1032568-63-0 | C23H28N8O4 | 480.529 | BAY 80-6946; Aliqopa; BAY-80-6946; 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide |
COPAIBA OIL | 8001-61-4 | COPAIBA OIL; balsamcapivi; Balsamcopaiba,dewaxed; Balsams,copaiba; Copaibabalsamextract; copaibaoleoresin; jesuit'sbalsam; Copaibabalm | ||
CONVULXIN | 37206-04-5 | 0 | CONVULXIN | |
Continentalic acid | 19889-23-7 | C20H30O2 | 302.45 | Pimaradienoic acid; Pimara-8(14),15-diene-19-oic acid |
Conquinine | 56-54-2 | C20H24N2O2 | 324.42 | Quinidine;Chinidin;Pitayine;(+)-Quinidine;Quinidex;Chinidin;(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol |
Conquinamine | 464-86-8 | C19H24N2O2 | 312.41 | Epiquinamine,3-epi-Quinamine |
Conophylline | 142741-24-0 | C44H50N4O10 | 794.9 | Polyervine; [8,15'-Biaspidospermidine]-3,3'-dicarboxylicacid,2,2',3,3'-tetradehydro-6',7':7,16'-diepoxy- 6,15-dihydroxy-16,17-dimethoxy-,dimethyl ester, (5a,6b,7a,8a,12b,19a)-(5'a,6'b,7'b,12'b, 19'a)-; 2H,22H-Indolo[2'',3'':7',8']pyrrolo[1'',2'',3 |
Conoidin A | 18080-67-6 | C10H8Br2N2O2 | 348 | 2,3-Bis(bromomethyl)quinoxaline 1,4-dioxide |
Conodurine | 2665-57-8 | C43H52N4O5 | 704.912 | |
Conocarpan acetate | 56319-04-1 | C20H20O3 | 308.37 | [4-[(2R,3R)-3-methyl-5-[(E)-prop-1-enyl]-2,3-dihydro-1-benzofuran-2-yl]phenyl] acetate |
Conjugated Estrogen | 12126-59-9 | C18H19NaO5S | 370.40 | Equilin sodium sulfate; Sodium equilin sulfate |
Conjugated (9Z,11E)-linoleic acid | 2540-56-9 | C18H32O2 | 280.45 | Conjugated (9Z,11E)-linoleic acid; Conjugated Linoleic Acid (9Z,11E) |
Conivaptan-d4 | 1129433-63-1 | C32H22N4O2D4 | 502.61 | |
Conivaptan hydrochloride Impurity I | 717917-14-1 | |||
Conivaptan hydrochloride Impurity H | 29489-04-1 | |||
Conivaptan hydrochloride Impurity G | 168626-93-5 | |||
Conivaptan hydrochloride Impurity E | 877858-27-0 | |||
Conivaptan hydrochloride Impurity D | 168626-74-2 | |||
Conivaptan Hydrochloride | 168626-94-6 | C32H26N4O2.HCl | 535.04 | N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-Biphenyl]-2-carboxamide Hydrochloride; Vaprisol; YM 087 |
Conivaptan | 210101-16-9 | C32H26N4O2 | 498.58 | Conivaptan;210101-16-9;YM087;Conivaptan(INN);Conivaptan[INN];UNII-0NJ98Y462X |
Coniferyl ferulate | 63644-62-2 | C20H20O6 | 356.37 | [(E)-3-(4-Hydroxy-3-methoxyphenyl)prop-2-enyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate |
Coniferyl alcohol | 32811-40-8 | C10H12O3 | 180.203 | Coniferol; Coniferylalcohol; 4-(3-hydroxyprop-1-en-1-yl)-2-methoxyphenol; Gamma-Hydroxyisoeugenol; 4-[(E)-3-hydroxyprop-1-enyl]-2-methoxyphenol |
Coniferin | 531-29-3 | C16H22O8 | 342.34 | 4-(3-Hydroxy-1-propen-1-yl)-2-methoxyphenyl b-glucopyranoside; 4-Hydroxy-3-methoxy-1-(gamma-hydroxypropenyl)benzene-4-D-glucoside; Abietin |
Coniferin | 124151-33-3 | C16H22O8 | ||
Citraconic acid dimethyl ester | 617-54-9 | C7H10O4 | 158.15 | 2-Butenedioic acid, 2-methyl-, dimethyl ester (Z)-; 2-methyl-,dimethylester,(z)-2-butenedioicaci; 2-Methyl-but-2-enedioic acid dimethyl ester, Z; cis-2-methyl-2-butenedioicacid,dimethylester; cis-2-methyl-but-2-enoicaciddimethylester; Dimethyl (2Z)-2-meth |
Citicoline Sodium Salt | 33818-15-4 | C14H25N4O11P2. Na | 510.31 | Cytidine 5'-(Trihydrogen Diphosphate) P'-[2-(Trimethylammonio)ethyl] Ester Inner Salt Sodium Salt; Acticolin; Brassel; Cebroton; Cidifos; Citicoline Sodium; Flussorex; Gerolin; IP 302 Sodium; Logan; Neurotron; Sinkron |
Citicoline | 987-78-0 | C14H26N4O11P2 | 488.327 | Cytidine 5'-diphosphocholine; CDP-choline; Citicholine; Citidoline; Cytidoline |
Ciprofloxacin-d8 HCl | 1216659-54-9 | C17H10FN3O3D8·HCl | 375.85 | 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl-d8)-3-quinolinecarboxylic Acid Hydrochloride; Bay q 3939-d8 Hydrochloride |
Ciprofloxacin-d8 | 1130050-35-9 | C17H10D8FN3O3 | 339.39 | 1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-d8-1-yl-1,4-dihydro-quinoline-3-carboxylic acid |
Ciprofloxacin Related Compound | 528851-30-1 | C15H16ClN3O3. HCl | 321.77 36.46 | 6-(2-aminoethylamino)-7-chloro-1-cyclopropyl-4-oxo-quinoline-3-carboxylic acid hydrochloride; |
Ciprofloxacin N-Oxide | 860033-22-3 | C17H18FN3O4 | 347.35 | 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(1-oxido-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid; |
Ciprofloxacin Lactate | 97867-33-9 | C20H22FN3O5 | 403.4 | 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid lactate; CIPROFLOXACIN LACTATE; mono(2-hydroxypropanoate); Ciprofloxacin lactate CP2000; 85721-33-1; Ciprofloxacine lactate; CIPROFLOXACIN-QACID |
Ciprofloxacin Impurity E | 105394-83-0 | C16H18FN3O | 287.34 | 1-Cyclopropyl-6-fluoro-7-(1-piperazinyl)-4(1H)-quinolinone; |
Ciprofloxacin Impurity D HCl | 526204-10-4 | C17H19Cl2N3O3 | 384.3 | Ciprofloxacin Impurity D hydrochloride; USP Ciprofloxacin Related Compound A |
Cilostazol | 73963-72-1 | C20H27N5O2 | 369.46 | AT2266; CI919; Pd107779; NSC629661; AT 2266; CI 919; Pd 107779; NSC 629661; AT-2266; CI-919; Pd-107779; NSC-629661 |
Cilostamide | 68550-75-4 | C20H26N2O3 | 342.44 | OCP 3689; N-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide; 6-[3-(N-Cyclohexyl-N-methylcarbamoyl)propoxy]quinolin-2[1H]-one |
Cilomilast | 153259-65-5 | C20H25NO4 | 343.423 | Cilomilast; Ariflo; SB-207499. |
Cilofungin | 79404-91-4 | C49H71N7O17 | 1030.13 | |
Cilofexor | 1418274-28-8 | C28H22Cl3N3O5 | 586.9 | 2-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl]methoxy]phenyl]-3-hydroxy-1-azetidinyl]-4-pyridinecarboxylic acid |
Cilobradine hydrochloride | 186097-54-1 | C28H39ClN2O5 | 519.07 | 3-[[(3S)-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one;hydrochloride 1,3,4,5-tetrahydro-7,8-dimethoxy-3-((1-(2-(3,4-dimethoxyphenyl)ethyl)-3-piperidinyl)methyl)-2H-3-benzazepin-2-one hydrochloride |
Cilnidipine | 132203-70-4 | C27H28N2O7 | 492.52 | FRC-8653 |
Coniferaldehyde | 20649-42-7 | C10H10O3 | 178.2 | 4-Hydroxy-3-methoxycinnamaldehyde |
Congo Red | 573-58-0 | C32H22N6Na2O6S2 | 696.66 | 1-Naphthalenesulfonic acid, 3,3'-((1,1'-biphenyl)-4,4'-diylbis(azo))bis(4-amino-, disodium salt; C.I. #22120, Direct Red; 3,3'-[(1,1'-Biphenyl)-4,4'-diyl-bis(2,1-diazenediyl)]bis(4-amino-1-naphthalenesulfonic acid) disodium salt |
CongmunosideVII | 340982-22-1 | C54H88O24 | 1121.28 | Congmunoside VII |
Conglobatin | 72263-05-9 | C28H38N2O6 | 498.6 | |
Confluentin | 585534-03-8 | C22H30O2 | 326.5 | (2R)-2-[(3E)-4,8-Dimethyl-3,7-nonadien-1-yl]-2,7-dimethyl-2H-chro men-5-ol |
Confluentic acid | 6009-12-7 | C28H36O8 | 500.6 | 2-Hydroxy-4-methoxy-6-(2-oxoheptyl)benzoic acid 4-carboxy-3-methoxy-5-pentylphenyl ester;2-Methoxy-4-[2-(2-oxoheptyl)-4-methoxy-6-hydroxybenzoyloxy]-6-pentylbenzoic acid;Confluentin acid |
Conduritol D | 4782-75-6 | C6H10O4 | 146.14 | (1R,2R,3S,4S)-rel-5-cyclohexene-1,2,3,4-tetrol |
Conduritol B epoxide | 6090-95-5 | C6H10O5 | 162.1 | CBE; 1,2-anhydro-myo-inositol |
Concanavalin A | 11028-71-0 | C15H24 | 0 | CON A TYPE IV; CONCANAVALIN A, CANAVALIA ENSIFORMIS; CONCANAVALIN A; CON A; CONCANAVALIN A TYPE V; CONCANAVALIN A TYPE VI; CONCANAVALIN A, JACK BEAN; CONCANAVALIN A TYPE III |
Concanamycin C | 81552-34-3 | C45H74O13 | 823.1 | 4'-O-de(aminocarbonyl)-Concanamycin A |
Concanamycin B | 81552-33-2 | C45H73NO14 | 851.5 | S 45B |
Concanamycin A | 80890-47-7 | C46H75NO14 | 866.1 | Folimycin, TAN 1323B |
Conantokin-T | 127476-26-0 | C110H175N31O45S | 2683.80 | |
Conantokin-R | 202925-60-8 | C127H201N35O49S3 | 3098.40 | |
Compstatin control peptide | 301544-78-5 | C66H101N23O17 | 1488.67 | |
Compound W | 173550-33-9 | C19H12N2O8 | 396.31 | 3,5-bis(4-Nitrophenoxy)benzoic acid; 173550-33-9; gamma-Secretase Modulator, CW; ACMC-1CUIP; SCHEMBL264541; CHEMBL1553155; CTK8B1007; JOSXKPZXMVHRKU-UHFFFAOYSA-; DTXSID10587892; JOSXKPZXMVHRKU-UHFFFAOYSA-N; HMS3269J17; ZINC2576957; ANW-22664; MFCD020934 |
Compound 56 | 171745-13-4 | C18H18BrN3O2 | 388.3 | N-(3-bromophenyl)-6,7-diethoxy-4-quinazolinamine |
Compound 48/80 trihydrochloride | 94724-12-6 | C32H46N3O3.3HCl | 687.7 | R 24571; R 24571 CHLORIDE; COMPOUND 48/80; COMPOUND 48/80 TRIHYDROCHLORIDE; COMPOUND R24571; CALMODULIN INHIBITOR R 24571; CALMIDAZOLIUM; CALMIDAZOLIUM CHLORIDE |
Compound 48/80 hydrochloride | 848035-21-2 | C32H45N3O3·3HCl | 629.1 | 4-methoxy-3,5-bis[[2-methoxy-5-[2-(methylamino)ethyl]phenyl]methyl]-N-methyl-benzeneethanamine trihydrochloride |
Compound 43 TAO Kinase Inhibitor | 850467-66-2 | C25H24N2O2 | 384.47 | N-[2-oxo-2-[(1,2,3,4-tetrahydro-1-naphthalenyl)amino]ethyl]-[1,1'-biphenyl]-4-carboxamide |
Compound 401 | 168425-64-7 | C16H15N3O2 | 281.31 | 2-morpholin-4-ylpyrimido[2,1-a]isoquinolin-4-one Compound 401 168425-64-7 2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one CHEMBL179242 2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one SCHEMBL10092321 CTK4D2994 S-7713 2-(morpholin-4-yl)pyrimido[ |
Coenzyme Q10 (Ubiquinones ) | 2382-48-1 | Coenzyme Q10 (Ubiquinones ); Ubichromenol | ||
Colchicine fluorescein | 66091-34-7 | C41H34N2O10S | 746.79 | |
Complanatuside A | 116183-66-5 | C28H32O16 | 624.54 | Complanatuside; 3-(beta-D-Glucopyranosyloxy)-2-[4-(beta-D-glucopyranosyloxy)phenyl]-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one |
Complanatoside A | 146501-37-3 | C27H30O18 | 3-(beta-D-Glucopyranosyloxy)-2-[4-(beta-D-glucopyranosyloxy)-3,5-dihydroxyphenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one; Myricetin 3,4'-diglucoside | |
Commendamide | 193825-78-4 | C18H35NO4 | 329.5 | N-acyl-3-hydroxypalmitoyl-Glycine; 2-(3-hydroxyhexadecanoylamino)acetic acid |
Colutehydroquinone | 181311-16-0 | C18H20O6 | 332.35 | (R)-Colutehydroquinone |
Coluracetam | 135463-81-9 | C19H23N3O3 | 341.4 | MKC-231; MKC 231; MKC231 |
Colupulone | 468-27-9 | C25H36O4 | 400.56 | |
COLUMBIUM PENTAFLUORIDE | 7783-68-8 | F5Nb | 187.9 | (betab-5-11)-niobiumfluoride(nbf5; NIOBIUM FLUORIDE; NIOBIUM PENTAFLUORIDE; NIOBIUM(V) FLUORIDE; COLUMBIUM PENTAFLUORIDE; Niobium(V)fluoride,99%; Niobium(V)fluoride,99.5%; Niobium pentafluoride 99.5% |
Columbin | 546-97-4 | C20H22O6 | 358.39 | (1R,4R,4aR,6aR,9S,10aS,10bS)-9-(3-Furanyl)-1,4,4a,5,6,6a,9,10,10a,10b-decahydro-4-hydroxy-4a,10a-dimethyl-1,4-etheno-3H,7H-benzo[1,2-c:3,4-c']dipyran-3,7-dione |
Columbianetin acetate | 23180-65-6 | C16H16O5 | 288.3 | (+)-Columbianetin acetate; (S)-Columbianetin acetate; O-Acetylcolumbianetin |
Columbianetin | 3804-70-4 | C14H14O4 | 246.26 | 2H-Furo(2,3-h)-1-benzopyran-2-one, 8,9-dihydro-8-(1-hydroxy-1-methylet hyl)-, (S)- |
Columbianadin | 5058-13-9 | C19H20O5 | 328.36 | (S)-8-[1-[(Z)-2-Methyl-2-butenoyloxy]-1-methylethyl]-8,9-dihydro-2H-furo[2,3-h]-1-benzopyran-2-one; Columbianadin; ColuMbianin; ZosiMin; Columbianetin angelate |
Columbamine hydrochloride | 1916-10-5 | C20H20NO4Cl | 373.84 | |
Columbamine | 3621-36-1 | C20H20NO4 | 338.38 | Dehydroisocorypalmine; 2-hydroxy-3,9,10-trimethoxy-5,6-dihydroisoquino[3,2-a]isoquinolinium; 3,9,10-trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-2-ol |
Colterol-D9 acetate | 1420043-63-5 | 4-(2-tert-Butyl-D9-amino- 1-hydroxy-ethyl)- benzene-1,2-diol acetate | ||
Colterol acetate | 10255-14-8 | C14H23NO5 | 285.336 | 4-(2-tert-Butylamino-1-hydroxyethyl)-benzene-1,2-diol acetate |
Color developing agent CD-3 | 24567-76-8 | 2(C12H21N3O2S).3(H2SO4).2(H2O) | 873.01 | 4-Ethyl-N4-(2-methanesulfonamidoethyl)-2-methyl-1,4-phenylenenediaminesesquisulfate,monohydrate; 4-(N-ETHYL-N-2-METHANESULFONYLAMINOETHYL)-2-METHYLPHENYLENEDIAMINE; 4-(N-Ethyl-N-2-methanesulfonylaminoethyl)-2-methylphenylenediamine 1.5-H2SO4; CD3; N-4-ETH |
Colominic acid sodium salt - Average MW 30,000 | 70431-34-4 | (C11H16NNaO8)n | Poly[2,8-(N-acetylneuraminic acid sodium salt)] | |
Collismycin | 158792-24-6 | C13H13N3O2S | 275.3 | SF 2738A |
Collagens polypeptide | 9007-34-5 | Collagenpowder; collagens; BOVINE COLLAGEN TYPE II; COLLAGEN TYPE IV, HUMAN; COLLAGEN, TYPE IV, HUMAN PLACENTA; COLLAGEN TYPE IV (HU PLACENTA); COLLAGEN TYPE V (HU PLACENTA); COLLAGEN, TYPE 5 | ||
Collagen proline hydroxylase inhibitor-1 | 223663-32-9 | C24H21N5O4 | 443.45 | 1,10-Phenanthrolin-4(1H)-one, 3-nitro-8-[[4-(phenylmethyl)-1-piperazinyl]carbonyl]- |
Collagen proline hydroxylase inhibitor | 223666-07-7 | C18H18N4O4 | 354.36 | 1,10-Phenanthroline-3-carboxamide, N-ethyl-7,10-dihydro-8-nitro-7-oxo-N-propyl- |
Collagen hydrolysate | 92113-31-0 | CO(NH2)2,Fe+++ | 0 | Collagen hydrolysate; Hydrolyzed beef protein powder |
Colivelin | 867021-83-8 | C119H206N32O35 | 2645.13 | H-Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala-Pro-Ala-Gly-Ala-Ser-Arg-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro-OH; 18:PN: WO2008153788 SEQID: 9 claimed sequence; 19: PN: WO2007096859 SEQID: 28unclaimed sequence; 340: PN: WO2008115525 SEQID: 218 unclaimed seque |
Colitose | 4221-05-0 | C6H12O4 | 148.16 | 3,6-Dideoxy-L-xylo-hexose; L-Colitose |
Colistin sulfate | 1264-72-8 | [C52H98N16O13]2·5H2SO4 | 2801.3 | Polymyxin E Complex; Colistin, sulfate salt (2:5) |
Colistin sodium methanesulfonate | 8068-28-8 | C58H115N16Na5O28S5 | 1759.90 | |
Colistimethate sodium | 30387-39-4 | |||
Colipase | 55126-92-6 | |||
Colestipol hydrochloride | 37296-80-3 | C11H28ClN5O.HCl | 318.29 | COLESTIPOL HCL; COLESTIPOL HYDROCHLORIDE; N-(2-AMINOETHYL)-N'-[2-[(2-AMINOETHYL)AMINO]ETHYL]-1,2-ETHANEDIAMINE POLYMER WITH (CHLOROMETHYL)OXIRANE HYDROCHLORIDE; n'-(2-aminoethyl)-n-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine 2-(chloromethyl)oxirane hyd |
Colestipol | 50925-79-6 | C11H28ClN5O | 281.82592;g/mol | COLESTIPOL; Colestid; Cholestabyl; Colestipolum; Colestipolum[INN-Latin]; Epichlorohydrin-tetraethylenepentaminepolymer |
Colestilan | 95522-45-5 | C6H9N2OX2.Cl | 160.603 | Colestilan; Colestilan chloride; Colestimide; Epichlorohydrin-2-methylimidazole copolymer |
Colesevelam Methoxyquat Impurity | 863031-14-5 | C10H24NOI | 301.21 | |
Colesevelam Hydroxyquat Impurity | 676578-21-5 | C9H22NOCl | 195.73 | |
Colesevelam hydrochloride | 182815-44-7 | (C13H27N)n.(C12H27ClN2)n.(C3H7N)n.(C3H5ClO)n.xHCl | CholestaGel; GT 31-104; GT 31-104HB; Welchol | |
Colesevelam Aminoquat Impurity HBr | 33968-67-1 | C9H24N2Br2 | 320.11 | (6-Aminohexyl)trimethylammonium Bromide Hydrobromide |
Colemanite (CaH(BO2)3.2H2O) | 1318-33-8 | 0 | Colemanite (CaH(BO2)3.2H2O) | |
Cohumulone | 511-25-1 | C20H28O5 | 348.44 | |
Coffee bean oil | 8001-67-0 | COFFEE OIL; Coffeebeanextract; Coffeeessence; Oils,coffee; Roastedcoffeeresinoid; Coffeebeanoil; Coffeebeanoil,CoffeeOil; ARABICACOFFEEOIL | ||
Coenzyme Q9 | 303-97-9 | C54H82O4 | ||
COENZYME Q2 | 606-06-4 | C19H26O4 | 318.41 | COENZYME Q2; 2,3-DIMETHOXY-5-METHYL-GERANYL-1,4-BENZOQUINONE; 2,3-dimethoxy-5-methyl-6-[poly0-2-methylbutenyl(2)]-1,4-quinone; 2,3-dimethoxy-5-methyl-6-geranyl-1,4-benzoquinone; 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5,6-dimethoxy-3-methyl-cyclohexa-2,5-die |
Coenzyme Q10-d6 | 1331655-96-9 | C59H84O4D6 | 869.38 | (all-E)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-(dimethoxy-d6)-3-methyl-2,5-cyclohexadiene-1,4-dione; Bio-Quinone Q10-d6; CoQ10-d6; Cosmesome Q 10-d6; Ensorb-d6; Kaneka Q10-d6; Kudesan-d6; Li-Q-Sorb-d6 |
Coenzyme Q10 | 303-98-0 | C59H90O4 | 863.34 | CoQ10 |
Palmitoyl coenzyme A potassium salt | 1763-10-6 | C37H65N7O17P3SK | 1044.03 | palmitoyl-CoA; Coenzyme A S-hexadecanoate; S-palmitoylcoenzyme A; PALMITOYL COENZYME A,K SALT; potassium [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[(3R)-4-[[3-(2-hexadecanoylsulfanylethylamino)-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-hydrox |
Coenzyme A, S-(hydrogen3-hydroxy-3-methyl pentanedioate), disodium salt (9CI) | 103476-21-7 | C27H44 N7 O20 P3 S . 2 Na | 1009.67 | (DL-3-HYDROXY-3-METHYLGLUTARYL) COENZYM&; (dl-3-hydroxy-3-methylglutaryl) coenzyme A so-salt trihydr.; DL-3-HYDROXY-3-METHYLGLUTARYL COENZYME*A SODIUM; (DL-3-HYDROXY-3-METHYLGLUTARYL) COENZYME A DISODIUM SALT, 95%; DL-3-Hydrxy-3-methylglutaryl-coenzym A |
Coenzyme A Trilithium Salt | 18439-24-2 | C21H33Li3N7O16P3S | 785.33 | CoA Trilithium Salt; Trilithium Coenzyme A |
COENZYME A SODIUM SALT | 55672-92-9 | C21H35N7NaO16P3S | 789.52 | COENZYME A DISODIUM SALT; COENZYME A SODIUM SALT; COENZYME A SODIUM SALT HYDRATE; COENZYME A TRISODIUM SALT; COA NA2; coenzyme A sodium from yeast; COENZYME A, SODIUM CELL CULTURE TESTED; CoenzymeA hydrate sodium salt |
Coenzyme A | 85-61-0 | C21H36N7O16P3S | 767.53 | Coenzyme a, free acid |
Codergocrine mesilate | 8067-24-1 | C20H29N3O5S | 423.53 | Dihydroergotoxine mesylate;Dihydroergotoxine methanesulfonate;Dihydroergotoxine methanesulphonate;Dihydroergotoxine monomethanesulfonate(salt);Ergoloid mesylates |
Codaphniphylline | 14694-15-6 | C30H47NO3 | 469.7 | 23-[(1R,4R,5S)-1,4-Dimethyl-2,8-dioxabicyclo[3.2.1]oct-4-yl]daphnan-23-one |
Cocoyl chloride | 68187-89-3 | |||
Coconut oil, reaction products with diethanolamine | 8051-30-7 | 0 | Coconut oil, reaction products with diethanolamine; COCO-AMIDES; diethanolamine cocoate | |
Coconut oil | 8001-31-8 | Mixture | Coconut fat; Copra oil | |
Coconut dimethyl amine oxide | 61788-90-7 | alkyl(c10-16)dimethylamine; alkyl(c10-16)dimethylamineoxide; Amines,cocoalkyldimethyl,N-oxides; coconutdimethylamineoxide; N,N-Dimethyl(coconutoilalkyl)amineoxide; COCO DIMETHYLAMINE OXIDE; COCAMINE OXIDE; Amine oxides, cocoalkyldimethyl | ||
Coconut bis-(2-hydroxyethyl) methyl ammonium chloride | 70750-47-9 | |||
Coconut amine ethoxylate ether (5EO) | 61791-14-8 | Coconut amine ethoxylate ether (5EO); Coconut amine ethoxylate ether (15EO) | ||
Coconut alkyl trimethyl ammonium chloride | 61789-18-2 | 0 | Quaternary ammonium compounds, coco alkyltrimethyl, chlorides; COCOTRIMONIUM CHLORIDE; Coconutalkyltrimethylammoniumchloride; (Coconut oil alkyl) trimethylammonium chloride; Cocoyl trimethyl ammonium chloride; ARQUADC; Quaternare Ammoniumverbindungen, Kok | |
Coco-caprylate/caprate | 95912-86-0 | Fatty acids, C8-10, C12-18-alkyl esters | ||
Cocoamine acetate | 61790-57-6 | 0 | alkylamine; alkylamineacetate; amines,cocoalkyl,acetates; Amine, Kokos-alkyl-, Acetate; Cocamine acetate | |
Cocoamidopropyl dimethyl amine | 68140-01-2 | |||
Cocoamidopropyl betaine | 86243-76-7 | 0 | Cocoamidopropyl betaine; Aerosol 30; 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-coco acyl derivs., hydroxides, inner salts; Alkateric cab-a; Coco amido betaine; Einecs 263-058-8; N-(3-Cocoamidopropyl)-N,N-dimethyl-N-carboxymethyl betaine; | |
Cocoa, ext. | 84649-99-0 | 0 | Cocoa, ext.; THEOBROMA CACAO (COCOA) EXTRACT; Cocoaextract; CACAO EXTRACT; COCOAPOWDEREXTRACT | |
Cocoa Butter | 8002-31-1 | |||
Coco amine | 61788-46-3 | C38H46N2O8 | Coco amine; Coconut amine | |
Coco Alkyldimethyl Betaine | 68424-94-2 | Betaines, coco alkyldimethyl; Alkyl(C8-C18) aminobetaine; Betaine, Kokos-alkyldimethyl-; N-(Cocoalkyl)-N,N-dimethylbetaine; N-coco-N-dimethylcarboxymethylene betaines | ||
Coco alkyl dimethyl benzyl ammonium chloride | 61789-71-7 | 0 | Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides; Cocoalkyldimethylbenzylammoniumchloride; C8-18ALKYLDIMETHYLBENZYLAMMONIUMCHLORIDE; ALKYL(C8-C18)DIMETHYLBENZYLAMMONIUMCHLORIDE; Quaternare Ammoniumverbindungen, Benzyl-kokos-alkyldimethyl | |
Coclaurine Related Compound 1 | 138644-99-2 | C18H22ClNO4 | 351.8 | (S)-3'-Hydroxy-N-methylcoclaurine Hydrochloride; (S)-4-[(1,2,3,4-Tetrahydro-7-hydroxy-6-methoxy-2-methyl-1-isoquinolinyl)methyl]-1,2-benzenediol Hydrochloride |
Coclaurine | 486-39-5 | C17H19NO3 | 285.3 | (1S)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol |
Coclauril | 127350-68-9 | C8H9NO2 | 151.165 | (2E)-2-[(4R,6S)-4,6-dihydroxycyclohex-2-en-1-ylidene]acetonitrile |
Cocinic acid | 61788-47-4 | 0 | Cocinic acid; Fatty acids of coconut oil; Fatty acids of coconut oil, distilled | |
Cochlioquinone B | 32450-26-3 | C28H40O6 | 472.6 | |
Cochlioquinone A | 32450-25-2 | C30H44O8 | 532.7 | Luteoleersin |
Cochineal | 1343-78-8 | C22H20O13 | 492.39 | Carmine |
Cochinchinenin C | 956103-79-0 | C33H34O7 | 542.62 | |
Cochinchinenin | 400603-95-4 | C31H30O7 | 514.56 | |
Coccinic acid | 107783-45-9 | C30H46O3 | 454.7 | |
Coccineone B | 135626-13-0 | C16H10O6 | 298.25 | 6,9,11-Trihydroxy-6H-chromeno[3,4-b]chromen-12-one; [1]Benzopyrano[3,4-b][1]benzopyran-12(6H)-one,6,9,11-trihydroxy- |
Cocarboxylase Tetrahydrate | 68684-55-9 | C12H18N4O7P2S 4H2O | 496.37 | Thiamine diphosphoric acid ester |
Cocamidopropyl Betaine | 61789-40-0 | C19H38N2O3 | 342.53 | 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-coco acyl derivs., hydroxides, inner salts; NorfoxCapb; 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-coco acyl derivs., inner salts; N-Cocamidopropyl-N,N-dimethylglycine inner salt |
Cobratoxin | 12584-83-7 | C277H443N97O98S8 | 0 | ALPHA-COBRATOXIN FROM NAJA ATRA; Cobrotoxin |
COBRATEC(R) 122 | 80584-90-3 | C24H42N4 | 386.62 | COBRATEC(R) 122; N,N-BIS-(2-ETHYLHEXYL)-AR-METHYL-1H-BENZOTRIAZOLE-1-METHANAMINE; 1H-Benzotriazole-1-methanamine,N,N-bis(2-ethylhexyl)-4-methyl-(9Cl); n,n-bis(2-ethylhexyl)-4-methyl-1h-benzotriazole-1-methanamin; N,N-bis(2-ethylhexyl)-4-methyl-1H-benzotri |
COBINAMIDE DICYANIDE | 27792-36-5 | C50H73CoN13O8 | 1043.13 | ETIOCOBALAMIN, FACTOR B; COBINAMIDE DICYANIDE; dicyanocobinamide; etiocobalamin; Cobinamide dicyanide, Etiocobalamin, Factor B |
Cobimetinib racemate | 934662-91-6 | C21H21F3IN3O2 | 531.31 | GDC-0973 racemate; XL-518 |
Clorsulon | 60200-06-8 | C8H8Cl3N3O4S2 | 380.66 | |
Clinofibrate | 30299-08-2 | C28H36O6 | 468.58 | Clinofibrate |
Clinodiside G | 172335-97-6 | C48H78O20 | 975.12 | |
Clauszoline M | 187110-72-1 | C13H9NO3 | 227.22 | 2,8-Dihydroxy-9H-carbazole-3-carboxaldehyde |
Clausine Z | 866111-14-0 | C13H9NO3 | 227.2 | 1,6-Dihydroxy-9H-carbazole-3-carbaldehyde;3-formyl-1,6-dihydroxycarbazole |
Clausine I | 182261-94-5 | C14H11NO3 | 241.246 | 9H-Carbazole-3-carboxaldehyde,1-hydroxy-6- methoxy-; 1-hydroxy-6-methoxy-9H-carbazole-3-carbaldehyde |
Clausine D | 142846-95-5 | C18H17NO2 | 279.339 | 1-hydroxy-4-(3-methylbut-2-enyl)-9H-carbazole-3-carbaldehyde |
Clausenamide | 103541-15-7 | C18H19NO3 | 297.35 | Clausenamide |
Clary Sage Oil | 8016-63-5 | CAS: 8016-63-5 | 0 | FEMA 2321; CLARY SAGE OIL; SAGE OIL CLARY; Muscatel sage oil Salvia sclarea L.; Clary sage oil ester; SALVIA SCLAREA (CLARY) OIL; MUSCATEL SAGEOIL FROM SALVIA SCLAREA L., NATURAL; CLARY SAGE OIL FCC |
CK-636 | 442632-72-6 | C16H16N2OS | 284.38 | |
Clarithromycin Trityl Hydrazone | 1030374-65-2 | C57H85N3O12 | 1004.3 | |
Clarithromycin related compound M | 127182-43-8 | C37H68N2O13 | 748.94 | N-Desmethyl-6-O-methylerythromycin (9E)-Oxime; 3''-N-Demethyl-6-O-methylerythromycin A (E)-9-oxime; Oxacyclotetradecane Erythromycin deriv. |
Clarithromycin related compound I | 118058-74-5 | C30H55NO10 | 589.77 | |
Clarithromycin related compound H | 127140-69-6 | C38H67NO14 | 761.94 | N-Demethyl-N-formyl Clarithromycin; N-Demethyl-N-formyl-6-O-methylerythromycin; 3"-N-Demethyl-3""-N-formylclarithromycin; USP Clarithromycin Impurity H" |
Clarithromycin related compound C | 103450-87-9 | C38H70N2O13 | 762.97 | |
Clarithromycin N-Oxide | 118074-07-0 | C38H69NO14 | 763.95 | 6-O-Methylerythromycin N-Oxide; USP Clarithromycin Impurity Q |
Clarithromycin lactobionate | 135326-55-5 | 1106.25 | CLARITHROMYCIN LACTOBIONATE | |
Corypalmine | 6018-40-2 | C20H23NO4 | 341.4 | (13aS)-2,9,10-Trimethoxy-5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quinolizine-3-ol; |
Ciprofibrate Impurity A | 1474058-89-3 | C12H14O3 | 206.24 | 2-(4-Ethenylphenoxy)-2-methyl-propanoic Acid |
Ciprofibrate | 52214-84-3 | C13H14Cl2O3 | 289.15 | BRN 1984981; BRN1984981; BRN-1984981; CCRIS 173; CCRIS173; CCRIS-173; Ciprofibrate; WIN 35833; WIN35833; WIN-35833 |
Ciprefadol | 59889-36-0 | C19H27NO | 285.428 | |
Ciprazafone | 75616-03-4 | C19H18Cl2N2O2 | 377.26400 | |
Cinchonain Iia | 85081-23-8 | C39H32O15 | 740.66 | (2R,3R,4S,10R)-2,10-bis(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-3,5-dihydroxy-3,4,9,10-tetrahydro-2H-pyrano[2,3-h]chromen-8-one |
Cinchonain Ib | 85022-69-1 | C24H20O9 | 452.41 | (2R,3R,10S)-2,10-bis(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4,9,10-tetrahydro-2H-pyrano[2,3-f]chromen-8-one |
Cinchonain Ia | 85081-24-9 | C24H20O9 | 452.41 | (2R,3R,10R)-2,10-bis(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4,9,10-tetrahydro-2H-pyrano[2,3-f]chromen-8-one |
Cinchocaine Impurity B | 84906-81-0 | C10H7NO3 | 189.17 | 2-Hydroxyquinoline-4-Carboxylic Acid |
Cinanserin hydrochloride | 54-84-2 | C20H25N2OSCl | 376.94 | (E)-N-[2-[3-(Dimethylamino)propylsulfanyl]phenyl]-3-phenylprop-2-enamide hydrochloride; N-[2-[[3-(Dimethylamino)propyl]thio]phenyl]-3-phenyl-2-propenamide Hydrochloride; MAPTC; SQ 10643; 2'-[[3-(Dimethylamino)propyl]thio]cinnamanilide Hydrochloride |
Cobimetinib hemifumarate | 1369665-02-0 | C21H21F3IN3O2.1/2C4H4O4 | 589.35 | |
Cobimetinib (R-enantiomer) | 934660-94-3 | C21H21F3IN3O2 | 531.31 | GDC-0973 R-enantiomer; XL-518 R-enantiomer |
Cobimetinib | 934660-93-2 | C21H21F3IN3O2 | 531.31 | XL518; GDC-0973; RG7420 |
Cobicistat Impurity ((2S)-2-Amino-4-Meorpholine-4-yl-Butanoic Acid) | 854893-19-9 | C8H16N2O3 | 188.23 | |
Cobicistat | 1004316-88-4 | C40H53N7O5S2 | 776.028 | Cobicistat, GS-9350; GS 9350; GS9350 |
Cobamamide | 13870-90-1 | C72H100CoN18O17P | 1579.608 | Coenzyme B12; 5'-Deoxyadenosylcobalamine; Calomide |
Coal tar pitch,brown-coal | 100403-58-5 | |||
COAL TAR | 65996-92-1 | C14H18O4CLN5 | 0 | COAL TAR CRUDE; Coal Tar Pitch Volatiles (Benzene Soluble Fraction); Pitch, coal tar, high-temp.; Distillates (coal tar); CoalTarPitch; Pitch, coal tar, high temperature; Coal tar distillates.; Coal tar pitch volatiles. |
CO-1686 hydrobromide | 1446700-26-0 | C27H29BrF3N7O3 | 636.46 | N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;hydrobromide CO-1686 (hydrobromide) CO-1686 hydrobromide HY-15729A CS-5247 KB-310894 1446700-26-0 |
Co 102862 | 181144-66-1 | C14H12FN3O2 | 273.26 | [[4-(4-fluorophenoxy)phenyl]methylideneamino]urea; 4-(4-fluorophenoxy)benzaldehyde semicarbazone; Co 102862; Co-102862; FPhOBal semicarbazone; 181144-66-1; 2-(4-(4-Fluorophenoxy)benzylidene)hydrazinecarboxamide; Hydrazinecarboxamide, 2-[[4-(4-fluorophen |
Co 101244 hydrochloride | 193356-17-1 | C21H27NO3.HCl | 377.91 | 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-methylphenyl)methyl]piperidin-4-ol;hydrochloride; 4-hydroxy-N-(2-(4-hydroxyphenoxy)ethyl)-4-(4-methylbenzyl)piperidine; Co 101244; 193359-26-1 (Co 101244 free base); Co-101244; PD 174494; PD-174494 |
Co 101244 | 193359-26-1 | C21H27NO3 | 341.45 | 1-[2-(4-Hydroxyphenoxy)ethyl]-4-[(4-methylphenyl)methyl]-4-piperidinol; PD 174494; Ro 63-1908 |
CNX-774 | 1202759-32-7 | C26H22FN7O3 | 499.49638 | CNX-774; CNX 774; CNX774. |
CNX-2006 | 1375465-09-0 | C26H27F4N7O2 | 545.543 | CNX2006; CNX 2006; N-[3-[[2-[4-[[1-(2-fluoroethyl)azetidin-3-yl]amino]-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide |
CNX-1351 | 1276105-89-5 | C30H35N7O3S | 573.716 | CNX-1351; CNX 1351; CNX1351. |
CNQX disodium salt | 479347-85-8 | C9H2N4O4Na2 | 276.12 | 6-Cyano-7-nitroquinoxaline-2,3-dione disodium |
CNQX | 115066-14-3 | C9H4N4O4 | 232.15 | 7-nitro-2,3-dioxo-1,4-dihydroquinoxaline-6-carbonitrile; 1,4-dihydro-2,3-dihydroxy-7-nitro-6-quinoxalinecarbonitrile; 6 Cyano 2,3 dihydroxy 7 nitroquinoxaline; 6 Cyano 7 nitroquinoxaline 2,3 dione; 6-Cyano-2,3-dihydroxy-7-nitroquinoxaline; 6-Cyano-7-nitro |
Cnidioside B methyl ester | 158500-59-5 | C19H24O10 | 412.39 | methyl 3-[7-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1-benzofuran-5-yl]propanoate |
Cnidimol A | 103629-80-7 | C15H16O5 | 276.284 | (Z)-5,7-dihydroxy-6-(4-hydroxy-3-methylbut-2-en-1-yl)-2-methyl-4H-chromen-4-one |
Cnidilin | 14348-22-2 | C17H16O5 | 300.31 | Kinidilin; Isophellopterin; 9-methoxy-4-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one |
Cnidicin | 14348-21-1 | C21H22O5 | 354.4 | Kinidilin; Knidicin; 5,8-Diprenyloxypsoralen; 4,9-bis(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one |
CMPO | 83242-95-9 | C24H42NO2P | 407.57 | CMPO; N,N-bis-(2-Methylpropyl)-2-(octyl-phenylphosphoryl)acetamide; Octyl(phenyl)-N,N-diisobutylcarbamoylmethylphosphine oxide |
CMX 001 | 444805-28-1 | C27H52N3O7P | 561.70 | Brincidofovir; [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid; |
CMP-N-glycolylneuraminic acid | 98300-80-2 | C20H31N4O17P | 630.45 | N-(2-hydroxyacetyl)-b-neuraminic acid 2-(hydrogen 5-cytidylate); CMP-NeuGc |
CMP-NeuAc | 37399-47-6 | C20H29N4O16P.2Na | 658.415 | disodium; (2R,4S,5R,6R)-5-acetamido-2-[[(2S,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate; 37399-47-6; CMP-N-acetylneuraminicacidsodiumsalt |
CMP-N-acetylneuraminic acid sodium salt | 3063-71-6 | C20H30N4O16P Na | 636.43 | CMP-NANA; Cytidine 5-monophospho-b-D-N-acetylneuraminic acid sodium salt; CMP-Sialic Acid; CMP-Neu5Ac |
CMPF | 86879-39-2 | C12H16O5 | 240.25 | CMPF; 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid; 3-[(3-Carboxy-4-methyl-5-propylfuran)-2-yl]propionic acid; 3-Carboxy-4-methyl-5-propylfuran 2-propanoic acid; Furanic acid; Propylfuranoic acid |
CMPDA | 380607-77-2 | C16H28N2O4S2 | 376.53 | |
CMPD101 | 865608-11-3 | C24H21F3N6O | 466.46 | 3-[[[4-Methyl-5-(4-pyridinyl)-4H-1,2,4-triazol-3-yl]methyl]amino]-N-[[2-(trifluoromethyl)phenyl]methyl]benzamide |
CMPD-1 | 41179-33-3 | C22H20FNO2 | 349.4 | 4-[4-(2-fluorophenyl)phenyl]-N-(4-hydroxyphenyl)butanamide; MK2a Inhibitor; MAPKAPK2a Inhibitor; CMPD1; CHEMBL235658; 41179-33-3; IN1225; 4-(2′ -Fluorobiphenyl-4-yl)-N-(4-hydroxyphenyl)-butyramide; Mitogen-activated protein kinase-activated protein |
CMA | 38609-97-1 | C15H11NO3 | 253.25 | 9-Oxo-10(9H)-acridineacetic acid |
CM-352 | 1542205-83-3 | C24H29N3O6S | 487.57 | CM352; CM 352; CM-352; (R)-N-hydroxy-2-((4-(4-(methylcarbamoyl)phenoxy)phenyl)sulfonyl)-8-azaspiro[4.5]decane-2-carboxamide |
CM1 | 1643659-63-5 | C14H22N2O3 | 266.34 | |
Closantel Sodium | 61438-64-0 | C22 H13 Cl2I2N2O2.Na | 685.06 | |
Clozapine EP Impurity D | 65514-71-8 | C18H21ClN4O | 344.84 | [2-[(2-Amino-4-chlorophenyl)amino]phenyl](4-methyl-1-piperazinyl)methanone; 1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine |
CM 10 | 692269-09-3 | C20H23N3O | 321.42 | 2-(2-Propen-1-yl)-6-[[(1-propyl-1H-benzimidazol-2-yl)amino]methyl]phenol |
CLP 257 | 1181081-71-9 | C14H14FN3O2S | 307.34 | (5Z)-5-[(4-Fluoro-2-hydroxyphenyl)methylene]-2-(tetrahydro-1-(2H)-pyridazinyl)-4(5H)-thiazolone |
Clozapine-d8 | 1185053-50-2 | C18H11D8ClN4 | 334.87 | 8-Chloro-11-(4-methyl-1-piperazinyl-d8)-5H-dibenzo[b,e][1,4]diazepine; HF-1854-d8; Liponex-d8; |
Clozapine-d4 | 204395-52-8 | C18H15D4ClN4 | 330.85 | HF 1854-d4; Azaleptin-d4; Fazaclo-d4; Iprox-d4; Sizopin-d4 |
Clozapine-d3 | 1215691-72-7 | C18H16D3ClN4 | 329.84 | 8-Chloro-11-[4-(methyl-d3)-1-piperazinyl]-5H-Dibenzo[b,e][1,4]diazepine; HF-1854,-d3; Liponex-d3 |
Clozapine-5-N-Glucuronide | 390651-03-3 | C24H27ClN4O6 | 502.95 | |
Clozapine N-oxide dihydrochloride | 2250025-93-3 | C18H19ClN4O·2HCl | 415.74 | 8-Chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine dihydrochloride; CNO |
Clozapine N-Oxide | 34233-69-7 | C18H19ClN4O | 342.827 | 3-chloro-6-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-11H-benzo[b][1,4]benzodiazepine |
Clozapine Impurity A | 50892-62-1 | C13H9ClN2O | 244.68 | 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]-diazepin-11-one |
Clozapine EP Impurity B | 263366-81-0 | C30H24Cl2N6 | 539.46 | 11,11'-(Piperazine-1,4-diyl)bis(8-chloro-5H-dibenzo[b,e][1,4]-diazepine) |
Clozapine | 5786-21-0 | C18H19ClN4 | 326.82 | HF 1854; HF1854; HF-1854; LX 100-129; LX-100-129; LX100-129 |
Cloxyfonac | 6386-63-6 | C9H9ClO4 | 216.62 | |
Cloxacillin Benzathine (2:1) | 23736-58-5 | 2(C19H18ClN3O5S).C16H20N2 | 1112.10 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-, compd. with N,N'-dibenzylethylenediamine (2:1); 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5 |
Cloxacillin Sodium Salt | 642-78-4 | C19H17ClN3O5SNa | 457.86 | (2S,5R,6R)-6-[[[3-(2-Chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Sodium Salt; Ankerbin; 3-(o-Chlorophenyl)-5-methyl-4-isoxazolylpenicillin Sodium Salt; Austrastaph; BRL 1621 So |
Cloxacillin Sodium EP Impurity E | 18704-55-7 | C27H27ClN5O7S2 | 633.13 | |
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) | 1642559-64-5 | C18H19ClN3O4S | 408.89 | |
Cloxacillin sodium | 7081-44-9 | C19H19ClN3NaO6S | 475.88 | |
Cloxacillin EP Impurity D | 23598-72-3 | C11H8ClNO3 | 237.64 | 3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic Acid |
Cloxacillin | 61-72-3 | C19H18ClN3O5S | 435.88 | Cloxacillinum;Cloxacilina;Syntarpen;Tegopen;(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;[3-(O-chlorophenyl)-5-methyl-4-isoxazolyl]penicillin;3-Dimethyl-7-o |
Clovin | 81970-00-5 | C33H40O20 | 756.663 | 4H-1-Benzopyran-4-one, 3-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-galactopyranosyl)oxy)-7-((6-deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5-hydroxy- |
Red Clover Extract | 85085-25-2 | C16H12O5 | N/A | Clover extract; Red clover extract |
Clove oil | 8000-34-8 | |||
Clovanediol diacetate | 2649-68-5 | C19H30O4 | 322.445 | [(3S,3aS,6R,7R,9aS)-3-acetyloxy-1,1,7-trimethyl-3,4,5,6,8,9,9a,10-octahydro-2H-tricyclo[6.3.1.0^{1,5}]dodecan-6-yl] acetate |
Clovanediol | 2649-64-1 | C15H26O2 | 238.4 | (1S,2S,5S,8R,9R)-4,4,8-Trimethyltricyclo[6.3.1.01,5]dodecane-2,9-diol |
Clotrimazole-d5 | 1185076-41-8 | C22H12ClN2D5 | 349.87 | 1-[(2-Chlorophenyl)-diphenyl-d5-methyl]-1H-imidazole; FB-5097-d5; Bay b 5097-d5; Canesten-d5; Canifug-d5; Empecid-d5; Mycofung-d5; Desamix F-d5; Diphenyl(2-chlorophenyl)(1-imidazolyl)methane-d5; Empecid-d5; Femcare-d5; Gyne-Lotrimin-d5; Gyne-Lotrimin 7-d5 |
Clotrimazole Impurity F | 15469-97-3 | C22H18N2 | 310.39 | 1-Tritylimidazole; 1-(Triphenylmethyl)-1H-imidazole; 1-(Triphenylmethyl)imidazole; CDD 3501; N-Tritylimidazole |
Clotrimazole | 23593-75-1 | C22H17ClN2 | 344.84 | BAY b 5097, FB 5097; BAYb 5097, FB5097; BAY-b 5097, FB-5097 |
clotiapine | 2058-52-8 | C18H18ClN3S | 343.874 | 2-Chloro-11-(4-methyl-1-piperazinyl)dibenzo(b,f)(1,4)thiazepine; 2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)thiazepine; Clotiapine; Dibenzo[b,f][1,4]thiazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-; Dibenzothiazepine; Entumin; Entumine; Etumine |
Clothianidin | 210880-92-5 | C6H8ClN5O2S | 249.70 | CLOTHIANIDIN; Clothianidin PESTANAL; Guanidine, N-(2-chloro-5-thiazolyl)methyl-N-methyl-N-nitro-, C(E)-; clothianidine; 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitro-guanidine; CLOTHIANIDIN STANDARD |
Closantel Impurity F | 50274-07-2 | C21H13Cl2I2NO3 | 652.05 | N-[5-Chloro-4-(4-chlorobenzoyl)-2-methylphenyl]-2-hydroxy-3,5-diiodo-benzamide |
Closantel | 57808-65-8 | C22H14Cl2I2N2O2 | 663.07 | R-31520 |
Clortermine hydrochloride | 10389-72-7 | C10H15Cl2N | 220.14 | Voranil;SU-10568;1-(2-chlorophenyl)-2-methylpropan-2-amine hydrochloride;Clortermine HCl;Benzeneethanamine, 2-chloro-alpha,alpha-dimethyl-, hydrochloride |
Clorsulon-13C6 | 1325559-24-7 | 4-Amino-6-trichloro- ethenyl-1,3-benzene- 13C -disulfonamide 6 |
||
CLORGYLINE | 17780-72-2 | C13H15Cl2NO | 272.1703 | clorgiline; m&b9302; mandb9302; n-(3-(2,4-dichlorophenoxy)propyl)-n-methyl-2-propyn-1-amin; n-(3-(2,4-dichlorophenoxy)propyl)-n-methyl-2-propynylamin; N-[3-(2,4-Dichlorophenoxy)propyl]-N-methyl-2-propyn-1-amine |
Cloretazine | 173424-77-6 | C6H14ClN3O5S2 | 307.77 | Cloretazine; Laromustine; Onrigin; VNP40101M; VNP 40101M; VNP-40101M; 1-[2-chloroethyl(methylsulfonyl)amino]-3-methyl-1-methylsulfonylurea |
Cloransulam | 159518-97-5 | C14H11ClFN5O5S | 415.78 | |
Cloquintocet-mexyl | 99607-70-2 | C18H22ClNO3 | 335.83 | 1-Methylhexyl (5-chloroquinolin-8-yloxy)acetate;Cloquintocet-1 heptan-2-yl 2-(5-chloroquinolin-8-yl)oxyacetate;Acetic acid,[(5-chloro-8-quinolinyl)oxy]-,1- methylhexyl ester;CGA 185072;Heptan-2-yl 2-((5-chloroquinolin-8-yl)oxy)acetate |
Cloprostenol sodium | 55028-72-3 | C22H28ClNaO6 | 446.9 | Estrumate; (+/-)-Cloprostenol sodium; (±)-Cloprostenol sodium; DL-Cloprostenol sodium; Sodium (Z)-7-(2-((E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate |
cloprednol | 5251-34-3 | C21H25ClO5 | 392.876 | CLOPREDNOL; Cloradryn; Novacort; Syntestan; 5251-34-3; UNII-SYP56O3GJG |
Clopidol | 2971-90-6 | C7H7Cl2NO | 192.04 | WR 61112 |
Clopidogrel thiolactone | 1147350-75-1 | C16H16ClNO3S | 337.82 | Clopidogrel thiolactone; 2-oxoclopidogrel; UNII-0IX303KU54; 2-oxo-clopidogrel; 0IX303KU54 |
Clopidogrel Thienylethyl Impurity | 141109-20-8 | C15H16ClNO2S | 309.81 | (S)-Methyl 2-l)ethyl)amin+) -(s)-alpha(2(thien-2-yl)ethylamino)-alpha-(2-chlorophenyl) acetate |
Clopidogrel Thieno Impurity HCl | 28783-41-7 | C7H10ClNS | 175.68 | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine Hydrochloride; 6,7-Dihydro-4H-thieno[3,2-c]pyridine Hydrochloride |
Clopidogrel sulfate | 120202-66-6 | C16H16ClNO2S.H2SO4 | 419.9 | SR-25990C |
Clopidogrel Related Compound C (R-Clopidogrel) | 120202-71-3 | C16H18ClNO6S2 | 419.9 | R-(-)-Clopidogrel Hydrogen Sulfate; (R)-(-)-Methyl 2-(2-Chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate Hydrogen Sulfate; (R)-Clopidogrel Bisulfate; SR 25989C |
Clopidogrel Related Compound A | 144457-28-3 | C15H14ClNO2S | 307.8 | SR 26334 |
Clopidogrel Related Compound A | 144750-42-5 | C15H15Cl2NO2S | 344.2561;g/mol | (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)aceticacid; hydrochloride; 144750-42-5; (S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)aceticacidhydrochloride; ClopidogrelcarboxylicacidHCl; SCHEMBL1031048 |
Clopidogrel Metabolite II | 1287430-40-3 | C25H26ClNO6S | 504.01 | |
Clopidogrel Impurity D | 1421283-60-4 | C24H21Cl2NO4S | 490.4 | Clopidogrel Carboxylic Acid [Methyl (R)-o-chloromandelate] Ester |
Clopidogrel Impurity 7 | 444728-13-6 | C15H15ClN2OS | 306.82 | |
Clopidogrel Impurity 3 | 53885-64-6 | C14H11Cl2NS | 296.21 | 5-(2-Chlorobenzyl)-thieno[3,2-c]pyridinium Chloride; 5-[(2-Chlorophenyl)methyl]-thieno[3,2-c]pyridinium Chloride |
Clopidogrel Impurity 2 | 1396607-49-0 | C16H15ClNO2SBr | 400.71 | Clopidogrel Pyridinium Bromide Impurity; 5-[1-l]-6,7-dihydrothieno[3omide |
Clopidogrel camphorsulfonate | 120202-68-8 | 554.12 | Clopidogrel camphorsulfonate | |
Clomipramine N-Oxide | 14171-67-6 | C19H23ClN2O | 330.85 | 3-Chloro-10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine N-Oxide |
Clopidogrel | 113665-84-2 | C16H16ClNO2S | 321.82 | Clopidogrel; Plavix; Zyllt; (S)-Clopidogrel; CLOPIDOGREL SULFATE |
Cloperidone | 4052-13-5 | C21H23ClN4O2 | 0 | Cloperidone; 3-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-2,4(1H,3H)-quinazolinedione; 3-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-1H-quinazoline-2,4-dione; 3-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-1H-quinazoline-2,4-quinone |
Cloperastine hydrochloride | 14984-68-0 | C20H25Cl2NO | 366.32 | 1-[2-[(4-Chlorophenyl)(phenyl)methoxy]ethyl]piperidine Hydrochloride |
Cloperastine fendizoate | 85187-37-7 | C40H38ClNO5 | 648.18 | Levocloperastine fendizoate |
cloperastine | 3703-76-2 | C20H24ClNO | 329.8634 | CLOPERASTINE; 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)-piperidin; 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)piperidine; 1-(2-((p-chloro-alpha-phenylbenzyl)oxy)ethyl)-piperidin; 1-(2-[(4-Chlorophenyl)(phenyl)methoxy]ethyl)piperidine; 1-[2-[p-Chloro-pheny |
Clopamide-d6 | 1346602-07-0 | C14H14ClN3O3SD6 | 351.88 | rel-3-(Aminosulfonyl)-4-chloro-N-[(2R,6S)-2,6-(dimethyl-d6)-1-piperidinyl]benzamide; 4-Chloro-N-[(cis-2,6-(dimethyl-d6)piperidino]-3-sulfamoylbenzamide; Adurix-d6; Aquex-d6; Brinaldix-d6; Chlosudimeprimyl-d6; Clopamide-d6; Clopamidum-d6; DT 327-d6 |
Clopamide | 636-54-4 | C14H20ClN3O3S | 345.84 | rel-3-(Aminosulfonyl)-4-chloro-N-[(2R,6S)-2,6-dimethyl-1-piperidinyl]benzamide; 4-Chloro-N-(cis-2,6-dimethylpiperidino)-3-sulfamoylbenzamide; Adurix; Aquex; Brinaldix; Chlosudimeprimyl; Clopamide; Clopamidum; DT 327; N-(cis-2',6'-Dimethyl-1'-piperidyl)-3- |
Clonixin | 17737-65-4 | C13H11ClN2O2 | 262.69 | 2-[(3-Chloro-2-methylphenyl)amino]-3-pyridinecarboxylic Acid; 2-(3-Chloro-o-toluidino)-nicotinic Acid; 2-(2-Methyl-3-chloroanilino)nicotinic Acid; 2-(2'-Methyl-3'-chloro)-anilinonicotinic Acid; 2-(3-Chloro-2-methylanilino)-3-pyridinecarboxylic Acid; 2-(3- |
Clonidine-D4 Hydrochloride | 67151-02-4 | C9H6D4Cl3N3 | 270.58 | N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-(imidazol-d4)-2-amine Hydrochloride; 2-(2,6-Dichloroanilino)-2-(imidazoline-d4) Hydrochloride; Atensina-d4; Capresin-d4; Catapres-d4; Haemiton-d4; Hemiton-d4; Isoglaucon-d4; Katapresan-d4; Neuclon-d4; Normopresan-d4; |
Clonidine Related Compound A | 54707-71-0 | C11H11Cl2N3O | 272.13 | Acetylclonidine; 1-Acetyl-N-(2,6-dichlorophenyl)-4,5-dihydro-1H-Imidazol-2-amine; SKF 34874 |
Clonidine Impurity A | 5391-39-9 | C5H8N2O2 | 128.13 | 1-Acetyl-2-imidazolidinone |
Clonidine Impurity 1 | 21709-18-2 | C7H3Cl4N | 242.92 | N-(2,6-Dichlorophenyl)-carbonimidic Dichloride; (2,6-Dichlorophenyl)carbonimidic Dichloride |
Clonidine Hydrochloride | 4205-91-8 | C9H9Cl2N3.HCl | 266.5 | N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine Hydrochloride; 2-(2,6-Dichloroanilino)-2-imidazoline Hydrochloride; Atensina; Capresin; Catapres; Haemiton; Hemiton; Isoglaucon; Katapresan; Neuclon; Normopresan; ST 155 |
Clonidine | 4205-90-7 | C9H9Cl2N3 | 230.09 | CLONIDINE BASE;Clonidine (base and/or unspecified salts);CLONIDINE (200 MG);1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-;2-((2,6-dichlorophenyl)amino)-2-imidazoline;2-(2,6-dichloroanilino)-1,3-diazacyclopentene-(2);2-(2,6-dichloroanilino)-2-i |
Clonazepam Impurity 1 | 180854-85-7 | C15H10Cl2N2O4 | 353.16 | 2-Chloro-N-(2-(2-chlorobenzoyl)-4-nitrophenyl)acetamide |
Clomoxir | 88431-47-4 | C14H17ClO3 | 268.737 | 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylic acid; 2-Oxiranecarboxylicacid, 2-[5-(4-chlorophenyl)pentyl]-; Clomoxirum |
Clomipramine-d3 HCl (N-methyl-d3) | 1398065-86-5 | C19D3H20ClN2·HCl | 354.34 | 3-Chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine |
Clomipramine impurity C | 2095-42-3 | C19H22Cl2N2 | 349.3 | 3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine Hydrochloride |
Clomipramine Hydrochloride | 17321-77-6 | C19H23ClN2.HCl | 351.31 | 3-Chloro-10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine Hydrochloride; 3-Chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine Hydrochloride; Chlorimipramine Hydrochloride; Anafranil; Clomicalm |
Clomipramine HCl EP Impurity G | 1425793-87-8 | C17H16ClN | 269.77 | N-Allyl-3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine; 3-Chloro-10,11-dihydro-5-(2-propen-1-yl)-5H-dibenz[b,f]azepine |
Clomipramine HCl EP Impurity F | 32943-25-2 | C14H12ClN | 229.7 | 3-Chloroiminodibenzyl; 3-Chloro-10,11-dihydro-5H-dibenz[b,f]azepine |
Clomipramine HCl EP Impurity E | 494-19-9 | C14H13N | 195.27 | 10,11-Dihydro-5H-dibenzo[b,f]azepine; 10,11-Dihydrodibenz[b,f]azepine; 2,2'-Iminobibenzyl; 2,2'-Iminodibenzyl; Iminobibenzyl; Iminodibenzyl; NSC 72110 |
Clomipramine HCl EP Impurity B | 50-49-7 | C19H24N2 | 280.41 | 1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine; 10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine (113-52-0 Imipramine hydrochloride ) |
Clomipramine D3 | 136765-29-2 | C19H20D3ClN2 | 317.87 | CLOMIPRAMINE-D3;5H-Dibenzb,fazepine-5-propanamine, 3-chloro-10,11-dihydro-N-methyl-N-(methyl-d3)-;CLOMIPRAMINE-D3,100/MLINMETHANOL |
Clomiphene N-Oxide | 97642-74-5 | C26H28ClNO2 | 421.96 | 2-[4-(2-Chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethyl-ethanamine N-Oxide; Clomifenoxide |
Clomifene citrate | 50-41-9 | C26H28ClNO.C6H8O7 | 598.08 | NSC 35770; CLOMIPHENE CITRATE; Zuclomiphene citrate; Clomivid; Clomphid |
Clomifene | 911-45-5 | C26H28ClNO | 405.96 | clomifene; Clomiphene; Clomiphene,E/Z-mixture; 2-(4-[2-Chloro-1,2-diphenylethenyl]phenoxy)-N,N-diethylethanamine; CLOMIFENE (CLOMIPHENE); 2-[4-(2-Chloro-1,2-diphenylvinyl)phenoxy]-N,N-diethylethan-1-amine; 2-[4-(2-Chloro-1,2-diphenylvinyl)phenoxy]-N,N-die |
Clometacin | 25803-14-9 | |||
Clofoctol | 37693-01-9 | C21H26Cl2O | 365.34 | 2-[(2,4-dichlorophenyl)methyl]-4-(2,4,4-trimethylpentan-2-yl)phenol; |
Clofibric acid acyl-b-D-glucuronide | 72072-47-0 | C16H19ClO9 | 390.77 | 1-[2-(4-Chlorophenoxy)-2-methylpropanoate] b-D-glucopyranuronic acid; Clofibric b-glucuronide; Clofibric acid glucuronide |
Clofibrate-d4 | 1189654-03-2 | C12H11D4ClO3 | 246.73 | 2-(4-Chlorophenoxy-d4)-2-methylpropanoic Acid Ethyl Ester; Ethyl Clofibrate-d4; Ethyl 2-(4-Chlorophenoxy-d4)-2-methylpropionate; |
Clofibrate | 637-07-0 | C12H15ClO3 | 242.7 | Atromid-S |
Clofezone | 60104-29-2 | 629.1935 | ||
Clofentezine Metabolite 3 | 107573-63-7 | C15H11ClN4OS | 330.8 | |
Clofentezine Metabolite 2 | 107573-62-6 | C14H8Cl2N4O | 319.15 | |
Clofentezine Metabolite 1 | 107595-49-3 | C14H8Cl2N4O | 319.15 | |
Clofentezine | 74115-24-5 | C14H8Cl2N4 | 303.15 | NC 21314;3,6-Bis(2-chlorophenyl)-1,2,4,5-tetrazine;Acaristop;Apollo;Bisclofentezin |
Clofedanol | 791-35-5 | C17H20ClNO | 289.8 | 1-(2-chlorophenyl)-3-dimethylamino-1-phenylpropan-1-ol |
Clocinizine | 298-55-5 | C26H27ClN2 | 402.97 | Chlorcinnarizine; Chlorcinnazine; Clocinizina |
Clofazimine Related Compound 2 | 90712-89-3 | C24H15Cl2N3O | 432.31 | |
Clofazimine Related Compound 1 | 90690-85-0 | C24H16Cl2N4 | 431.33 | |
Clofarabine-5'-triphosphate | 167620-89-5 | C10H14ClFN5O12P3 (free acid) | 543.62 (free acid) | |
Clofarabine-5'-monophosphate | 134646-42-7 | C10H12ClFN5O6P (free acid) | 383.66 (free acid) | |
Clofarabine | 123318-82-1 | C10H11ClFN5O3 | 303.68 | C1-F-Ara-A; Clofarabine, US brand names: Clofarex; Clolar. Abbreviation: CAFdA. |
Clodronate disodium tetrahydrate | 88416-50-6 | CH10Cl2Na2O10P2 | 360.908 | (Dichloromethylene)bisphosphonic Acid Disodium Salt Tetrahydrate; Sodium clodronate hydrate; Disodium [dichloro(phosphonato)methyl]phosphonic acid tetrahydrate |
Clodronate Disodium | 22560-50-5 | CH2Cl2Na2O6P2 | 288.86 | Clodronic acid |
Clodronate disodium | 10596-23-3 | CH4Cl2O6P2 | 244.885 | clodronic acid disodium salt; disodium dichloromethylene diphosphonate; Dichloromethylenediphosphonic acid disodium salt. Bonefos; Clasteon; Difosfonal; Loron; Mebonat; Ossiten. CL2MDP; DMDP. |
CLODINAFOP | 114420-56-3 | C14H11ClFNO4 | 311.69 | CLODINAFOP; clodinafop free acid; Cga 193469; Clodinafop [iso]; Propanoic acid, 2-(4-((5-chloro-3-fluoro-2-pyridinyl)oxy)phenoxy)-, (2R)-; (R)-Clodinafop |
Clinopodiside A | 142809-89-0 | C48H78O19 | 959.12 | 2-[[4,5-dihydroxy-6-[[8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl]oxy]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
Clobetasol Propionate Related Compound 1 | 61618-89-1 | C22H27FO4 | 374.46 | |
Clobetasol Propionate | 25122-46-7 | C25H32ClFO5 | 466.974 | Clobex; Cosvate (India); Temovate (US); Olux; Tenovate; Dermovate; Dermatovate; Butavate; Movate; Novate; [17-(2'-chloroacetyl)- 9-fluoro-11-hydroxy-10,13,16-trimethyl- 3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate |
Clobetasol Impurity (9-Fluoro-11-beta-21-Dihydroxy-16-Methylpregna-1, 4, 16-triene-3, 20-Dione) | 59860-99-0 | C22H27FO4 | 374.46 | |
Clobenpropit dihydrobromide | 145231-35-2 | C14H17ClN4S.2HBr | 470.65 | N-(4-Chlorobenzyl)-S-[3-(4(5)-imidazolyl)propyl]isothiourea dihydrobromide |
Clioxanide | 14437-41-3 | C15H10ClI2NO3 | 541.50 | Clioxanide; Tremerad; SYD 230; Clioxanidum [INN-Latin]; Clioxanida [INN-Spanish]; SYD-230; EINECS 238-414-0;2-(4-Chlorphenylcarbamoyl)-4,6-diodphenyl acetat |
Clinoposaponin D | 1822328-43-7 | C48H78O18 | 943.12 | |
Clinofibrate Impurity 2 | 30299-17-3 | C23H28O4 | 368.48 | |
Clindamycin palmitate hydrochloride | 25507-04-4 | C34H63ClN2O6S.HCl | 699.85 | Clindamycin palmitate hydrochloride |
Clindamycin Impurity (Sulfone) | 887402-22-4 | C18H33ClN2O7S | 456.99 | |
Clindamycin | 18323-44-9 | C18H33ClN2O5S | 424.98 | |
Clinafloxacin hydrochloride | 105956-99-8 | C17H18Cl2FN3O3 | 402.25 | 7-(3-Amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride;7-(3-Aminopyrrolidin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-4-keto-quinoline-3-carboxylic acid hydrochloride;7-(3-Azanylpyrrolidin-1-yl)-8 |
Clinafloxacin | 105956-97-6 | C17H17ClFN3O3 | 365.79 | CI-960, PD127391, AM-1091 |
Climbazole | 38083-17-9 | C15H17ClN2O2 | 292.76 | |
Climazolam | 59467-77-5 | C18H13Cl2N3 | 342.22192;g/mol | Climazolam; UNII-O9KZB9HG1Y; Climazolam(INN); Climazolam[INN]; 59467-77-5; Ro21-3982 |
Clidinium Bromide | 3485-62-9 | C22H26BrNO3 | 432.35 | (1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate;bromide; |
Cladinose | 470-12-2 | C8H16O4 | 176.21 | 2,6-Dideoxy-3-C-methyl-3-O-methyl-ribo-hexose; (4R,5S,6S)-4-Methoxy-4,6-dimethyl-tetrahydropyran-2,5-diol |
CL-387785 | 194423-06-8 | C18H13BrN4O | 381.233 | CL-387785; CL 387785; CL-387,785; CL387785; EKI-785 |
CL-316243 sodium | 138908-40-4 | C20H18ClNNa2O7 | 465.79 | disodium;5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate;BTA 243; HP186 |
cis-Ned 19 | 1137264-00-6 | C30H31FN4O3 | 514.59 | (1S,3S)-1-[3-[[4-(2-Fluorophenyl)piperazin-1-yl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid |
CIS-2-AMINO-CYCLOPENTANOL HYDROCHLORIDE | 31889-37-9 | C5H12ClNO | 137.61 | CIS-2-AMINO-CYCLOPENTANOL HYDROCHLORIDE |
cis-2-Amino-cyclopentanecarboxylic acid ethyl ester hydrochloride | 142547-15-7 | C8H16ClNO2 | 193.67114 | cis-2-Amino-cyclopentanecarboxylic acid ethyl ester hydrochloride; Ethyl cis-2-amino-1-cyclopentane carboxylate hydrochloride |
Cinnamyl caffeate | 115610-32-7 | C18H16O4 | 296.322 | Caffeic acid cinnamyl ester; 3,4-Dihydroxycinnamic acid 3-phenyl-2-propenyl ester; 3-(3,4-Dihydroxyphenyl)propenoic acid 3-phenyl-2-propenyl ester; [(E)-3-phenylprop-2-enyl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
Cinnamyl acetate | 21040-45-9 | C11H12O2 | 176.2 | (2E)-3-Phenyl-2-propen-1-yl acetate |
Chromanol 293B | 163163-23-3 | C15H20N2O4S | 324.39 | rel-N-[(3R,4S)-6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-methyl-ethanesulfonamide; rel-N-[(3R,4S)-6-Cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-methylethanesulfonamide; trans-N-[6-Cyano-3,4-dihydro-3-hydroxy-2 |
Click N-Acetylmuramic acid-alkyne | 2245794-65-2 | C14H21NO8 | 331.32 | (2R)-2-(((3R,4R,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-3-(pent-4-ynamido)tetrahydro-2H-pyran-4-yl)oxy)propanoic acid |
Clibucaine | 15302-10-0 | C15H20Cl2N2O | 315.242 | Clibucaine |
Clevudine | 163252-36-6 | C10H13FN2O5 | 260.22 | L-FMAU; L FMAU; LFMAU; Levovir |
Clevidipine Impurity 8 | 105383-68-4 | C15H13Cl2NO2 | 310.18 | 4-(2,3-Dichlorophenyl)-2,6-dimethyl-3-pyridinecarboxylic acid methyl ester; methyl 4-(2,3-dichlorophenyl)-2,6-dimethylnicotinate |
Clevidipine Impurity 7 | 91854-02-3 | C16H13Cl2NO4 | 354.19 | 4-(2,3-Dichlorophenyl)-2,6-dimethyl-3-methoxycarbonyl-5-pyridinecarboxylic acid; H-152/66; 4-(2,3-dichlorophenyl)-5-(methoxycarbonyl)-2,6-dimethylnicotinic acid |
Clevidipine Impurity 6 | 138279-32-0 | C15H13Cl2NO4 | 342.18 | 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid |
Clevidipine Impurity 4 | 253597-20-5 | C15H15Cl2NO2 | 312.2 | 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3-pyridinecarboxylic acid methyl ester; H 168/79; methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate |
Clevidipine Impurity 2 | 253597-19-2 | C25H29Cl2NO8 | 542.42 | |
Clevidipine | 167221-71-8 | C21H23Cl2NO6 | 456.32 | |
Cletoquine | 4298-15-1 | C16H22ClN3O | 307.83 | 2-[[4-[(7-Chloro-4-quinolyl)amino]pentyl]amino]ethanol; (±)-Desethylhydroxychloroquine; Desethyl Hydroxy Chloroquine |
Clethodim Sulfoxide | 111031-14-2 | C17H26ClNO4S | 375.91 | 2-[1-[[((E)-3-Chloro-2-propen-1-yl)oxy]imino]propyl]-5-[2-(ethylsulfinyl)propyl]-3-hydroxy-2-cyclohexen-1-one; 2-[1-[[(3-Chloro-2-propenyl)oxy]imino]propyl]-5-[2-(ethylsulfinyl) propyl]-3-hydroxy-2-cyclohexen-1-one |
Clethodim Sulfone | 111031-17-5 | C17H26ClNO5S | 391.91 | 2-[1-[[(3-Chloro-2-propen-1-yl)oxy]imino]propyl]-5-[2-(ethylsulfonyl)propyl]-3-hydroxy-2-cyclohexen-1-one |
Clethodim | 99129-21-2 | C17H26ClNO3S | 359.91 | 2-[1-[[[(2E)-3-Chloro-2-propen-1-yl]oxy]imino]propyl]-5-[2-(ethylthio)propyl]-3-hydroxy-2-cyclohexen-1-one; Centurion; Centurion 240; E-Clethodim; Ogive; Prism; RE 45601; Select; Select MAX; Trigger; Volunteer |
Cleroindicin F | 189264-47-9 | C8H10O3 | 154.2 | (3aR,7aR)-3a-Hydroxy-3,3a,7,7a-tetrahydro-1-benzofuran-6(2H)-one |
Cleroindicin E | 165197-71-7 | C8H14O3 | 158.2 | |
Cleroindicin D | 189264-45-7 | C8H12O4 | 172.2 | (3aR,4R,7aR)-3a,4-Dihydroxyhexahydro-1-benzofuran-6(2H)-one |
Cleroindicin C | 183626-28-0-189264-44-6 | C8H12O3 | 156.2 | (3aR,7aS)-Hexahydro-3a-hydroxy-6(2H)-benzofuranone |
Cleroindicin B | 107389-91-3 | C8H14O3 | 158.2 | 4-hydroxy-4-(2-hydroxyethyl)cyclohexan-1-one |
Clerodenoside A | 164022-75-7 | C35H44O17 | 736.7 | |
Cleomiscosin C | 84575-10-0 | C21H20O9 | 416.4 | |
Cleomiscosin A | 76948-72-6 | C20H18O8 | 386.4 | (2R,3R)-rel-2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-9H-pyrano[2,3-f]-1,4-benzodioxin-9-one; |
Clenproperol-D7 | 1173021-09-4 | 1-(4-Amino-3,5-dichloro- phenyl)-2-isopropyl-D7- amino-ethanol | ||
Clenproperol hydrochloride | 75136-83-3 | C11H16Cl2N2O.HCl | 299.627 | 1-(4-Amino-3,5-dichlorophenyl)-2-isopropylaminoethanol hydrochloride |
Clenproperol | 38339-11-6 | C11H16Cl2N2O | 263.162 | 1-(4-Amino-3,5-dichlorophenyl)-2-isopropylaminoethanol |
Clenpirin | 27050-41-5 | C14H18Cl2N2 | 285.21 | 1-butyl-N-(3,4-dichlorophenyl)pyrrolidin-2-imine; Clenpirin; BRN 1540697; Clempirina; Clempirina [INN-Spanish]; UNII-PFM79PGI92; Clenpirin; Clenpirine; Clenpirine [INN-French;] Clenpirinum; Clenpirinum [INN-Latin]; Clenpyrin; EINECS 248-190-6 |
Clenpenterol-D5 hydrochloride | 1794793-20-6 | 1-(4-Amino-3,5-dichloro-phenyl)-2-(1,1-dimethyl-hydrochloride | ||
Clenpenterol-D11 hydrochloride | 1325559-11-2 | 1-(4-Amino-3,5-dichloro- phenyl)-2-(1,1-dimethyl- propyl-D11-amino)- ethanol hydrochloride | ||
Clenisopenterol hydrochloride | 1435935-00-4 | C13H20Cl2N2O.HCl | 327.681 | 1-(4-Amino-3,5-dichlorophenyl)-2-(3-methylbutylamino)-ethanol hydrochloride |
Clenisohexerol hydrochloride | 37158-48-8 | C14H22Cl2N2O.HCl | 341.708 | 1-(4-Amino-3,5-dichlorophenyl)-2-(1,1-dimethylbutylamino)-ethanol hydrochloride |
Clenhexerol | 78982-88-4 | C14H22Cl2N2O | 305.243 | 1-(4-Amino-3,5-dichlorophenyl)-2-hexylaminoethanol |
Clencyclohexerol hydrochloride | 1435934-75-0 | C14H20Cl2N2O2 | 319.23 | 4-[2-(4-Amino-3,5-dichlorophenyl)-2-hydroxyethylamino]-cyclohexanol hydrochloride |
Clenbuterol-D9 hydrochloride | 184006-60-8 | 1-(4-Amino-3.5-dichloro- phenyl)-2-tert-butyl-D9- amino-ethanol hydro- chloride | ||
Clenbuterol Impurity F | 37153-52-9 | C12H18BrClN2O | 321.65 | |
Clenbuterol Impurity E | 37148-47-3 | C8H6BrCl2NO | 282.95 | 4-Amino-3,5-dichlorophenacylbromide; 1-(4-Amino-3,5-dichlorophenyl)-2-bromoethan-1-one |
Clenbuterol Impurity B | 37148-49-5 | C12H17Cl3N2O | 311.63 | 1-(4-amino-3,5-dichloro-phenyl)-2-(tert-butylamino)ethanone hydrochloride |
Clenbuterol Impurity A | 62909-66-4 | C7H5Cl2NO | 190.03 | 4-Amino-3,5-dichlorobenzaldehyde |
Clenbuterol Hydrochloride | 21898-19-1 | C12H19Cl3N2O | 313.65 | Clenbuterol |
Clemizole hydrochloride | 1163-36-6 | C19H20ClN3.HCl | 362.30 | Allercur; Clemizole HCl; Clemizole (hydrochloride); Reactrol; 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole hydrochloride |
Clemizole | 442-52-4 | C19H20ClN3 | 325.8350 | 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole; |
Clematomandshurica saponin B | 916649-91-7 | C92H142O46 | 1984.1 | |
Clematiunicinoside E | 916649-92-8 | C76H124O39 | 1661.77 | Clematomandshurica saponin C |
Clematichinenoside AR | 761425-93-8 | C64H104O34 | 1417.5 | (-)-Platycoside G1; Deapi-platycoside E; Deapioplatycoside E |
Clemastine N-Oxide | 108825-05-4 | C21H26ClNO2 | 359.89 | [R-(R*,R*)]- 2-[2-[1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine 1-Oxide |
Clemastine Fumarate Impurity B | 61771-18-4 | C21H26ClNO | 343.89 | N-Methyl-4-[1-(4-chlorophenyl)-1-phenylethoxy)hexahydroazepine; 4-(1-(4-Chlorophenyl)-1-phenylethoxy)-1-methylazepane; 4-[1-(4-Chlorophenyl)-1-phenylethoxy]hexahydro-1-methyl-1H-azepine |
Clemastine fumarate | 14976-57-9 | C25H30ClNO5 | 459.96 | Agasten; Tavist; Mecloprodine; (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine fumarate |
Clemastine | 15686-51-8 | C21H26ClNO | 343.895 | Meclastin; Mecloprodin; Clemastina; Tavist; Meclastine |
Clemastanin B | 112747-98-5 | C32H44O16 | 684.68 | |
Clemaphenol A | 362606-60-8 | C20H22O6 | 358.39 | rel-3,3'-[(1R,3aS,4R,6aS)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[6-methoxyphenol] |
Clebopride Malate | 57645-91-7 | C23H28ClN3O6 | 477.94 | 4-Amino-5-chloro-2-methoxy-N-(1-benzyl-4-piperidyl)benzamide malate; 4-amino-N-(1-benzylpiperidin-1-ium-4-yl)-5-chloro-2-methoxybenzamide;2,4-dihydroxy-4-oxobutanoate; |
Clazosentan | 180384-56-9 | C25H23N9O6S | 577.57 | N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methylpyridine-2-sulfonamide AXV 034 AXV 343434 AXV-034 AXV-034343 AXV-343434 AXV343434 clazosentan Ro 61-1790 Ro-61-1790 VML 588 VML-588 VML588 |
Clavulanic acid, lithium salt | 61177-44-4 | C8H8LiNO5 | 205.09 | |
Clavulanate potassium | 61177-45-5 | C8H8KNO5 | 237.25 | Potassium (z)-(2r,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate;Monopotassiumsalt,(2r-(2-alpha,3z,5-alpha))-xo;MM-14151;MM14151;Potassium (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carbox |
Clarithromycin Impurity O | 127252-80-6 | C39H72N2O13 | 776.99 | Clarithromycin (9Z)-O-Methyloxime; 6-O-Methylerythromycin (9Z)-9-O-Methyloxime; Oxacyclotetradecane Erythromycin deriv. |
Clarithromycin Impurity N | 144604-03-5 | C38H67NO12 | 729.94 | (10E)-10,11-Didehydro-11-deoxy-6-O-methylerythromycin; Oxacyclotetradecane Erythromycin Derivative |
Clarithromycin Impurity L | 127253-05-8 | C38H70N2O13 | 762.97 | Clarithromycin (9Z)-Oxime; 6-O-Methylerythromycin (9Z)-9-Oxime; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,Z)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-di |
Clarithromycin Impurity G (Mixture of Z and E Isomers) | 107216-09-1 | C39H72N2O13 | 777.01 | |
Clarithromycin Impurity E | 81103-14-2 | C39H71NO13 | 761.98 | 6,11-Di-O-methylerythromycin; 11-O-Methylclarithromycin; USP Clarithromycin Related Compound A |
Clarithromycin Impurity C | 127253-06-9 | C38H70N2O13 | 762.97 | Clarithromycin oxime |
Clarithromycin EP Impurity P | 123967-58-8 | C39H71NO13 | 761.98 | 4'',6-Di-O-methylerythromycin; Oxacyclotetradecane, Erythromycin deriv.; 4'-O-Methylclarithromycin |
Clarithromycin 2'-O-Acetate | 103461-66-1 | C40H71NO14 | 789.99 | 2'-O-Acetylclarithromycin; 2'-O-Acetyl-6-O-methylerythromycin A; Oxacyclotetradecane Erythromycin Derivative; 6-O-Methyl-erythromycin 2'-Acetate; (2S,3R,4S,6R)-4-(Dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5 |
Clarithromycin (9E)-O-Methyloxime | 127182-44-9 | C39H72N2O13 | 776.99 | 6-O-Methylerythromycin (9E)-9-(O-Methyloxime); Clarithromycin Impurity G; Clarithromycin EP Impurity G |
Clarithromycin | 81103-11-9 | C38H69NO13 | 747.95 | Biaxin; 6-O-Methylerythromycin; Klaricid; Abbott-56268 |
Cl-ANT-ITP | 1350521-48-0 | C17H19ClN5O15P3 (free acid) | 661.7 (free acid) | 2'- / 3'- O- (5- Chloroanthraniloyl)inosine- 5'- O- triphosphate, sodium salt |
Cl-ANT-ATP | 1350521-45-7 | C17H20ClN6O14P3 (free acid) | 660.8 (free acid) | 2'- / 3'- O- (5- Chloroanthraniloyl)adenosine- 5'- O- triphosphate, sodium salt |
Clanfenur | 51213-99-1 | C16H15ClFN3O2 | 335.764 | N-[(4-chlorophenyl)carbamoyl]-2-(dimethylamino)-6-fluorobenzamide;Clanfenur;UNII-KAM54NKT1Q;MLS002701735;NSC603108;51213-99-1 |
Clamoxyquin Hydrochloride | 4724-59-8 | C17H26Cl3N3O | 394.76 | 5-chloro-7-[[3-(diethylamino)propylamino]methyl]quinolin-8-ol;dihydrochloride; |
Cl-Amidine hydrochloride | 1373232-26-8 | C14H19ClN4O2·HCl | 347.24 | N-[(1S)-1-(aminocarbonyl)-4-[(2-chloro-1-iminoethyl)amino]butyl]-benzamide monohydrochloride |
Cl-amidine | 1043444-18-3 | C14H19ClN4O2·C2HF3O2 | 424.8 | N-[(1S)-1-(aminocarbonyl)-4-[(2-chloro-1-iminoethyl)amino]butyl]-benzamide |
Cladribine Impurity G | 99-75-2 | C9H10O2 | 150.17 | Methyl p-Toluate; 4-(Methoxycarbonyl)toluene; 4-Methylbenzoic Acid Methyl Ester; Methyl 4-Methylbenzoate; Methyl 4-Toluate; Methyl p-Methylbenzoate; Methyl p-Toluate; Methyl p-Toluenecarboxylate; NSC 24761; p-(Methoxycarbonyl)toluene; p- Carbomethoxytolue |
Cladribine Impurity F | 619-55-6 | C8H9NO | 135.16 | 4-Methylbenzamide; p-Toluamide |
CL-316243 | 183720-02-7 | C20H20ClNNa2O7 | 419.794 | 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate; 138908-40-4 (CL-316243 sodium) |
CL307 | 1548551-79-6 | C29H47N11O3 | 597 | N1-glycinyl[4-((6-amino-2- (butylamino)-8- hydroxy-9H- purin- 9-yl)methyl) benzoyl] spermine |
CL264 | 1510712-69-2 | C47H73N13O7S | 413.43 | 2-(4-((6-amino-2-(butylamino)-8-hydroxy-9H_purin_9-yl)methyl)benzamido)acetic acid |
CL097 | 1026249-18-2 | C13H14N40 | 242.28 | |
CL075 | 256922-53-9 | C13H13N3S | 243.33 | 2-propyl-[1,3]thiazolo[4,5-c]quinolin-4-amine; CL-075; CL075 cpd |
CL 82198 hydrochloride | 1188890-36-9 | C17H23N2O3.HCl | 338.83 | N-[4-(4-Morpholinyl)butyl]-2-benzofurancarboxamide hydrochloride |
CL 82,198 | 307002-71-7 | C17H22N2O3 | 302.4 | CL-82198; N-[4-(4-Morpholinyl)butyl]-2-benzofurancarboxamide |
CL 43356 | 3572-55-2 | C5H10NO2PS3 | 242.96 | O,O-dimethyl 1,3-dithiolan-2-ylidenephosphoramidothioate; N-dimethoxyphosphinothioyl-1,3-dithiolan-2-imine; |
CL 316243 disodium salt | 151126-84-0 | C20H18ClNNa2O7 | 465.80 | 5-[(2R)-2-[[(2R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylic acid disodium salt |
CL 218872 | 66548-69-4 | C13H9F3N4 | 278.24 | 3-Methyl-6-[-3-(trifluoromethyl)phenyl]-1,2,4-triazolo[4,3-b]pyridazine |
CKI 7 dihydrochloride | 1177141-67-1 | C11H14Cl3N3O2S | 358.67 | CKI-7 dihydrochloride; N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulphonamide dihydrochloride |
CKD-516 HCl | 1240321-53-2 | C26H29ClN6O5S | 573.065 | CKD-516; CKD516; CKD 516 |
CKD-516 HCl | 1188371-47-2 | C26H29ClN6O5S | 573.07 | (2S)-2-amino-3-methyl-N-[4-[3-(1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl]-1,3-thiazol-2-yl]butanamide;hydrochloride;1188371-47-2 (free base) |
CKD 602 | 213819-48-8 | C25H27N3O4·H3PO4 | 531.49 | (4S)-4-Ethyl-4-hydroxy-11-[2-[(1-methylethyl)amino]ethyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione phosphate; Belotecan hydrochloride |
CK-492B | 64169-11-5 | C36H66N10O8S2 | 831.11 | CK492B;1-(1-Adamantyl)-3-[N'-[3-[4-[3-[[(1-adamantylcarbamoylamino)-aminomethylidene]amino]propyl]piperazin-1-yl]propyl]carbamimidoyl]urea;methanesulfonic acid;1,4-Bis-(3-(1-adamantyl carbamylguanidino)propyl)piperazine |
CK-2289 | 101183-99-7 | C15H14N4O2 | 282.30 | CK2289;4-[4-(1H-Imidazol-1-yl)benzoyl]-5-ethyl-1H-imidazol-2(3H)-one;4-Ethyl-5-[4-(1H-imidazol-1-yl)benzoyl]-1H-imidazol-2(3H)-one;2H-Imidazol-2-one,4-ethyl-1,3-dihydro-5-[4-(1H-imidazol-1-yl)benzoyl]-;4-Ethyl-1,3-dihydro-5-[4-(1H-imidazol-1-yl)benzoyl]-2 |
CK-2130 | 101184-07-0 | C16H16N4O2 | 296.33 | 4-Ethyl-1,3-dihydro-5-[4-[(2-methyl-1H-imidazol)-1-yl]benzoyl]-2H-imidazol-2-one;CK2130;4-Ethyl-5-[4-(2-methylimidazol-1-yl)benzoyl]-1,3-dihydroimidazol-2-one |
CK2 inhibitor 10 | 1361229-76-6 | C18H14N2O4S | 354.38 | 4-[2-[(4-methoxybenzoyl)amino]-1,3-thiazol-5-yl]benzoic acid |
CK-119 | 197917-10-5 | C21H23ClN4O5 | 446.88 | diethyl 6-[(4-chlorophenyl)methyl]-1,4-dimethyl-5-oxopyridazino[4,5-c]pyridazine-3,4-dicarboxylate; CK-119; CK119; CK 119; UNII-AL53N923EI; GC-6119 |
CK-102 | 6236-97-1 | C15H13NO | 223.27 | CK102;3,4-Dimethyl-9(10H)-acridone;3,4-Dimethyl-9-acridanone;3,4-Dimethyl-10H-acridin-9-one |
CK0106023 | 336115-72-1 | C30H32BrClN4O2 | 595.966 | CK0106023; CK 0106023; CK-0106023 |
CK 869 | 388592-44-7 | C17H16BrNO3S | 394.28 | 2-(3-Bromophenyl)-3-(2,4-dimethoxyphenyl)-4-thiazolidinone |
CK 683A | 83539-21-3 | C32H57N9O5S | 679.92 | 1,7-Bis((1-adamantyl)carbamylguanidino)-4-methyl-4-azaheptane |
CK 666 | 442633-00-3 | C18H17FN2O | 296.34 | 2-Fluoro-N-[2-(2-methyl-1H-indol-3-yl)ethyl]benzamide |
CK 3197 | 132523-92-3 | C23H22N4O3 | 402.45 | 1-benzoyl-5-(4-(4,5-dihydro-2-methyl-1H-imidazol-1-yl)benzoyl)-4-ethyl-1,3-dihydro-2H-Imidazol-2-one |
CK 17 | 86727-00-6 | C17H15BrN2OS | 375.29 | 5-Bromotetrahydro-5-methyl-3-phenyl-2-(phenylimino)-4H-1,3-thiazin-4-one |
CJC-1295 | 863288-34-0 | C152H252N44O42 | 3367.9 | CJC 1295; CJC1295; L-tyrosyl-D-alanyl-L-alpha-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-g |
CJ463 | 600142-19-6 | C21H27N5O6S | 477.54 | CJ-463;(S)-N-(4-carbamimidoylbenzyl)-3-hydroxy-2-((R)-3-hydroxy-2-((phenylmethyl)sulfonamido)propanamido)propanamide |
CJ-42794 | 847728-01-2 | C22H17ClFNO4 | 413.83 | 4-[(1S)-1-[[5-chloro-2-(4-fluorophenoxy)benzoyl]amino]ethyl]benzoic acid;(S)-4-(1-(5-chloro-2-(4-fluorophenoxy)benzaMido)ethyl)benzoic acid;CJ-042794;4-((S)-1-(2-(4-fluorophenoxy)-5-chlorobenzamido)ethyl)benzoic acid; |
CJ-15161 | 204970-97-8 | C23H31N3O2 | 381.52 | CJ-15161; CJ-15,161; |
CJ-13610 | 179420-17-8 | C22H23N3O2S | 393.5 | 4-[3-[4-(2-methylimidazol-1-yl)phenyl]sulfanylphenyl]oxane-4-carboxamide; Tetrahydro-4-[3-[[4-(2-methyl-1H-imidazol-1-yl)phenyl]thio]phenyl]-2H-pyran-4-carboxamide |
CJ 033466 | 519148-48-2 | C19H28ClN5O | 377.91 | 5-Amino-6-chloro-2-methyl-N-[[1-(2-methylpropyl)-4-piperidinyl]methyl]-imidazo[1,2-a]pyridine-8-carboxamide |
Cixiophiopogon A | 288143-27-1 | C44H70O18 | 887.02 | |
Ciwujiatone | 218901-26-9 | C22H26O9 | 434.44 | (4-hydroxy-3,5-dimethoxyphenyl)-[(3R,4R,5S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methanone |
Ciwujianoside-B | 114902-16-8 | C58H92O25 | 1189.35 | yemuoside YM(10); CIWUJIANOSIDE B (RG); acanthopanax senticosides B |
Ciwujianoside E | 114912-36-6 | C40H62O11 | 718.925 | Guaianin A |
Ciwujianoside C3 | 114906-74-0 | C53H86O21 | 1059.2 | |
Ciwujianoside A1 | 120768-65-2 | C59H96O26 | 1221.38 | |
Citrostadienol | 474-40-8 | C30H50O | 426.29 | alpha1-Sitosterol; 24-Ethylidenelophenol; (Z)-24-ethylidenelophenol |
Citroside A | 120330-44-1 | C19H30O8 | 386.441 | (1R,5S)-5-Hydroxy-1,3,3-trimethyl-2-(3-oxobut-1-en-1-ylidene)cyclohexyl beta-D-glucopyranoside |
Citropten | 487-06-9 | C11H10O4 | 206.2 | 2H-1-Benzopyran-2-one, 5,7-dimethoxy-;5,7-dimethoxy-2h-1-benzopyran-2-on;5,7-Dimethoxy-2H-chromen-2-one |
CITRONELLYL TIGLATE | 24717-85-9 | C15H26O2 | 238.37 | 2-Butenoic acid, 2-methyl-, 3,7-dimethyl-6-octenyl ester, (2E)-, 3,7-Dimethyloct-6-en-1-yl 2-methylbut-2-enoate, CITRONELLYL TIGLATE |
CITRONELLYL PROPIONATE | 141-14-0 | C13H24O2 | 212.33 | 3,7-Dimethyl-6-octen-1-yl propanoate, 3,7-Dimethyloct-6-en-1-yl propionate, 6-Octen-1-ol, 3,7-dimethyl-, propanoate, Citronellyl propanoate, CITRONELLYL PROPIONATE FCC |
Citronellyl nitrile | 51566-62-2 | C10H17N | 151.25 | 3,7-Dimethyl-6-octene-1-nitrile; 3,7-dimethyl-6-octenenitril; Agrunitrile; Baranylnitrile; Citronellonitrile; Citrylone; CITRONELLYL NITRILE; CITRONALVA |
CITRONELLYL ISOBUTYRATE | 97-89-2 | C14H26O2 | 226.36 | CITRONELLYL ISOBUTYRATE FCC, Propanoic acid, 2-methyl-, 3,7-dimethyl-6-octenyl ester |
CITRONELLYL BUTYRATE | 141-16-2 | C14H26O2 | 226.36 | Butanoic acid, 3,7-dimethyl-6-octenyl ester, CITRONELLYL BUTYRATE FCC |
CITRONELLYL ACETATE BRI | 150-84-5 | C12H22O2 | 198.31 | 3,7-Dimethyl-6-octen-1-yl acetate, 6-Octen-1-ol, 3,7-dimethyl-, acetate, CITRONELLYL ACETATE BRI FCC |
cis-4-DODECENAL | 21944-98-9 | C12H22O | 182.31 | (* Alt. CAS #) CAS: 30390-51-3; Dodec-4-en-1-al, 4-Dodecenal, (4Z)-, cis-4-Dodecen-1-al, cis-4-DODECENAL, z-4-Dodecenal |
cis-4-Decene | 19398-88-0 | C10H20 | 140.27 | (4Z)-4-Decene; (Z)-4-C10H20; (Z)-4-decene; 4-Decene, (Z)-; cis-dec-4-ene; CIS-4-DECENE |
CIS-4-DECENAL DIETHYL ACETAL | 73545-19-4 | C14H28O2 | 228.37 | 1,1-diethoxy-,(Z)-4-Decene; 1-diethoxy-(z)-4-decen; 4-Decene,1,1-diethoxy-,(Z)-; CIS-4-DECENAL DIETHYL ACETAL; (Z)-1,1-diethoxy-4-decene; 4-Decene, 1,1-diethoxy-, (4Z)- |
CIS-2,6-PIPERIDINE DICARBOXYLIC ACID | 59234-40-1 | C7H11NO4 | 173.16654;g/mol | (2R,6S)-piperidine-2,6-dicarboxylicacid;CIS-2,6-PIPERIDINEDICARBOXYLICACID;59234-40-1;CIS-2,6-PIPERIDINE-DICARBOXYLICACID;SCHEMBL68389;CHEMBL124513 |
cis-2,6-Dimethylmorpholine | 6485-55-8 | C6H13NO | 115.17 | CIS-2,6-DIMETHYLMORPHOLINE; Cis-2,6-Methylmorpoline; P-methoxy-alpha-Bromoacetophenone; Cdmm; (Z)-2,6-Dimethylmorpholine; cis-2,6-Dimethylmorpholine,97%; cis-2,6-Dimethylmorpoline; cis-2,6-Dimethylmorpholin |
CI 969 | 113590-49-1 | C10H17ClN2O2 | 232.71 | (Z)-1-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)ethanone O-acetyl oxime hydrochloride |
CI 966 hydrochloride | 110283-66-4 | C23H21F6NO3.HCl | 509.87 | 1-[2-[bis[4-(Trifluoromethyl)phenyl]methoxy]ethyl]-1,2,5,6-tetrahydropyridine-3-carboxylic acid hydrochloride |
CI 951 | 126661-07-2 | C22H23F3N2O3 | 420.42 | 1,6-Naphthyridine-3-carboxylic acid, 1,4-dihydro-2-methyl-5-(1-methylethoxy)-4-(2-(trifluoromethyl)phenyl)-, ethyl ester |
CI 924 | 79520-77-7 | C26H34O6 | 442.54 | EINECS 279-174-7;5,5'-((1,1'-Biphenyl)-2,5-diylbis(oxy))bis(2,2-dimethylpentanoic acid) |
CI 750 | 47739-68-4 | C29H36ClN3O | 478.07 | 1-(((2-Chloro-3-methoxyphenyl)methyl)methylamino)-N,N-diethyl-2,3-dihydro-3-phenyl-1H-indole-3-ethanamine; |
CI 600 | 13450-70-9 | C17H20ClN3O | 317.81 | Methylaminopropyldibenzodiazepinone;5,10-Dihydro-5-(3-(methylamino)propyl)-11H-dibenzo(b,e)(1,4)diazepin-11-one;5,10-Dihydro-5-[3-(methylamino)propyl]-11H-dibenzo[b,e][1,4]diazepin-11-one;AC1L2DG1;63915-70-8 (hydrochloride.monohydrate) |
Chloropyrazine Carboxamide | 76599-74-1 | C6H7ClN6O2 | 230.61 | |
Chloropyramine impurity HCl (salt) | 91428-63-6 | C11H16ClNO | 250.16 | (p-Chlorobenzyl Ether) HCl |
Chloropyramine Impurity 1 HCl | 154-69-8 | C16H22ClN3 | 291.82 | Tripelennamine HCl; Ahistamin; Piristin; N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine hydrochloride |
Chloropyramine impurity | 22881-33-0 | C12H11ClN2 | 218.69 | p-Chlorobenzylaminopyridine |
Chloroprocaine HCl | 3858-89-7 | C13H20Cl2N2O2 | 307.22 | |
Citromycin | 37209-30-6 | C13H10O5 | 246.218 | 8,9-dihydroxy-2-methyl-5H-pyrano[3,2-c]chromen-4-one |
Citromycetin | 478-60-4 | C14H10O7 | 290.2 | Frequentic acid |
Citrinin | 518-75-2 | C13H14O5 | 250.25 | (3R,4S)-4,6-Dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-3H-2-benzopyran-7-carboxylic Acid; (3R-trans)-4,6-Dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-3H-2-benzopyran- 7-carboxylic Acid; Citrinin; NSC 186 |
Citricacidsesquipiperazinesalt | 41372-10-5 | C24H56N6O19 | 732.73000 | |
Citric acid-1,3-dibenzylester | 101996-62-7 | |||
Citric acid trimagnesium salt | 3344-18-1 | 2(C6H5O7).3Mg | 451.12 | Citric acid trimagnesium salt; Magnesium citrate tribasic; tri-Magnesium dicitrate 9-hydrate; Trimagnesium dicitrate anhydrous; Trimagnesium dicitrate 14-hydrate |
Citreoviridin | 25425-12-1 | C23H30O6 | 402.5 | Citreoviridin A |
CITCO | 338404-52-7 | C19H12Cl3N3OS | 436.74 | (E)-1-[6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazol-5-yl]-N-[(3,4-dichlorophenyl)methoxy]methanimine;6-(4-Chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime; |
Citalopram, Hydrobromide Salt | 59729-32-7 | C20H22BrFN2O | 405.31 | Citalopram HBr; Cipramil; Celexa; 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide |
Citalopram Related Compound II | 488787-59-3 | C20H23FN2O2 | 342.42 | (S)-4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile; Escitalopram intermediate B |
Citalopram Oxalate D6 | 1246819-94-2 | C20H15D6FN2O.C2H2O4 | 420.46 | 1-[3-(Dimethylamino-d6)propyl]-1-(4-fluorophenyl)-1,3-dizohydro-5-isobenzofurancarbonitrile Oxalate Salt |
Citalopram Olefinic Impurity | 920282-75-3 | C20H21FN2O | 324.39 | 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-buten-1-yl]-3-(hydroxymethyl)-benzonitrile |
Citalopram N-Oxide | 63284-72-0 | C20H21FN2O2 | 340.39 | Escitalopram EP Impurity H; Citalopram USP Related Compound E; 3-[5-cyano-1-(4-fluorophenyl)-3H-2-benzofuran-1-yl]-N,N-dimethylpropan-1-amine oxide |
Citalopram Impurity | 1433278-32-0 | C25H35FN2O3 | 430.56 | 1-Descyano 1-(4-Dimethylamino)oxobutyl Citadiol; 4-(Dimethylamino)-1-[4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)phenyl]-1-butanone |
Citalopram hydrochloride | 85118-27-0 | C20H21FN2O HCl | 360.86 | Citalopram hydrochloride; 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrochloride |
Citalopram EP Impurity F (Oxalate salt form) | 64372-43-6 | C21H23BrFNO5 | 468.319 | SCHEMBL5188469; CTK7I3850; 3-[(1R)-5-Bromo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine Hydrogen Oxalate; 3-[5-bromo-1-(4-fluorophenyl)-3H-2-benzofuran-1-yl]-N,N-dimethylpropan-1-amine;oxalic acid; 5-BROMO-1-(3-DIMETHYLAMIN |
Citalopram EP Impurity B | 411221-53-9 | C20H21FN2O2 | 340.39 | 3-Hydroxy Citalopram; 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-3-hydroxy-5-isobenzofurancarbonitrile |
Citalopram EP Impurity A | 64372-56-1 | C20H23FN2O2 | 342.41 | rac-Citalopam Carboxamide; USP Citalopram Related Compound A; 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarboxamide |
Citalopram Dimethylaminobutanone Di-Oxalate (Citalopram Impurity G) | 1329745-98-3 | C25H35Cl2FN2O2 | 485.46 | 4-(Dimethylamino)-1-[1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuranyl]-1-butanone Dihydrochloride Salt |
Citalopram Descyano Impurity Oxalate | 390817-87-5 | C21H24FNO5 | 389.43 | |
Citalopram D4 HBr | 1219803-58-3 | C20H17D4FN2O.HBr | 409.33 | |
Citalopram Carboxylic Acid Impurity | 440121-09-5 | C20H22FNO3 | 343.39 | 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarboxylic Acid |
Citalopram Alkene Dimer Chloride | 1370643-27-8 | C40H41ClF2N4O | 667.23 | 5-Cyano-N-[[5-cyano-2-[(1E)-4-(dimethylamino)-1-(4-fluorophenyl)-1-buten-1-yl]phenyl]methyl]-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanaminium Chloride |
Citadiol Hydrobromide | 103146-26-5 | C20H24BrFN2O2 | 423.32 | 4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile Hydrobromide; 4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile Hydrobromide; 4-[4-(Dimethylamino)-1-(4'-fluorophenyl)-1-[hydroxy]bu |
cis-Zeatin-o-glucoside | 71866-93-8 | C16H23N5O6 | 381.38 | 6-((Z)-4-b-D-glucopyranosyloxy-3-methylbut-2-enylamino)purine |
cis-Zeatin-9-glucoside | 169565-72-4 | C16H23N5O6 | 381.38 | 6-((Z)-4-hydroxy-3-methylbut-2-enylamino)-9-b-Dglucopyranosylpurine |
N6-(cis-hydroxyisopentenyl)adenosine | 15896-46-5 | C15H21N5O5 | 351.36 | Adenosine, N-(4-hydroxy-3-methyl-2-butenyl)-, (Z); 9-beta-D-ribofuranosyl-cis-zeatin; (2R,3R,4S,5R)-2-(6-(((Z)-4-Hydroxy-3-methylbut-2-en-1-yl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol |
cis-Vitamin K1 (Z-Phytonadione) | 16033-41-3 | C31H46O2 | 450.71 | 2-Methyl-3-[(2Z,7R,11R)-3,7,11,15-tetramethyl-2-hexadecen-1-yl]-1,4-naphthalenedione; [R-[R*,R*-(Z)]]-2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4- naphthalenedione; cis-Phylloquinone |
cis-Trismethoxy resveratrol | 94608-23-8 | C17H18O3 | 270.3 | cis-Trimethoxy Stilbene; 1,3-dimethoxy-5-[(Z)-2-(4-methoxyphenyl)ethenyl]benzene; 3,4',5-Trimethoxy-cis-stilbene |
cis-trans-Permethric acid | 55667-40-8 | C8H10Cl2O2 | 209.071 | 55667-40-8; cis-DCCA; AC1LDRLN; 1R-cis-Permethrinicacid; cis-trans-Permethricacid; 1R-cis-Permethrinicacid |
cis-Thiothixene | 3313-26-6 | |||
Cistanoside F | 97411-47-7 | C21H28O13 | 488.44 | Ligupurpuroside E |
Cistanoside | 93236-42-1 | C36H48O20 | 800.75 | |
cis-ROSE OXIDE | 3033-23-6 | C10H18O | 154.24 | (* Alt. CAS #) CAS: 16409-43-1; Rose Oxide, 2H-Pyran, tetrahydro-4-methyl-2- (2-methyl-1-propenyl)-, (2S-cis)-, cis-ROSE OXIDE, FEMA CAS: 16409-43-1 |
cis-Resveratrol 4-O-b-D-glucuronide | 387372-26-1 | C20H20O9 | 404.37 | 4-[(1Z)-2-(3,5-Dihydroxyphenyl)ethenyl]phenyl |
cis-Resveratrol | 61434-67-1 | C14H12O3 | 228.25 | 5-[(1Z)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; cis-3,4',5-Trihydroxystilbene; Z-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; (Z)-Resveratrol; |
Cis-Quaternary Acid | 1075727-04-6 | C24H31NO6 | 429.52 | Atracurium Impurity E; 3-((1R,2R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl)propanoate |
cis-Pyrrolidine-3,4-diyldimethanol | 848616-45-5 | C6H13NO2 | 131.18 | cis-Pyrrolidine-3,4-diyldimethanol; (3R,4S)-Rel-3,4-pyrrolidinedimethanol |
Cisplatin | 15663-27-1 | Cl2H6N2Pt | 300.05 | (SP-4-2)-diamminedichloro-platinum |
cis-Permethrin | 61949-76-6 | C21H20Cl2O3 | 391.29 | (±)-cis-Permethrin; 1RS,cis-Permethrin; Cispermethrin; FMC 35171; NRDC 148; (±)-cis-FMC 33297; cis-3-(2,2-Dichloroethenyl)-2,2-dimethyl-cyclopropanecarboxylic Acid (3-Phenoxyphenyl)methyl ester; m-Phenoxybenzyl cis-3-(2,2-dichlorovinyl)-2,2-dimethylcyclop |
cis-Permethric Acid | 59042-49-8 | C8H10Cl2O2 | 209.07 | (1R,3R)-rel-3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic Acid; cis-3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic Acid; (±)-cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic Acid; (±)-cis-Cypermethric Acid; (±)-cis-Per |
cis-Perfluorodecalin | 60433-11-6 | C10F18 | 462.08 | CIS-PERFLUORODECALIN; CIS-OCTADECAFLUORODECAHYDRONAPHTHALENE; cis-perfluorodecahydronaphthalene; perfluoro(cis-decahydro-naphthalene); Perfluorodecaline-cis |
CIS-PARINARIC ACID | 593-38-4 | C18H28O2 | 276.41 | CIS-PARINARIC ACID; (9Z,11E,13E,15Z)-9,11,13,15-Octadecatetraenoic acid; (9Z,11E,13E,15Z)-Octadeca-9,11,13,15-tetrenoic acid; (9Z,11E,13E,15Z)-Parinaric acid; cis-Parinarate |
Cis-Mulberroside A | 166734-06-1 | C26H32O14 | 568.54 | |
cis-Montelukast | 774538-96-4 | C35H36ClNO3S | 586.2 | 1-[[[(1R)-1-[3-[(1Z)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic Acid; Montelukast Impurity G; Montelukast EP Impurity G; |
cis-Miyabenol C | 168037-22-7 | C42H32O9 | 680.709 | Miyabenol C |
cis-Methylkhellactone | 20107-13-5 | C15H16O5 | 276.288 | (+)-cis-Methylkellactone; (9R,10R)-8,8-Dimethyl-9,10-dihydro-10-methoxy-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-ol |
cis-Methylisoeugenol | 6380-24-1 | C11H14O2 | 178.2 | 1,2-Dimethoxy-4-[(Z)-1-propenyl]benzene; |
cis-Lacidipine | 103890-79-5 | C26H33NO6 | 455.55 | (Z)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Diethyl Ester; |
cis-Inositol | 576-63-6 | C6H12O6 | 180.16 | |
cis-Hydroxy Perhexiline HCl (Mixture of Diastereomers)(HCl salt) | 917877-73-7 | C19H35NO.HCl | 329.96 | |
cis-Hydroxy Loxoprofen | 371753-20-7 | C15H20O3 | 248.32 | |
CIS-HYDRINDANE | 4551-51-3 | C9H16 | 124.22 | CIS-BICYCLO[4.3.0]NONANE; CIS-HYDRINDANE; CIS-HEXAHYDROINDANE; 1H-indene,octahydro-,cis-; cis-hexahydrindan; cis-Hexahydroindan |
cis-Flupenthixol hydrochloride | 51529-01-2 | C23H25F3N2OS·2HCl | 507.4 | cis-Flupentixol; cis-(Z)-Flupentixol dihydrochloride; 2-[4-[(3Z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol dihydrochloride; Emergil |
Cis-Ethyl 2-hydroxy-cyclohexanecarboxylate | 6149-52-6 | C9H16O3 | 172.22 | |
CIS-EPOXYSUCCINIC ACID | 16533-72-5 | C4H4O5 | 132.07 | epoxysuccinicacid; CIS-2,3-OXIRANEDICARBOXYLIC ACID; CIS-EPOXYSUCCINIC ACID; 2,3-Oxiranedicarboxylicacid,(2R,3S)-rel-(9CI); (2S,3R)-2,3-Oxiranedicarboxylic acid; cis-Ethyleneoxidedicarboxylic acid |
cis-Dithiocyanatobis(N,N'-2,2'-bipyridyl-4,4'-dicarboxylic acid)ruthenium | 141460-19-7 | C26H16N6O8RuS2 | 705.64 | CIS-BIS(ISOTHIOCYANATO)BIS(2,2-BIPYRIDYL-4,4-DICARBOXYLATO)-RUTHENIUM(II); cis-Dithiocyanatobis(N,N'-2,2'-bipyridyl-4,4'-dicarboxylic acid)ruthenium |
Cis-diiododiammineplatinum(II) | 23555-38-6 | Cis-[Pt(NH3)2I2] | 482.96 | |
cis-Diethylstilbestrol | 22610-99-7 | C18H20O2 | 268.35 | 4,4'-[(1Z)-1,2-Diethyl-1,2-ethenediyl]bis-phenol; (Z)-3,4-Bis(4-hydroxyphenyl)-3-hexene |
CIS-DICHLOROBIS(2,2'-BIPYRIDINE)RUTHENIUM (II) DIHYDRATE, 99 | 15746-57-3 | C20 H16 Cl2 N4 Ru . 2 H2 O | 520.38 | CIS-DICHLOROBIS(2,2'-BIPYRIDINE)RUTHENIUM (II) DIHYDRATE, 99; -bipyridyl)ruthenium(II) chloride dihydrate; cis-Bis(2,2´ CIS-BIS-(2,2'-BIPYRIDYL)RUTHENIUM(II) CHLORIDE 2-HYDRATE; cis-Bis-(2,2'-bipyridine)dichlororuthenium(II) dihydrate |
Cis-dichlorobis (dimethysulfoxide) platinum(II) | 22840-91-1 | C4H12Cl2O2PtS2 | 422.25688;g/mol | dichloroplatinum; methylsulfinylmethane; 22840-91-1; SCHEMBL1903381; didimethylsulfoxidedichloroplatinum; Cis-dichlorobis(dimethysulfoxide)platinum(II) |
cis-Dehydroosthol | 109741-40-4 | C15H14O3 | 242.274 | (Z)-Dehydroosthol; 7-methoxy-8-[(1Z)-3-methylbuta-1,3-dienyl]chromen-2-one |
cis-Decahydroquinoline | 10343-99-4 | C9H17N | 139.23798 | cis-decahydroquinoline |
cis-Decahydronaphthalene-D18 | 80997-90-6 | C10D18 | 156.36 | CIS-DECAHYDRONAPHTHALENE-D18; CIS-DECAHYDRONAPHTHALENE-D18, 98+ ATOM % D; cis-decahydronaphthalene-d1899.5atom%dcis,3%rans; CIS-DECAHYDRONAPHTHALENE-D18,99.5 ATOM % D97% CIS, 3% TRANS; CIS-DECAHYDRONAPHTHALENE-D18, 99 ATOM% D, 95% CIS, 5% TRANS, FOR NMR; |
cis-Decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene | 79236-92-3 | C10H18N4 | 194.28 | Decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene; 2a,4a,6a,8a-Decahydrotetraazacyclopent[fg]acenaphthylene |
cis-Cyclopropane-1,2-dicarboxylic acid diethyl ester | 710-43-0 | C9H14O4 | 186.21 | |
cis-cyclohexanedicarboximide | 7506-66-3 | C8H11NO2 | 153.17800 | |
cis-Crotylboronic acid pinacol ester | 69611-01-4 | C10H19BO2 | 182.07 | Z-2-Buten-1-yl-boronic acid pinacol ester, Z-Crotylboronic acid pinacol ester, cis-2-(2-Buten-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
cis-Clomiphene Hydrochloride | 14158-66-8 | C26H29Cl2NO | 442.42 | (Z)-2-[p-(2-chloro-1,2-diphenylvinyl)phenoxy]-triethylamine Hydrochloride; 2-[4-[(1Z)-2-Chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethyl-ethanamine Hydrochloride; (Z)-Clomiphene Hydrochloide; RMI 16312; Zuclomifene Hydrochloride; Zuclomiphene Hydrochloride |
CIS-CLOMIPHENE HCL | 15690-55-8 | C26H29Cl2NO | 442.42 | 2-diphenylethenyl)phenoxy)-n,n-diethyl-2-(4-(2-chloro-(z)-ethanamin; 2-diphenylvinyl)phenoxy)-2-(p-(2-chloro-(z)-triethylamin; cis-2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethylethanamine; cis-2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamin |
cis-Citral | 106-26-3 | C10H16O | 0 | cis-Citral=cis-3,7-Dimethyl-octa-2,6-dien-1-al; neral,3,7-dimethyl-(Z)-2,6-octadienal; 2,6-Octadienal, 3,7-dimethyl-, (2Z)-; CITRALPQEXTRA; BETA-CITRAL; NERAL, REFINED 60 - 63% |
cis-Capsaicin-d3 | 1185237-43-7 | C18H24NO3D3 | 308.44 | (6Z)-N-[(4-Hydroxy-3-(methoxy-d3)phenyl)methyl]-8-methyl-6-nonenamide; (Z)-8-Methyl-N-vanillyl-6-nonenamide-d3; (Z)-8-Methyl-N-vanillyl-6-nonenamide-d3; (Z)-Capsaicin-d3; Civamide-d3; Zucapsaicin-d3 |
cis-Capsaicin | 25775-90-0 | C18H27NO3 | 305.42 | (Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide; BRN 4261852; cis-Capsaicin; Civamide; Zucapsaicin, trade name Civanex |
Cis-Atracurium Besylate | 96946-42-8 | C65H82N2O18S2 | 1243.487 | (1R,1'R,2R,2'R)-2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium dibenzenesulfonate; Cisatracurium besilat |
Cisapride Related Compound (Mosapride Impurity E) | 112885-33-3 | C21H26ClN3O3 | 403.91 | 4-Amino-N-((4-benzyl-2-morpholinyl)-methyl)-5-chloro-2-ethoxybenzamid |
Cisapride hydrate | 260779-88-2 | C23H29N3O4ClFH2O | 483.96 | 4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide; hydrate;Cisapridemonohydrate;260779-88-2;cis-4-Amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenxamidemonohydrate;CI |
Cisapride | 81098-60-4 | C23H29ClFN3O4 | 465.95 | 4-Amino-5-chloro-N-{(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl}-2-methoxybenzamide;Rel-Cisapride;benzamide,4-amino-5-chloro-n-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperi;monohydrate,cis-dinyl)-2-methoxy;R 51619;(±)-Cisapride |
cis-Anethol | 104-46-1 | C10H12O | 148.2 | PARA METHOXY ALPHA PHENYL PROPENE;P-METHOXYPROPENYLBENZENE;P-PROPENYLPHENYL METHYL ETHER;TRANS-1-METHOXY-4-(1-PROPENYL)BENZENE;TRANS-P-METHOXYPROPENYLBENZENE;TRANS-P-PROPENYLANISOLE;FEMA 2086;(E)-1-METHOXY-4-(1-PROPENYL)BENZENE |
cis-ACPD | 477331-06-9 | C7H11NO4 | 173.17 | (±)-1-Aminocyclopentane-cis-1,3-dicarboxylic acid |
CIS-ACONITIC ANHYDRIDE | 6318-55-4 | C6H4O5 | 156.09 | 2,5-dihydro-2,5-dioxo-3-furanaceticaci; CIS-ACONITIC ACID ANHYDRIDE; CIS-ACONITIC ANHYDRIDE; CIS-PROPENE-1,2,3-TRICARBOXYLIC ACID ANHYDRIDE; CIS-PROPENE-1,2,3-TRICARBOXYLIC ANHYDRIDE; 2,5-dihydro-2,5-dioxofuran-3-acetic acid; Cis-AconiticAnhydride98%; aco |
cis-ACCP | 777075-44-2 | C7H15N2O4P | 222.2 | [(1R,2S)-2-aminocyclohexyl]carbamoylphosphonic acid; P-[[[(1R,2S)-2-aminocyclohexyl]amino]carbonyl]-phosphonic acid |
cis-ACBD | 73550-55-7 | C6H9NO4 | 159.14 | cis-1-Aminocyclobutane-1,3-dicarboxylic acid |
CIS-9-HEXADECENYL METHANESULFONATE | 93135-85-4 | C17H34O3S | 318.52 | METHANESULFONIC ACID PALMITOLEYL ESTER; CIS-9-HEXADECENYL METHANESULFONATE; PALMITOLEYL METHANE SULFATE |
cis-9-Heneicosene | 39836-21-0 | C21H42 | 294.56 | CIS-9-HENEICOSENE; CIS-9-HENEICOSENE APPROX. 97%; (Z)-9-Heneicosene |
cis-9,cis-12-Octadecadienoic acid methyl ester | 112-63-0 | C19H34O2 | Linoleic acid methyl ester~Methyl cis,cis-octadeca-9,12-dienoate; methyl (9Z,12Z)-octadeca-9,12-dienoate | |
cis-9,10-Methyleneoctadecanoic acid | 4675-61-0 | C19H36O2 | 296.49 | DIHYDROSTERCULIC ACID; CIS-9,10-METHYLENEOCTADECANOIC ACID |
CIS-8,11,14-EICOSATRIENOIC ACID | 1783-84-2 | C20H34O2 | 306.48 | DIHOMO-GAMMA-LINOLENIC ACID; DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING TRIGLYCERIDE; EICOSA-8Z,11Z,14Z-TRIENOIC ACID; CIS,CIS,CIS-8,11,14-EICOSATRIENOIC ACID; CIS-8,11,14-EICOSATRIENOIC ACID; DELTA 8 CIS 11 CIS 14 CIS EICOSATRIENOIC ACID; DGLA; HOMO-GAMMA-LI |
cis-6-NONENYL ACETATE | 76238-22-7 | C11H20O2 | 184.28 | 6-Nonen-1-ol, acetate, (6Z)-, cis-6-NONENYL ACETATE |
cis-6-NONEN-1-OL | 35854-86-5 | C9H18O | 142.23 | (Z)-non-6-en-1-ol, 6-Nonen-1-ol, (6Z)-, cis-6-NONEN-1-OL FCC, cis-6-Nonenol, z-6-Nonenol, cis-6-NONEN-1-OL FCC NO ANTIOXIDANT (special order) |
cis-6-NONEN-1-AL | 2277-19-2 | C9H16O | 140.22 | 6-Nonenal, (6Z)-, cis-6-NONEN-1-AL, z-6-Nonenal, cis-6-NONEN-1-AL NO ANTIOXIDANT (special order) |
cis-5-OCTENYL PROPIONATE | 196109-18-9 | C11H20O2 | 184.28 | 5-Octen-1-ol, propanoate, (5Z)-, cis-5-OCTENYL PROPIONATE, z-5-Octen-1-yl propanoate |
cis-5-OCTENAL | 41547-22-2 | C8H14O | 126.20 | 5-Octenal, (5Z)-, Aldehyde Melon, cis-5-OCTENAL |
cis-5-OCTEN-1-OL | 64275-73-6 | C8H16O | 128.21 | 5-Octen-1-ol, (5Z)-, cis-5-OCTEN-1-OL, cis-5-Octenol, Z-5-Octenol, cis-5-OCTEN-1-OL NO ANTIOXIDANT (special order) |
cis-5-Eicosenoic acid | 7050-07-9 | C20H38O2 | 310.51452 | cis-5-Eicosenoic acid; 5-cis-Eicosenoic acid |
cis-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-1-one | 912356-09-3 | C17H14ClNO2 | 299.75 | |
cis-4-Hydroxy-lomustine | 52049-26-0 | C9H16ClN3O3 | 249.69 | 1-(2-Chloroethyl)-3-(cis-4-hydroxycyclohexyl)-1-nitrosourea; N-(2-Chloroethyl)-N'-(cis-4-hydroxycyclohexyl)-N-nitrosourea; NSC 239724; cis-4-Hydroxy CCNU |
cis-4-HEXEN-1-OL | 928-91-6 | C6H12O | 100.16 | (* Alt. CAS #) CAS: 6126-50-7; 4-Hexen-1-ol, 4-Hexen-1-ol, (4Z)-, c-4-Hexen-1-ol, c-4-Hexenol, cis-4-HEXEN-1-OL, cis-4-Hexenol, FEMA CAS: 6126-50-7, z-4-Hexenol |
cis-4-HEPTENAL DIETHYL ACETAL | 18492-65-4 | C11H2202 | 186.30 | 1,1-Diethoxy-cis-4-heptene, 3-Heptene, 7,7-diethoxy-, (3Z)-, cis-4-Heptenal DEA, cis-4-HEPTENAL DIETHYL ACETAL, z-4-Heptenal DEA |
cis-4-Aminocyclohexanol Hydrochloride | 56239-26-0 | C6H13NO . HCl | 151.63 | cis-4-Hydroxycyclohexylamine hydrochloride |
CIS-4-AMINOCROTONIC ACID | 55199-25-2 | C4H7N1O2 | 101.1 | |
cis-4-Amino-5-chloro-2-methoxy-N-(3-methoxy-piperidin-4-yl)-benzamide HCl | 221180-26-3 | C14H21Cl2N3O3 | 350.24 | rel- |
cis-4-Amino-5-chloro-2-methoxy-N-(3-methoxy-4-piperidyl)benzamide | 83863-69-8 | C14H20ClN3O3 | 313.78000 | |
cis-4-Amino-1-Boc-3-methoxypiperidine | 1171124-68-7 | C11H22N2O3 | 230.3 | |
CIS-4,7,10,13,16,19-DOCOSAHEXAENOIC ACID SODIUM SALT | 81926-93-4 | C22H31NaO2 | 350.47 | |
cis-4,7,10,13,16,19-Docosahexaenoic Acid Ethyl Ester | 84494-72-4 | C24H36O2 | 356.54 | |
cis-4,5-dichloro-4,5-dimethyl-1,3-dioxolan-2-one | 129482-56-0 | C5H6Cl2O3 | 185.01 | |
cis-4-(Hydroxymethyl)cyclohexanecarboxylic acid | 73094-35-6 | C8H14O3 | 158.20 | |
CIS-3-PENTEN-1-YNE | 1574-40-9 | C5H6 | 66.1 | (3Z)-3-Penten-1-yne; (Z)-CH3CH=CHCequivCH; 3-Pentene-1-yne, (Z)-; cis-2-Penten-4-yne; cis-Penten-1-yne; Pent-1-yn-3-ene, (Z)-; Z-3-Penten-1-yne; CIS-3-PENTEN-1-YNE |
cis-3-OCTEN-1-OL | 20125-84-2 | C8H16O | 128.21 | 3-Octen-1-ol, (3Z)-, cis-3-OCTEN-1-OL, cis-3-Octenol, Z-3-Octen-1-ol, cis-3-OCTEN-1-OL NO ANTIOXIDANT (special order) |
cis-3-NONEN-1-OL | 10340-23-5 | C9H18O | 142.24 | (Z)-Non-3-en-1-ol, 3-Nonen-1-ol, (3Z)-, cis-3-NONEN-1-OL, cis-3-Nonenol, z-3-Nonenol |
cis-3-Methylcyclobutanecarboxylic acid | 87863-08-9 | C6H10O2 | 114.14 | |
cis-3-Methylcyclobutanamine hydrochloride | 1093951-55-3 | C5H11N.HCl | 121.61 | |
CIS-3-METHYL-1,3-PENTADIENE | 2787-45-3 | C6H10 | 82.14 | (3Z)-3-Methyl-1,3-pentadiene; (E)-CH2=CHC(CH3)=CHCH3; (Z)-3-Methyl-1,3-pentadiene; CIS-3-METHYL-1,3-PENTADIENE; 1,3-Pentadiene, 3-methyl-, (Z)- |
cis-3-Hydroxy-4-phenyl-2-azetidinone | 133161-35-0 | C27H41ClN2O5 | 509.07784;g/mol | (2R)-2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; hydrate; hydrochloride; R(+)-Verapamilmonohydrochloridehydrate; V106_SIGMA |
(3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone | 132127-34-5 | C9H9NO2 | 163.17 | (3R-cis)-3-Hydroxy-4-phenyl-2-azetidinone; Cephalomannine Impurity 6; cis-3-hydroxy-4-phenyl-2-azetidinone; 3alpha-Hydroxy-4alpha-phenylazetidin-2-one |
cis-3-HEXENYL VALERATE | 35852-46-1 | C11H20O2 | 184.28 | C-3-HEXENYL VALERATE, cis-3-Hexenyl pentanoate, cis-3-HEXENYL VALERATE, Pentanoic acid, (3Z)-3-hexenyl ester, Z-3-Hexenyl valerate |
cis-3-HEXENYL TIGLATE | 67883-79-8 | C11H18O2 | 182.27 | (Z)-3-hexenyl 2-methylcrotonate, 2-Butenoic acid, 2-methyl-, (3Z)-3-hexenyl ester, (2E)-, C-3-HEXENYL TIGLATE, cis-3-HEXENYL TIGLATE, Z-3-Hexenyl tiglate |
cis-3-HEXENYL SALICYLATE EXTRA | 65405-77-8 | C13H16O3 | 220.27 | Benzoic acid, 2-hydroxy-, (3Z)-3-hexenyl ester, C-3-HEXENYL SALICYLATE, CIS-3-HEXENYL SALICYLATE, cis-3-HEXENYL SALICYLATE EXTRA, Z-3-Hexenyl salicylate |
cis-3-HEXENYL PYRUVATE | 68133-76-6 | C9H14O3 | 170.21 | C-3-HEXENYL PYRUVATE, cis-3-HEXENYL PYRUVATE, Propanoic acid, 2-oxo-, (3Z)-3-hexenyl ester, Z-3-Hexenyl pyruvate |
cis-3-HEXENYL PROPIONATE | 33467-74-2 | C9H16O2 | 156.23 | (Z)-hex-3-enyl propionate, 3-Hexen-1-ol, propanoate, (3Z)-, Also listed under FEMA/GRAS# 3778, C-3-HEXENYL PROPIONATE, cis-3-HEXENYL PROPIONATE, PROPANOIC ACID, 3-HEXENYL ESTER, (Z)-, Z-3-Hexenyl propionate, cis-3-HEXENYL PROPIONATE NO ANTIOXIDANT (specia |
cis-3-HEXENYL PHENYLACETATE | 42436-07-7 | C14H18O2 | 218.30 | Benzeneacetic acid, (3Z)-3-hexenyl ester, C-3-HEXENYL PHENYLACETATE, cis-3-HEXENYL PHENYLACETATE, Z-3-Hexenyl phenylacetate |
cis-3-HEXENYL METHYL CARBONATE | 67633-96-9 | C8H14O3 | 158.00 | Carbonic acid, (3Z)-3-hexenyl methyl ester, cis-3-HEXENYL METHYL CARBONATE, cis-hex-3-en-1-yl methyl carbonate, Liffarome; cis-3-HEXENYL METHYL CARBONATE, NO ANTIOXIDANT (special order) |
cis-3-HEXENYL LACTATE | 61931-81-5 | C9H16O3 | 172.22 | C-3-HEXENYL LACTATE, cis-3-HEXENYL LACTATE, Propanoic acid, 2-hydroxy-, (3Z)-3-hexenyl ester, Z-3-Hexenyl lactate, cis-3-HEXENYL LACTATE NO ANTIOXIDANT (special order) |
cis-3-HEXENYL ISOVALERATE | 35154-45-1 | C11H20O2 | 184.28 | (* Alt. CAS #) CAS: 10032-11-8; 3-Hexenyl 3-methylbutanoate, Butanoic acid, 3-methyl-, (3Z)-3-hexenyl ester, C-3-HEXENYL ISOVALERATE, cis-3-Hexen-1-yl 3-methylbutyrate, cis-3-HEXENYL ISOVALERATE FCC, FEMA CAS: 10032-11-8, z-3-Hexenyl 3-methylbutanoate, z- |
cis-3-HEXENYL ISOBUTYRATE | 41519-23-7 | C10H18O2 | 170.25 | (Z)-hex-3-enyl isobutyrate, C-3-HEXENYL ISOBUTYRATE, cis-3-HEXENYL ISOBUTYRATE, Propanoic acid, 2-methyl-, (3Z)-3-hexenyl ester, Verdural B Extra, Z-3-Hexenyl isobutyrate; cis-3-HEXENYL ISOBUTYRATE, NO ANTIOXIDANT (special order) |
cis-3-HEXENYL FORMATE | 33467-73-1 | C7H12O2 | 128.17 | 3-Hexen-1-ol, formate, (3Z)-, C-3-HEXENYL FORMATE, cis-3-HEXENYL FORMATE, Z-3-Hexenyl formate, cis-3-HEXENYL FORMATE NO ANTIOXIDANT (special order) |
cis-3-HEXENYL CIS-3-HEXENOATE | 61444-38-0 | C12H20O2 | 196.28 | 3-Hexenoic acid, (3Z)-3-hexenyl ester, (3Z)-, C-3-HEXENYL C-3-HEXENOATE, cis-3-HEXENYL CIS-3-HEXENOATE, Z-3-Hexenyl-Z-3-Hexenoate |
cis-3-HEXENYL BUTYRATE | 16491-36-4 | C10H18O2 | 170.25 | (Z)-hex-3-enyl butyrate, Butanoic acid, (3Z)-3-hexenyl ester, C-3-HEXENYL BUTYRATE, cis-3-HEXENYL BUTYRATE, Z-3-Hexenyl butyrate; cis-3-HEXENYL BUTYRATE, NO ANTIOXIDANT (special order) |
cis-3-HEXENYL BENZOATE | 25152-85-6 | C13H16O2 | 204.27 | 3-Hexen-1-ol, benzoate, (3Z)-, C-3-Hexenyl benzoate, cis-3-HEXENYL BENZOATE, Z-3-Hexenyl benzoate; cis-3-HEXENYL BENZOATE, NO ANTIOXIDANT (special order) |
cis-3-HEXENYL ANTHRANILATE | 65405-76-7 | C13H17NO2 | 219.29 | (Z)-Hex-3-enyl anthranilate, 3-Hexen-1-ol, 2-aminobenzoate, (3Z)-, C-3-Hexenyl Anthranilate, cis-3-HEXENYL ANTHRANILATE, Z-3-Hexenyl Anthranilate |
cis-3-HEXENYL ALPHA METHYL BUTYRATE | 53398-85-9 | C11H20O2 | 184.28 | (* Alt. CAS #) CAS: 10094-41-4; 3-Hexenyl 2-methylbutanoate, Butanoic acid, 2-methyl-, (3Z)-3-hexenyl ester, cis-3-Hexenyl 2-methyl butyrate, cis-3-Hexenyl 2-methylbutanoate, cis-3-Hexenyl 2-methylbutyrate, cis-3-HEXENYL ALPHA METHYL BUTYRATE FCC, FEMA CA |
cis-3-HEXENYL ACETATE | 3681-71-8 | C8H14O2 | 142.19 | (Z)-Hex-3-enyl acetate, 3-Hexen-1-ol, acetate, (3Z)-, C-3-Hexenyl acetate, cis-3-HEXENYL ACETATE FCC, Leaf acetate, Verdural Extra, z-3-Hexen-1-yl acetate, Z-3-Hexenyl acetate |
cis-3-HEXENYL 2-METHYL-2-PENTENOATE | 76649-17-7 | C12H20O2 | 196.28 | 2-Pentenoic acid, 2-methyl-, (3Z)-3-hexenyl ester, C-3-HEXENYL 2-METHYL-2-PENTENOATE, cis-3-HEXENYL 2-METHYL-2-PENTENOATE |
cis-3-HEXEN-1-AL (NEAT) | 6789-80-6 | C6H10O | 98.15 | 3-Hexenal, (3Z)-, cis-3-HEXEN-1-AL (NEAT) |
cis-3-HEPTEN-1-OL | 1708-81-2 | C7H14O | 114.19 | 3-Hepten-1-ol, (3Z)-, cis-3-HEPTEN-1-OL, z-3-Heptenol |
CIS-3-BENZOYLCYCLOPENTANE-1-CARBOXYLIC ACID | 732251-89-7 | C13H14O3 | 218.25 | CIS-3-BENZOYLCYCLOPENTANE-1-CARBOXYLIC ACID |
cis-3-Aminocyclohexanecarboxylic acid | 16636-51-4 | C7H13NO2 | 143.18 | |
cis-3-Aminocyclobutanecarboxylic acid ethyl ester hydrochloride | 957793-35-0 | C7H13NO2.HCl | 179.64 | |
Cis-3,5-Piperidinedicarboxylic acid | 876367-84-9 | C7H11NO4 | 173.17 | Cis-3,5-Piperidinedicarboxylic acid; 2,3-o-(R)-Isopropylidene-D-glycerol |
cis-3,4-Dimethylcyclopentanone | 19550-72-2 | C7H12O | 112.17 | CIS-3,4-DIMETHYLCYCLOPENTANONE |
cis-2-NONEN-1-OL | 41453-56-9 | C9H18O | 142.24 | (* Alt. CAS #) CAS: 22104-79-6; 2-Nonen-1-ol, 2-Nonen-1-ol, (2Z)-, 2-Nonenol, cis-2-NONEN-1-OL, z-2-Nonenol, cis-2-NONEN-1-OL NO ANTIOXIDANT (special order) |
cis-2-Methyl-1-cyclohexylamine | 2164-19-4 | C7H15N | 113.2007;g/mol | (1R,2S)-2-Methylcyclohexanamine; 2164-19-4; CIS-2-METHYL-CYCLOHEXYLAMINE; 79389-37-0; cis-2-methylcyclohexylamine; UNII-08OZI4NZZ2 |
cis-2-Butenoic acid | 503-64-0 | C4H6O2 | ||
CIS-2-BUTEN-1-OL | 4088-60-2 | C4H8O | 72.11 | (2Z)-2-Buten-1-ol; (z)-2-buten-1-o; (Z)-2-Buten-1-ol; (Z)-CH3CH=CHCH2OH; cis-2-Butenol; cis-2-Butenyl alcohol; cis-Crotyl Alcohol; Z-Crotyl alcohol |
cis-1-Chloro-2-pentene | 6261-19-4 | C5H9Cl | 104.57800 | |
cis-1-Boc-4-amino-L-proline | 132622-66-3 | C10H18N2O4 | 230.266 | |
CIS-15-OCTADECENOIC ACID METHYL ESTER | 10411-39-9 | C19H36O2 | 296.48794 | CIS-15-OCTADECENOIC ACID METHYL ESTER; cis-15-Octadecenoic methyl ester; (Z)-15-Octadecenoic acid methyl ester |
cis-13-Eicosenoic acid | 17735-94-3 | C20H38O2 | 310.51 | |
CIS-11-OCTADECENOIC ACID | 506-17-2 | C18H34O2 | 282.46 | 11-Octadecenoic acid, (Z)-; 11-OCTADECENOIC ACID (CIS); 11-CIS-OCTADECENOIC ACID; CIS-VACCENIC ACID; CIS-11-OCTADECENOIC ACID; DELTA 11 CIS OCTADECENOIC ACID |
cis-11-Hexadecanol | 56683-54-6 | C16H32O | 240.42468 | cis-11-Hexadecanol; cis-11-Hexadecen-1-ol |
cis-11-Eicosenoic acid | 5561-99-9 | C20H38O2 | 310.51 | CIS-11-EICOSENOICACID,STANDARDFORGC; GONDOIC ACID; C20:1 (CIS-11) ACID; CIS-11-EICOSENOIC ACID; EICOSENOIC ACID; DELTA 11 CIS EICOSENOIC ACID; 11-EICOSENOIC ACID; 11C-EICOSENOIC ACID |
cis-11-Eicosenamide | 10436-08-5 | C20H39NO | 309.53 | cis-11-Eicosenamide; 10436-08-5; AC1NSLGY; (Z)-11-Icosenamide; (Z)-icos-11-enamide; (11Z)-11-Icosenamide# |
CIS-11,14,17-EICOSATRIENOIC ACID METHYL ESTER | 55682-88-7 | C21H36O2 | 320.51 | CIS-11,14,17-EICOSATRIENOIC ACID METHYL ESTER; Methyl (11E,14E,17E)-11,14,17-icosatrienoate; Methyl cis-11,14,17-eicosatrienoate; 11,14,17-Eicosatrienoic acid, methyl ester; 11,14,17-Icosatrienoic acid methyl ester |
cis-10-Hydroxy Nortriptyline | 47132-19-4 | C19H21NO | 279.39 | (5Z)-10,11-Dihydro-5-[3-(methylamino)propylidene]-5H-dibenzo[a,d]cyclohepten-10- ol; (Z)-10-Hydroxynortriptyline; 10-Hydroxy-(Z)-nortriptyline; |
cis-1,4-Cyclohexanediol | 931-71-5 | C6H12O2 | 116.16 | cyclohexane-1,4-diol |
CIS-1,4-CYCLOHEXANEDIAMINE | 15827-56-2 | C6H14N2 | 114.19 | CIS-1,4-CYCLOHEXANEDIAMINE; CIS-1,4-DIAMINOCYCLOHEXANE; CI(S)-CYCLOHEXANE-1,4-DIAMINE; 1,4-Cyclohexanediamine, cis- |
CIS-1,2-DIMETHYL-CYCLOPROPANEDICARBOXYLIC ACID | 699-49-0 | C7H10O4 | 158.1519 | |
CIS-1,2-DIMETHYLCYCLOPROPANE | 930-18-7 | C5H10 | 70.13 | CIS-1,2-DIMETHYLCYCLOPROPANE; 1,cis-2-Dimethylcyclopropane; c-1,2-Dimethylcyclopropane; cyclopropane,1,2-dimethyl-,cis-; (1R,2S)-1,2-Dimethylcyclopropane; Inchi=1/C5H10/C1-4-3-5(4)2/H4-5H,3H2,1-2h |
cis-1,2-Dimethylcyclopentane | 1192-18-3 | C7H14 | 98.19 | 1,2-Dimethyl- cis-cyclopentane; 1,2-Dimethylcyclopentane, cis; 1,cis-2-Dimethylcyclopentane; 1-c-2-Dimethylcyclopentane; c-1,2-Dimethylcyclopentane; cyclopentane,1,cis-2-dimethyl- |
CIS-1,2-DIHYDROCATECHOL | 17793-95-2 | C6H8O2 | 112.13 | CIS-1,2-DIHYDROCATECHOL; CIS-3,5-CYCLOHEXADIENE-1,2-DIOL; 3,5-Cyclohexadiene-1,2-diol; cis-3,5-cyclohexadiene-1,2-diol solution; CIS-3 5-CYCLOHEXADIENE-1 2-DIOL SOLUTIO; CIS-3,5-CYCLOHEXADIENE-1,2-DIOL, 20 WT. % SOLUTION IN ETHYL ACETATE; CIS-1,2-DIHYDROC |
cis,trans-7,9-Dodecadienyl acetate | 54364-62-4 | C14H24O2 | 224.33916 | (7Z,9E)-dodeca-7,9-dienyl acetate; cis,trans-7,9-dodecadienylacetate; (7E,9Z)-7,9-Dodecadien-1-ol acetate; 7,9-Dodecadien-1-ol, 1-acetate, (7E,9Z)-; 7,9-Dodecadien-1-ol, acetate, (7E,9Z)-; 7,9-Dodecadien-1-ol, acetate, (Z,E)-; Ai3-36734; Ccris 9116 |
CIS,TRANS-2,7-NONADIENE | 92230-25-6 | C9H16 | 124.22 | CIS,TRANS-2,7-NONADIENE |
CIS,TRANS,TRANS-1,2,4-TRIMETHYLCYCLOHEXANE | 1678-80-4 | C9H18 | 126.24 | CIS,TRANS,TRANS-1,2,4-TRIMETHYLCYCLOHEXANE; cis-1,2,4-Trimethylcyclohexane; Cyclohexane, 1,2,4-trimethyl-, (1alpha,2alpha,4alpha)-; Cyclohexane, 1,2,4-trimethyl-, cis; c,t,t-1,2,4-TRIMETHYLCYCLOHEXANE; cis-1,2,cis-1,4-1,2,4-Trimethylcyclohexane |
cis,syn-Thymidine dimer methyl phosphoramidite | 118187-67-0 | C49H63N5O15P2 | 1024.0 | (1R,6S,7S,8R,9R,14R,16R,17S,22R,23S)-16-[[Bis(4-methoxyphenyl)-phenylmethoxy]methyl]-23-[[di(propan-2-yl)amino]-methoxyphosphanyl]oxy-19-methoxy-6,9-dimethyl-19-oxo-15,18,20,25-tetraoxa-2,4,11,13-tetraza-19lambda5-phosphahexacyclo[20.2.1.114,17.02,7.06,9. |
CIS,CIS-1,3,5-CYCLOHEXANETRIOL DIHYDRATE | 50409-12-6 | C6H12O3 | 132.16 | CIS-1,3,5-TRIHYDROXYCYCLOHEXANE; CIS,CIS-1,3,5-CYCLOHEXANETRIOL DIHYDRATE; CIS,CIS-1,3,5-TRIHYDROXYCYCLOHEXANE DIHYDRATE; CIS-PHLOROGLUCITOL DIHYDRATE; 1,3,5-Cyclohexanetriol, (1.alpha.,3.alpha.,5.alpha.)-; (1alpha,3alpha,5alpha)-1,3,5-Cyclohexanetriol |
cis,cis,cis-1,2,3,4-Tetrakis[(diphenylphosphino)methyl]cyclopentane | 333380-86-2 | C57H54P4 | 862.954 | Diphenyl-[[(1R,2R,3S,4S)-2,3,4-tris(diphenylphosphanylmethyl)cyclopentyl]methyl]phosphane |
cis-(2-Methyl-2-methylamino-cyclopentyl)-methanol | 421765-87-9 | C8H17NO | 143.23 | [(1R,2S)-2-methyl-2-(methylamino)cyclopentyl]methanol; 421765-87-9; cis-(2-Methyl-2-methylamino-cyclopentyl)-methanol; ZINC32098961; AKOS006344491; AB49853 |
cis-(1s,4s)-n-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine mandelate | 79617-97-3 | C25H25Cl2NO3 | 458.3769 | cis-(1s,4s)-n-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine mandelate |
cis-(+)-Hydroxy Lactum | 30825-34-4 | C8H5N2F3 | 186.13 | 3-amino-5-(trifluoromethyl)benzonitrile; 3-AMINO-5-(TRIFLUOROMETHYL)BENZONITRILE; 49674-28-4; 3-Amino-5-trifluoromethylbenzonitrile; 3-CYANO-5-AMINO-TRIFLUOROTOLUENE; 3-Trifluoromethyl-5-aminobenzonitrile |
cis tert-Butyl N-(3-aminocyclobutyl)carbamate | 1212395-34-0 | C9H18N2O2 | 186.253 | |
cis- Ligupurpuroside B | 350588-96-4 | C35H46O17 | 738.74 | |
cis 5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione | 145986-11-4 | C8H9FN2O4S | 248.23 | (2R-cis)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione |
cis 1,2-cyclopropane dicarboxylic acid | 696-74-2 | C5H6O4 | 130.1 | |
Cirsiumaldehyde | 7389-38-0 | C12H10O5 | 234.20 | 5,5'-Oxybis(5-methylene-2-furaldehyde); O-Bisme-furaldehyde |
Cirsimaritin | 6601-62-3 | C17H14O6 | 314.3 | |
Cirsimarin | 13020-19-4 | C23H24O11 | 476.43 | 2-[4-(b-D-Glucopyranosyloxy)phenyl]-5-hydroxy-6,7-dimethoxy-4H-1-Benzopyran-4-one; 5,4-Dihydroxy-6,7-dimethoxyflavone 4-O-b-D-glucoside |
Cirsiliol | 34334-69-5 | C17H14O7 | 330.29 | 6-Hydroxyluteolin-6,7-dimethyl ether; 6-Methoxyluteolin 7-methyl ether; Crisiliol |
Cirazoline hydrochloride | 40600-13-3 | C13H17N2OCl | 252.74 | 2-[(2-Cyclopropylphenoxy)methyl]-4,5-dihydro-1H-imidazole Hydrochloride; LD 3098 |
Ciraparantag | 1438492-26-2 | C22H48N12O2 | 512.71 | (2S)-2-amino-N-[3-[4-[3-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propyl]piperazin-1-yl]propyl]-5-(diaminomethylideneamino)pentanamide Ciraparantag UNII-U2R67KV65Q U2R67KV65Q PER-977 Aripazine Ciraparantag [USAN] PER977 CHEMBL35449 |
CIQ | 486427-17-2 | C26H26ClNO5 | 467.94 | (3-chlorophenyl)-[6,7-dimethoxy-1-[(4-methoxyphenoxy)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]methanone; (3-chlorophenyl)[3,4-dihydro-6,7-dimethoxy-1-[(4-methoxyphenoxy)methyl]-2(1H)-isoquinolinyl]-methanone; |
Ciproxifan maleate | 184025-19-2 | C20H22N2O6 | 386.40 | |
Ciproxifan | 184025-18-1 | C16H18N2O2.C4H4O4 | 386.4 | FUB 359 |
Ciprostene | 81845-44-5 | C22H36O4 | 364.522 | |
Ciprofloxacin Impurity C HCl | 528851-31-2 | C15H16FN3O3. HCl | 305.31 36.46 | Desethylene Ciprofloxacin, Hydrochloride; 7-[(2-Aminoethyl)amino]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; |
CiproFloxacin hydrochloride monohydrate | 86393-32-0 | C17H18FN3O3.HCl.H2O | 385.82 | |
CIPROFLOXACIN HCL/LACTATE | 86483-48-9 | C17H19ClFN3O3 | 367.80200 | |
Ciprofloxacin HCl | 93107-08-5 | C17H18FN3O3.HCl | 331.35 36.46 | 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, monohydrochloride; |
Ciprofloxacin Chloro Analog Impurity | 93106-58-2 | C17H18ClN3O3 | 347.8 | 6-Chloro-1-cyclopropyl-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid |
Ciprofloxacin b-D-glucuronide | 105029-31-0 | C23H26FN3O9 | 507.47 | 1-[1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate] b-D-glucopyranuronic acid |
Ciprofloxacin | 85721-33-1 | C17H18FN3O3 | 331.34 | |
Ciprofibrate-D6 | 2070015-05-1 | C13H8D6Cl2O3 | 295.19 | 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic Acid-d6; (±)-Ciprofibrate-d6; 2-[p-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropionic Acid-d6; Ciprol-d6; Lipanor-d6; Modalim-d6; Win 35833-d6 |
Ciprofibrate Impurity E | 52179-28-9 | C15H18Cl2O3 | 317.21 | Ciprofibrate Ethyl Ester; Ethyl 2-[p-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionate; Ethyl Ciprofibrate |
Ciprofibrate Impurity D | 130232-51-8 | C14H16Cl2O3 | 303.18 | Ciprofibrate Methyl Ester; 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methyl-propanoic Acid Methyl Ester; (±)-2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methyl-propanoic Acid Methyl Ester |
Ciprofibrate Impurity B | 52179-26-7 | C9H8Cl2O | 203.07 | 4-(2,2-Dichlorocyclopropyl)phenol; p-(2,2-Dichlorocyclopropyl)phenol |
Coumaric acid 4-O-glucoside | 14364-05-7 | C15H18O8 | 326.30 | |
COUMAPHOS-OXON | 321-54-0 | C14H16ClO6P | 346.7 | COUMAPHOS-O-ANALOG; COUMAPHOS-O-ANALOGUE; COUMAPHOS-OXON; PHOSPHORIC ACID 3-CHLORO-4-METHYL-2-OXO-2H-CHROMEN-7-YL ESTER DIETHYL ESTER; 3-chloro-4-methyl-7-coumarinyldiethylphosphate; 3-chloro-7-hydroxy-4-methyl-coumaridiethylphosphate |
Coulteropine | 6014-62-6 | C21H21NO6 | 383.4 | Cowlteropine; 14-Methoxy-7-methyl-6,8,9,16-tetrahydrodi[1,3]benzodioxolo[4,5-c:5,6-g]azecin-15(7H)-one |
Cottonseedoil, hydrogenated | 68334-00-9 | C57H110O6 | 891.48 | Cottonseedoil,hydrogenated; Cottonseedoil,partiallyhydrogenated; Partiallyhydrogenatedcottonseedoil; BATH WAX; GLYCERYL TRISTEARATE; GLYCEROL TRIOCTADECANOATE; 1,2,3-TRIOCTADECANOYLGLYCEROL; 1,2,3-TRIOCTADECANOYL-RAC-GLYCEROL |
Cotrimoxazole | 8064-90-2 | C24H29N7O6S | 543.6 | Abacin; Abactrim; Acuco; Alcorim F; Alfatrim; Andoprim; Anitrim; Antibiotic TMP-SMZ; Antrimox; Aop-Sulfatrim; Apo-Sulfatrim; BS; Bacdan; Bacidal; Bacin; Bacticel; Bactifor; Bactoprim; Bactramin; Bactrim; Bactrim DS; Bactrim Forte; Bactrimel; Baktar; Benco |
Cotinine-d4 | 350818-68-7 | C10H8N2OD4 | 180.24 | (±)-Cotinine-2,4,5,6-d4 |
Cotinine N-(4-deoxy-4,5-didehydro)-b-D-glucuronide | 146275-15-2 | C16H18N2O6 | 334.32 | N-(b-D-4-Deoxy-4,5-didehydroglucopyranosyl)uronate, cotinium inner salt |
COTI-2 | 1039455-84-9 | C19H22N6S | 366.48 | 2BTA1O65BR; ZINC114475331; CS-8156; N-[(E)-6,7-dihydro-5H-quinolin-8-ylideneamino]-4-pyridin-2-ylpiperazine-1-carbothioamide |
COTI 219 | 1039455-85-0 | C17H18N6S | 338.43 | 4-Methyl-1-piperazinecarbothioic Acid 2-(9H-Cyclopenta[1,2-b:4,3-b']dipyridin-9-ylidene)hydrazide |
Cot inhibitor-2 | 915363-56-3 | C26H25Cl2FN8 | 539.43 | 3-Quinolinecarbonitrile, 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-(1-ethyl-4-piperidinyl)-1H-1,2,3-triazol-4-yl]methyl]amino]- |
Cot inhibitor-1 | 915365-57-0 | C27H27Cl2FN8 | 553.46 | 3-Quinolinecarbonitrile, 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-[2-(hexahydro-1H-azepin-1-yl)ethyl]-1H-1,2,3-triazol-4-yl]methyl]amino]- |
Costunolide | 553-21-9 | C15H20O2 | 232.32 | NSC 106404 |
Cosmosiin | 578-74-5 | C21H20O10 | 432.39 | Apigenin 7-O-glucoside |
Corytuberine | 517-56-6 | C19H21NO4 | 327.37 | (S)-corytuberine; (6aS)-2,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1,11-diol |
Cinuperone | 82117-51-9 | C23H24FN3O | 377.45500 | |
CInQ-03 | 500272-80-0 | C22H12ClN5O | 397.822 | CInQ-03 |
CINPA 1 | 102636-74-8 | C23H29N3O3 | 395.49 | Ethyl [5-[(diethylamino)acetyl]-10,11-dihydro-5H-dibenz[b,f]azepin-3-yl]carbamate |
Cinoxopazide | 88053-05-8 | C20H25N3O4 | 371.435 | |
Cinoxacin | 28657-80-9 | C12H10N2O5 | 262.22 | 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid 64716, Compound Acid, Azolinic Azolinic Acid Cinobac Cinoxacin Clinoxacin Compound 64716 |
Cinoctramide | 28598-08-5 | C19H27NO4 | 333.43 | (E)-1-(azocan-1-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one Cinoctramide 28598-08-5 1-(Azocan-1-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one UNII-69J8AO72Q3 Cinoctramida Cinoctramidum (E)-1-(3,4,5-Trimethoxycinnamoyl)azocan AC1O5ZP2 ZINC153 C |
Cinobufotalin | 1108-68-5 | C26H34O7 | 458.54 | |
Cinobufaginol | 6691-83-4 | C26H34O7 | 458.55 | 5beta-Bufa-20,22-dienolide, 14,15beta-epoxy-3beta,16beta,19-trihydroxy-, 16-acetate |
Cinnzeylanol | 62394-04-1 | C20H32O7 | 384.5 | 3-Deoxyryanodol |
Cinnoline Hydrochloride | 5949-24-6 | C8H7ClN2 | 166.61 | Cinnoline Monohydrochloride |
Cinnarizine-d8 2HCl (piperazine-d8) | 1276545-36-8 | C26H22D8Cl2N2 | 449.49 | 1-trans-Cinmyl-4-diphenylmethylpiperazine 2HCl; 1-Benzhydryl-4-cinmylpiperazine 2HCl |
Cinnarizine-d8 | 1185242-27-6 | C26H20N2D8 | 376.56 | 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine-d8; Aplactan-d8; Aplexal-d8; Cerepar-d8; Cinaperazine-d8; Midronal-d8; Mitronal-d8; Olamin-d8 |
Cinnarizine Impurity E | 216581-01-0 | C30H30N2 | 418.57 | 1,4-bis-(Diphenylmethyl)piperazine |
Cinnarizine Impurity D | 1199751-98-8 | C35H36N2 | 484.67 | 1-(Diphenylmethyl)-4-[4-phenyl-1-(2-phenylethenyl)-3-buten-1-yl]piperazine; 1-(Diphenylmethyl)-4-[(1RS,3E)-4-phenyl-1-[(E)-2-phenylethenyl)-3-buten-1-yl]piperazine |
Cinnarizine Impurity B | 750512-44-8 | C26H28N2 | 368.51 | (Z)-Cinnarizine; 1-(Diphenylmethyl)-4-[(2Z)-3-phenyl-2-propen-1-yl]piperazine; (Z)-1-(Diphenylmethyl)- 4-(3-phenyl-2-propenyl)piperazine; cis-Cinnarizine |
Cinnarizine Impurity A | 841-77-0 | C17H20N2 | 252.35 | 1-Benzhydrylpiperazine; 1-(Diphenylmethyl)piperazine; 4-(Diphenylmethyl)piperazine; 4-Benzhydrylpiperazine; Benzhydrylpiperazine; N-(Diphenylmethyl)piperazine; N-Benzhydrylpiperazine; NSC 35536; Norcyclizine |
Cinnarizine | 298-57-7 | C26H28N2 | 368.51 | 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazin;1-Benzhydryl-4-[(2E)-3-phenyl-2-propenyl]piperazine;1-cinnamyl-4-(diphenylmethyl)-piperazin;1-Cinnamyl-4-(diphenylmethyl)piperazine;1-cinnamyl-4-(diphenylmethyl)-Piperazine;1-Cinnamyl-4-diphenylmethylp |
Cinnamylideneacetic acid | 1552-94-9 | C11H10O2 | 174.199 | 5-Phenyl-2,4-pentadienoic acid |
Cimoxatone | 73815-11-9 | C19H18N2O4 | 338.35700 | |
Cinitapride hydrogen tartrate | 1207859-16-2 | C25H36N4O10 | 552.57 | 4-amino-N-[1-(cyclohex-3-en-1-ylmethyl)piperidin-4-yl]-2-ethoxy-5-nitrobenzamide; (2R,3R)-2,3-dihydroxybutanedioic acid |
Cinnamyldenafil | 1446089-83-3 | C32H38N6O3 | 554.68 | |
CINNAMYLAMINE HYDROCHLORIDE | 5586-89-0 | C9H12ClN | 169.65 | 3-Phenyl-2-propen-1-amine hydrochloride; CINNAMYLAMINE HYDROCHLORIDE; 3-phenyl-2-propen-1-aminhydrochloride; gamma-phenylallylaminehydrochloride |
Cinnamyl isoferulate | 115610-31-6 | C19H18O4 | 310.349 | Isoferulic acid cinnamyl ester; (E)-cinnamyl (E)-isoferulate; Trans-cinnamyl-trans-isoferulate; [(E)-3-phenylprop-2-enyl] (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate |
Cinnamyl coumarate | 115610-30-5 | C18H16O3 | 280.323 | Coumaric acid cinnamyl ester; 3-(4-Hydroxyphenyl)propenoic acid 3-phenyl-2-propenyl ester; (E)-beta-(4-Hydroxyphenyl)acrylic acid 3-phenyl-2-propenyl ester |
Cinnamyl cinnamate | 122-69-0 | C18H16O2 | 264.32 | 3-Phenyl-2-propen-1-yl 3-phenyl propenoate; (2E)-3-Phenyl-2-propenyl (2E)-3-phenyl-2-propenoate |
Cinnamycin | 110655-58-8 | C89H125N25O25S3 | 2041.3 | Lanthiopeptin, Ro 09-0198 |
Cinnamtannin B1 | 88082-60-4 | C45H36O18 | 864.76 | |
Cinnamtannin A3 | 86631-39-2 | C75H62O30 | 1443.28 | |
Cinnamolide | 23599-47-5 | C15H22O2 | 234.339 | (-)-Cinnamolide; Naphtho(1,2-c)furan-3(1H)-one, 5,5a,6,7,8,9,9a,9b-octahydro-6,6,9a-trimethyl-, (5aS-(5a-alpha,9a-beta,9b-alpha))-; (5aS,9aS,9bR)-6,6,9a-trimethyl-5,5a,7,8,9,9b-hexahydro-1H-benzo[e]isobenzofuran-3-one |
cinnamic acid | 621-82-9 | C9H8O2 | 3-Phenylpropenoic acid; Phenylacrylic acid; Beta-Phenylacrylic acid; FEMA 2288; 2-Propenoic acid, 3-phenyl-, (2E)-; AKOS B004228 | |
Cinnamamide | 22031-64-7 | C9H9NO | 147.2 | 3-Phenyl-2-propenamide |
Cinnamaldehyde | 104-55-2 | C9H8O | 132.2 | 3-PHENYLPROPENAL; AKOS B004060; AKOS BBS-00003207; CINNAMIC ALDEHYDE; CINNAMALDEHYDE; CINNAMALDEHYDE, TRANS-; LABOTEST-BB LT00939010; FEMA 2286 |
Cinnabarinic acid | 606-59-7 | C14H8N2O6 | 300.22 | 2-Amino-3-oxo-3H-phenoxazine-1,9-dicarboxylic acid |
Cinitapride | 66564-14-5 | C21H30N4O4 | 402.49 | 4-Amino-N-[1-(3-cyclohexen-1-ylmethyl)-4-piperidinyl]-2-ethoxy-5-nitrobenzamide |
CINITAPRIDE | 96623-56-2 | |||
Cinfenine | 54141-87-6 | C25H27NO | 357.48798;g/mol | Cinfenine; UNII-P26FL0O04P; 54141-87-6; Cinfeninum; Cinfenina; [2-(diphenylmethoxy)ethyl](methyl)[(2E)-3-phenylprop-2-en-1-yl]amine |
CINERUBIN | 147657-35-0 | 0 | CINERUBIN; cinerubin R | |
Cinerin II | 121-20-0 | C21H28O5 | 359.43608 | 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate; Cyclopropanecarboxylic acid, 3-(1E)-3-methoxy-2-methyl-3-oxo-1-propenyl-2,2-dimethyl-, (1S)-3-(2Z)-2-butenyl-2-methyl-4-oxo-2-cyclope |
Cinepazide Maleate | 26328-04-1 | C22H31N3O5.C4H4O4 | 533.57 | Cinepazide maleate |
Cinepazide | 23887-46-9 | C22H31N3O5 | 417.5 | Cinepazide |
Cindunistat hydrochloride maleate | 753491-31-5 | C20H39ClN6O8S2 | 591.15 | PHA-728669F; PHA 728669F; PHA728669F; SD-6010; SD 6010; SD6010 PF-00572986; PF00572986; PF 00572986; PF-572986; PF572986; PF 572986; PHA-84250; PHA84250; PHA 84250; SC-084250; SC 084250; SC084250; Cindunistat. cindunistat hydrochloride maleate;(R,Z)-2-ami |
Cindunistat | 364067-22-1 | C8H17N3O2S | 219.30 | SC-84250; SD-6010; (2R)-2-amino-3-[2-(1-aminoethylideneamino)ethylsulfanyl]-2-methylpropanoic acid; |
Cinchonine | 118-10-5 | C19H22N2O | 294.39 | (9S)-Cinchonan-9-ol |
Cinchonidine sulphate | 524-61-8 | C38H46N4O6S | 686.86 | (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-quinolin-4-ylmethanol;sulfuric acid;(8-alpha,9R)-Cinchonan-9-ol sulfate (2:1) (salt);Cinchonan-9-ol, (8-alpha,9R)-, sulfate (2:1) (salt) (9ci) |
Cinchonidine | 485-71-2 | C19H22N2O | 294.39 | |
Cinchonain IIb | 85022-68-0 | C39H32O15 | 740.66 | (2R,3R,4S,10S)-2,10-bis(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-3,5-dihydroxy-3,4,9,10-tetrahydro-2H-pyrano[2,3-h]chromen-8-one |
Cinalukast | 128312-51-6 | C23H28N2O3S | 412.55 | Ro 24-5913; UNII-5E1O433QAI; CHEMBL283754;4-[[3-[(1E)-2-(4-Cyclobutyl-2-thiazolyl)ethenyl]phenyl]amino]-2,2-diethyl-4-oxo-Butanoic Acid |
Cinalbicol | 69904-85-4 | C15H20O | 216.324 | (5S)-4,5-dimethyl-3-prop-1-en-2-yl-5,6,7,8-tetrahydronaphthalen-1-ol |
Cinaciguat | 329773-35-5 | C36H39NO5 | 565.70 | BAY 58-2667 ; 4-((4-carboxybutyl)(2-((4-phenethylbenzol) oxy)phenethyl)amino)methyl(benzoic) acid |
Cinacalcet N-Oxide | 1229224-94-5 | C22H21F3NO | 372.4 | (R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl) phenyl)propan-1-amine N-oxide |
Cinacalcet Impurity C | 955373-56-5 | C22H21ClF3N | 391.86 | Dehydro Cinacalcet Hydrochloride |
Cinacalcet Impurity B (HCl salt form) | 163831-65-0 | C19H20ClN | 297.82 | (R)-(-)-N-BENZYL-1-(1-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE; (R)-N-BENZYL 1-(1-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE; (R)-N-[1-(1-NAPHTHYL)ETHYL]BENZYLAMINE HYDROCHLORIDE; (R)-(-)-N-BENZYL-1-(1-NAPHTHYL)ETHYLAMI&; N-benzyl-1-(1-naphthyl)ethylamine hydrochloride |
Cinacalcet Impurity 7 | 21172-43-0 | C11H13F3O3S | 282.28 | |
Cinacalcet Impurity 24 | 166947-09-7 | C10H9F3O | 202.17 | 3-(4-Trifluoromethylphenyl)propionaldehyde; 4-(Trifluoromethyl)benzenepropanal; 3-(4-Trifluoromethylphenyl)propanal |
Cinacalcet Impurity 23 | 376641-58-6 | C10H9F3O | 202.17 | 3-(2-Trifluoromethylphenyl)propanal; 2-(Trifluoromethyl)-Benzenepropanal |
Cinacalcet Impurity 18 | 1020414-30-5 | C12H15N | 173.26 | |
Cinacalcet Impurity 17 | 802918-45-2 | C12H15N | 173.26 | |
Cinacalcet Impurity 16 | 802918-47-4 | C22H24F3N | 359.44 | |
Cinacalcet Hydrochloride | 364782-34-3 | C22H22F3N.HCl | 393.87 | AMG-073 HCl; AMG 073 HCl; AMG073 HCl |
Cinacalcet Dihydro Impurity 2 HCl | 802918-36-1 | C22H25ClF3N | 395.89 | (R)-N-(1-(5,6-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride - See more at: http://www.clearsynth.com/en/CSO13611.html#sthash.UHobNu1U.dpuf |
Cinacalcet Dihydro Impurity 1 HCl | 1020414-33-8 | C22H25ClF3N | 395.89 | N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride |
Cinacalcet | 226256-56-0 | C22H22F3N | 357.41 | Sensipar, (R)-N-[-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine |
Cimiside B | 152685-91-1 | C40H64O13 | 752.9 | |
Cimiracemoside D | 290821-39-5 | C37H58O11 | 678.85 | Cimiracemoside D |
Cimiracemoside C | 256925-92-5 | C35H56O9 | 620.8 | Cimigenol 3-O-alpha-L-arabinopyranoside; |
Cimigenol-3-one | 31222-32-9 | C30H46O5 | 486.693 | |
Cimigenol | 3779-59-7 | C30H48O5 | 488.7 | |
Cimifugin | 37921-38-3 | C16H18O6 | 306.31 | Cimitin |
C-IMIDAZO[1,5-A]PYRIDIN-1-YL-METHYLAMINE | 885276-68-6 | C8H9N3 | 147.18 | C-IMIDAZO[1,5-A]PYRIDIN-1-YL-METHYLAMINE |
Cimicoxib | 265114-23-6 | C16H13ClFN3O3S | 381.82 | 4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide; UR-8880; UR8880; UR8880; Cimicoxib; trade name: Cimalgex |
Cimicifugoside | 66176-93-0 | C37H54O11 | 674.82 | |
Cimetropium bromide | 51598-60-8 | C21H28BrNO4 | 438.36 | |
Cimetidine-d3 | 1185237-29-9 | C10H13N6SD3 | 255.35 | N-Cyano-N'-methyl-d3-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine; SKF-9233-4-d3; Acibilin-d3; Acinil-d3; Cimal-d3; Cimetag-d3; Cimetum-d3; Edalened3; Peptol-d3; Tagamet-d3; Ulcedin-d3 |
Cimetidine Sulfoxide | 54237-72-8 | C10H16N6OS | 268.34 | N-Cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]sulfinyl]ethyl]guanidine; (±)-Cimetidine S-Oxide; SKF 92452 |
Cimetidine Impurity 3 | 208447-53-4 | C11H20N8S2 | 328.46 | |
Cimetidine EP Impurity J DiHCl | 38603-72-4 | C7H15Cl2N3S | 244.19 | 2-[[(5-Methyl-1H-imidazol-4-yl)methyl]thio]-ethanamine DiHydrochloride; 4-[(2-Aminoethyl)thiomethyl]-5-methylimidazole DiHydrochloride; 5-[[(2-Aminoethyl)thio]methyl]-4-methylimidazole DiHydrochloride |
Cimetidine EP Impurity I HCl | 38603-74-6 | C6H11N2OCl | 162.62 | |
Cimetidine EP Impurity H | 74886-59-2 | C10H18N8S2 | 314.43 | N-Cyano-3-(cyanoamino)-N'-methyl-7,8-dithia-2,4,11-triazadodec-2-en-12-imidamide |
Cimetidine EP Impurity G | 31857-31-5 | C4H8N4 | 112.13 | 1-Cyano-2,3-dimethyl-guanidine; 1,3-Dimethyl-2-cyanoguanidine; 2-Cyano-1,3-dimethylguanidine; N-Cyano-N',N''-dimethylguanidine |
Cimetidine EP Impurity F | 55272-86-1 | C16H24N8S2 | 392.55 | |
Cimetidine EP Impurity C | 52568-80-6 | C10H20Cl2N6OS | 343.28 | Cimetidine Amide Dihydrochloride; [(Methylamino)[[2-[[5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]amino]methylene]- urea Dihydrochloride |
Cimetidine EP Impurity B | 138035-55-9 | C10H15N5OS | 253.32 | Methyl 3-cyano-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]ethyl]-carbamimidate |
Cimetidine A | 2984-61-4 | C10H16N6S | 252.344 | |
Cimetidine | 51481-61-9 | C10H16N6S | 252.34 | SKF-92334; SKF 92334; SKF92334 |
Cimemoxin | 3788-16-7 | C7H16N2 | 128.217 | Cimemoxin |
Cimbuterol-D9 | 1246819-04-4 | 2-Amino-5-(2-tert-butyl- amino-D9-1-hydroxy- ethyl)-benzonitrile | ||
Cimbuterol | 54239-39-3 | C13H19N3O | 233.315 | 2-Amino-5-(2-tert-butylamino-1-hydroxyethyl)-benzonitrile |
Cimaterol-d7 | 1228182-44-2 | C12H10N3OD7 | 226.33 | 2-Amino-5-[1-hydroxy-2-[(1-methylethyl-d7)amino]ethyl]benzonitrile; CL 263780-d7 |
Cimaterol | 54239-37-1 | C12H17N3O | 219.28 | Cimater; 2-Amino-5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]benzonitrile; CL 263780; Cimaterolum |
Ciluprevir | 300832-84-2 | C40H50N6O8S | 774.93 | BILN 2061; BILN 2061ZW |
Cilostazol-d4 | 1215541-47-1 | C20H23D4N5O2 | 373.49 | 6-[4-(1-Cyclohexyl-d4-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone; OPC-13013-d4; Pletal-d4 |
Cilostazol related compound C | 865792-18-3 | C31H45N9O2 | 575.75 | 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone |
Ciliobrevin A | 302803-72-1 | C17H9Cl2N3O2 | 358.18 | HPI-4; Hedgehog Pathway Inhibitor 4; (E)-3-(2,4-dichlorophenyl)-3-oxo-2-(4-oxo-3,4-dihydroquinazolin-2(1H)-ylidene)propanenitrile |
Cilengitide TFA salt | 199807-35-7 | C29H41F3N8O9 | 702.68 | 2-((2S,5R,8S,11S)-5-benzyl-11-(3-((diaminomethylene)amino)propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid trifluroacetic acid; 2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methy |
Cilengitide | 188968-51-6 | C27H40N8O7 | 588.666 | 2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid |
Cilazaprilat | 90139-06-3 | C20H27N3O5 | 389.45 | (1S,9S)-9-[[(1S)-1-Carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic Acid; Ro 31-3113 |
Cilazapril Monohydrate | 92077-78-6 | C22H33N3O6 | 435.51 | |
Cilazapril | 88768-40-5 | C22H31N3O5 | 417.50 | Cilazapril; Ro 34-2848; Ro-34-2848; Ro34-2848. 7-[(2-amino-2-carboxylatoethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]hept-2-enoate;6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, 9-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]octahydro- |
Cilastatin sodium | 81129-83-1 | C16H25N2NaO5S | 380.43 | |
Cilastatin Ammonium Salt | 877674-82-3 | C16H29N3O5S | 375.48 | (2Z)-7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic Acid Ammonium Salt; MK-791 Ammonium Salt |
Cilastatin | 82009-34-5 | C16H26N2O5S | 358.45 | (2Z)-7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic Acid;MK-791; MK 791; MK791 |
CIL56 | 300802-28-2 | C23H27N3O5S2 | 489.605 | CA3; 2,7-Bis-(piperidine-1-sulfonyl)-fluoren-9-one oxime; N-[2,7-bis(piperidin-1-ylsulfonyl)fluoren-9-ylidene]hydroxylamine |
Ciguatoxin CTX-1B | 11050-21-8 | C60H86O19 | 1111.329 | CIGUATOXIN; Ciguatoxin 1; Pacific ciguatoxin 1; CTX 1; P-CTX 1 |
Ciglitazone | 74772-77-3 | C18H23NO3S | 333.44 | (+/-)-5-[4-(1-methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione; ADD-3878; 5-[[4-[(1-Methylcyclohexyl)methoxy]phenyl]methyl]-2,4-thiazolidinedione |
Cidofovir dihydrate | 149394-66-1 | C8H18N3O8P | 315.22 | HPMPC dihydrate; Vistide dihydrate; (S)-HPMPC dihydrate |
Cidofovir | 113852-37-2 | C8H14N3O6P | 279.19 | HPMPC |
CID-797718 | 370586-05-3 | C12H11NO3 | 217.22 | CID-797718 |
CID-755673 | 521937-07-5 | C12H11NO3 | 217.224 | CID-755673; CID 755673; CID755673 |
CID5721353 | 301356-95-6 | C15H9BrN2O6S2 | 457.26 | 2-((5Z)-5-(5-Bromo-2-oxo-1H-indol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanedioic acid; CID5721353; CID-5721353; CID 5721353; BCL6 Inhibitor, 79-6. |
CID-2858522 | 758679-97-9 | C28H39N3O3 | 465.63 | |
CID-25014542 | 220904-99-4 | C15H8Br2ClNO2 | 429.492 | 5-Chloro-3-(3,5-dibromo-4-hydroxybenzylidene)indolin-2-one; (3Z)-5-chloro-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-1H-indol-2-one |
CID-2011756 | 638156-11-3 | C22H21ClN2O3 | 396.871 | |
CID 5951923 | 749872-43-3 | C16H18N2O7S | 382.39 | 2-[Methyl(tetrahydro-1,1-dioxido-3-thienyl)amino]-2-oxoethyl (E)-3-(3-nitrophenyl)prop-2-enoate |
CID 2745687 | 264233-05-8 | C17H19F2N5O2S | 395.43 | 1-(2,4-Difluorophenyl)-5-[[2-[[(1,1-dimethylehyl)amino]thioxomethyl]hydrazinylidene]methyl]-1H-pyrazole-4-carboxylic acid methyl ester |
CID 16020046 | 834903-43-4 | C25H19N3O4 | 425.44 | |
CID 1375606 | 313493-80-0 | C20H14Cl2N2O2 | 385.24 | 2,4-Dichloro-N-(phenylcarbamoyl)phenylbenzamide; 2,4-Dichloro-N-(4-(phenylcarbamoyl)phenyl)benzamide |
CID 1067700 | 314042-01-8 | C18H18N2O4S2 | 390.48 | 2-(3-benzoylthioureido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid; MLS000673908; ML282; SMR000297947; CID-1067700 |
Ciclotizolam | 58765-21-2 | C20H18BrClN4S | 461.813 | Ciclotizolam;UNII-JK517QTN4Q;We973-BS;58765-21-2;Ciclotizolamum;Ciclotizolam[INN:BAN] |
Cicloprofen | 36950-96-6 | C16H14O2 | 238.285 | 2-(9H-fluoren-2-yl)propanoicacid; CICLOPROFEN; 2-Fluoren-2-ylpropionicacid; 36950-96-6; 2-(9H-Fluoren-2-yl)propanoicacid; SQ20824 |
Ciclopirox ethanolamine | 41621-49-2 | C12H17NO2.C2H7NO | 268.35 | |
Ciclopirox | 29342-05-0 | C12H17NO2 | 207.27 | Ciclopirox |
Ciclobendazole Cyclobendazole | 31431-43-3 | (5-Cyclopropanecar- bonyl-1H-benzoimida- zol-2-yl)-carbamic acid methyl ester | ||
Cicletanine | 89943-82-8 | C14H12ClNO2 | 261.707 | |
Ciclesonide | 126544-47-6 | C32H44O7 | 540.69 | (r)-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde 21-isobutyrate;(R)-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde 21-isobutyrate;Cicles |
Ciclesonide | 141845-82-1 | C32H44O7 | 540.69 | Ciclesonide; (R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate; Alvesco; Omnaris; Pregna-1,4-diene-3,20-dione, 16,17-(((R)-cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-met |
Cibenzoline succinate | 100678-32-8 | C18H18N2.C4H6O4 | 380.44 | (+-)-2-(2,2-diphenylcyclopropyl)-2-imidazolinesuccinate(1:1); 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1h-imidazol(+-)-1h-imidazolbutanedioate(; 4,5-dihydro-2-(2,2-diphenylcyclopropyl)-1h-imidazolesuccinate; 4,5-dihydro-2-(2,2-diphenylcyclopropyl)-1h-imida |
Cibenzoline Impurity (N-(2-Aminoethyl)-2,2-diphenylcyclopropanecarboxamide) | 109546-07-8 | C18H20N2O | 280.37 | |
Cibenzoline | 53267-01-9 | C18H18N2 | 262.36 | 2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1H-imidazole |
Cibacron Blue | 84166-13-2 | C29H20ClN7O11S3 | 774.16 | Cibacron blue 3GA; 1-amino-4-[4-[[4-chloro-6-(2-sulfoanilino)-1,3,5-triazin-2-yl]amino]-3-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid |
Cianopramine hydrochloride | 66834-20-6 | C20H24ClN3 | 341.88 | 5-[3-(Dimethylamino)propyl]-10,11-dihydro-5h-dibenzo[b,f]azepine-3-carbonitrile hydrochloride(1:1);Cianopramine HCl; Ro-11-2465 hydrochloride;Ro112465 hydrochloride;11-(3-Dimethylaminopropyl)-5,6-dihydrobenzo(b)(1)benzazepine-9-carbonitrile hydrochloride |
CI966 | 110283-79-9 | C23H21F6NO3 | 473.41 | CI-966;1-(2-(Bis(4-(trifluoromethyl)phenyl)methox)ethyl)-1,2,5,6-tetrahydro-3-pyrdinecarboxylic acid |
CI-959 free acid | 104795-66-6 | C14H15N5O3S | 333.37 | 3-(1-Methylethoxy)-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2-carboxamide;5-Methoxy-3-isopropoxy-N-(1H-tetrazole-5-yl)benzo[b]thiophene-2-carboxamide;Benzo[b]thiophene-2-carboxamide,5-methoxy-3-(1-methylethoxy)-N-2H-tetrazol-5-yl- |
CI-898 hydrochloride | 1658520-97-8 | C19H23N5O3·3HCl | 478.80 | Trimetrexate; CI 898 trihydrochloride; Trimetrexate trihydrochloride; TMTX |
CI-680 | 56287-31-1 | C32H36N2O11 | 624.64 | 3-(p-(alpha-(p-Methoxyphenyl)beta-nitrostyryl)phenoxy)-N,N-dimethylpropylamine monocitrate;2-Hydroxypropane-1,2,3-tricarboxylic acid;3-[4-[(Z)-1-(4-methoxyphenyl)-2-nitro-2-phenylethenyl]phenoxy]-N,N-dimethylpropan-1-amine;CI 680 |
CI-1044 | 197894-84-1 | C23H19N5O2 | 397.43 | CI-1044; CI 1044; CI1044; UNII-O4T475XIIY; PD-189659; N-(9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro(1,4)diazepino(6,7,1-hi)indol-3-yl)nicotinamide |
CI-1040 | 212631-79-3 | C17H14ClF2IN2O2 | 478.662 | CI-1040; PD184352 |
CI-1029 | 207736-05-8 | C28H37NO4S | 483.66 | (2S)-2-[2-(4-aminophenyl)ethyl]-5-[2-tert-butyl-4-(hydroxymethyl)-5-methylphenyl]sulfanyl-4-hydroxy-2-propan-2-yl-3H-pyran-6-one; PD 178390; PD-178390 |
CI-1018 | 245329-99-1 | C24H20N4O2 | 396.44 | 4-Pyridinecarboxamide, N-(3,4,6,7-tetrahydro-9-methyl-4-oxo-1-phenylpyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-; CI-1018; CI-1018; CI-1018; UNII-05127JZ9KQ |
CI-1002 hydrochloride | 149062-75-9 | C13H15Cl3N2 | 305.63 | UNII-I77CZ53Y9M; PharmaGSID_47259; 149062-75-9; 1,3-Dichloro-6,7,8,9,10,12-hexahydroazepino(2,1-b)quinazoline hydrochloride; CI-1002 hydrochloride; 1,3-dichloro-6,7,8,9,10,12-hexahydroazepino[2,1-b]quinazoline hydrochloride |
CI Pigment Yellow | 8007-18-9 | Ti-Ni-Sb-O | 414.09 | |
CI 992 | 135704-06-2 | C33H52N6O7S2 | 708.94 | N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-[(1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-alaninamide; [1S-(1R*,2S*,3R*)]- N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-[1-(cyclohexylmethyl)-2, |
CI 988 | 130332-27-3 | C35H42N4O6 | 614.73 | 4-[[(1R)-2-[[(2R)-3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid |
CI 986 | 130116-16-4 | C21H35N3O2S2 | 425.66 | 2-hydroxy-N,N,N-trimethylethanaminium 2,6-di-tert-butyl-4-(5-thioxo-4,5-dihydro-1,3,4-thiadiazol-2-yl)phenolate |
CI 976 | 114289-47-3 | C23H39NO4 | 393.57 | 2,2-Dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide |
CI 972 | 115787-68-3 | C11H12ClN5OS | 297.76 | 4H-Pyrrolo(3,2-d)pyrimidin-4-one, 2,6-diamino-1,5-dihydro-7-(3-thienylmethyl)-, monohydrochloride |
CI 1020 | 162256-50-0 | C28H26O9 | 506.50 | 3-(1,3-Benzodioxol-5-yl)-5-hydroxy-5-(4-methoxyphenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-2(5H)-furanone |
CI 1002 | 149028-28-4 | C13H14Cl2N2 | 269.17 | UNII-7U374ZW3YB; CI-1002; 1,3-Dichloro-6,7,8,9,10,12-hexahydroazepino(2,1-b)quinazoline; 1,3-dichloro-6,7,8,9,10,12-hexahydroazepino[2,1-b]quinazoline; PD-142676 |
CHZ868 | 1895895-38-1 | C22H19F2N5O2 | 423.42 | N-[4-[2-(2,4-difluoroanilino)-1,4-dimethylbenzimidazol-5-yl]oxypyridin-2-yl]acetamide; CHZ868; CHZ 868; CHZ-868 |
Chymostatin | 9076-44-2 | C31H41O6N7 | 607.7 | |
CHS-828 | 200484-11-3 | C19H22ClN5O | 371.869 | CHS 828; CHS-828; GMX 1778. |
Chrysothol | 911714-91-5 | C15H26O2 | 238.4 | (1R,2S,3R,6S,7S,10R)-10-Isopropyl-3,7-dimethyl-11-oxatricyclo[5.3.1.02,6]undecan-3-ol |
Chrysosplenol D | 14965-20-9 | C18H16O8 | 360.3 | 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,6,7-trimethoxychromen-4-one |
Chrysosplenetin | 603-56-5 | C19H18O8 | 374.4 | chrysosplenetin B;3,6,7,3'-Tetramethylquercetagetin;5-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-4H-1-benzopyran-4-one;EMD-20940;4H-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy- |
Chrysophanol tetraglucoside | 120181-08-0 | C39H50O24 | 902.80 | |
Chrysoobtusin | 70588-06-6 | C19H18O7 | 358.34 | Chryso-obtusin |
Chrysomycin B | 83852-56-6 | C27H28O9 | 496.5 | Chrysomycin M, Virenomycin M, Albacarcin M |
Chrysomycin A | 82196-88-1 | C28H28O9 | 508.5 | Chrysomycin V, Virenomycin V, Albacarcin V |
Chrysoeriol | 491-71-4 | C16H12O6 | 300.27 | 1. 5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone |
Chrysocauloflavone I | 899789-51-6 | C30H20O10 | 540.48 | |
Chrysin | 480-40-0 | C15H10O4 | 254.241 | 57Dihydroxyflavone; NP005901; NP 005901; NP-005901; Galangin flavanone. 5,7-Dihydroxyflavone; Chrysine; 5,7-Dihydroxy-2-phenyl-4H-chromen-4-one; Crysin |
Chrysene-d12 | 1719-03-5 | C18D12 | 240.3618 | CHRYSENE-D12; CHRYSENE-D12, 98 ATOM % D; CHRYSENE-D12, 25MG, NEAT; CHRYSENE-D12, 1X1ML, CH2CL2, 2000UG/ML; chrysene-d12 solution |
Chrysene, 5-nitro- | 89455-17-4 | C18H11 N O2 | 273.28500 | |
Chrysene, 5-(bromomethyl)- | 85083-61-0 | C19H13Br | 321.2105 | |
Chrysanthellin B | 74411-65-7 | C58H94O26 | 1207.35 | |
Chrysamine G disodium salt | 6472-91-9 | C26H16N4O6.2Na | 526.41 | CG; CHRYSAMINE; CHRYSAMINE G; CHRYSAMINE G DISODIUM SALT; CI NO 22250; 4,4'-BIS-(3-CARBOXY-4-HYDROXYPHENYLAZO)BIPHENYL; 4,4'-BIS(3-CARBOXY-4-HYDROXYPHENYLAZO)BIPHENYL DISODIUM SALT; 5,5'-[[1,1'-BIPHENYL]-4,4'-DIYLBIS(AZO)BIS]2-HYDROXYBENZOIC ACID |
CHROMOSORB 104 | 39429-20-4 | C9H18O3 | 0 | CHROMOSORB 104; CHROMOSORB 104 MESH SIZE 60-80; Chromosorb(R) 104 |
Chromomycin A3 | 7059-24-7 | C57H82O26 | 1183.3 | Aburamycin, Toyomycin, NSC 58514, B 599-III, SR1768E |
Chromomycin A2 | 6992-70-7 | C59H86O26 | 1211.3 | Aburamycin A, NSC 131187 |
Chromolaenide | 66148-25-2 | C22H28O7 | 404.459 | Hiyodorilactone B; [(1R,2R,7S,10R)-7-acetyloxy-4,8-dimethyl-13-methylidene-12-oxo-11-oxabicyclo[8.3.0]trideca-4,8-dien-2-yl] 4-hydroxy-2-methyl-but-2-enoate |
Chromoionophore II | 136499-31-5 | C46H59N3O5 | 733.98 | 9-Dimethylamino-5-[4-(16-butyl-2,14-dioxo-3,15-dioxaeicosyl)phenylimino]benzo[a]phenoxazine, ETH 2439 |
Chromocarb | 4940-39-0 | C10H6O4 | 190.15 | |
Chrome Yellow 34 | 1344-37-2 | PbCrO4 | 323.19 | Chrome Yellow 34; Lemon Chrome Yellow |
Chromate(2-),[2,4-dihydro-4-[2-[2-(hydroxy-kO)-4-nitrophenyl]diazenyl-kN1]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)-kO3][3-[2-[4,5-dihydro-3-methyl-5-(oxo-kO)-1-phenyl-1H-pyrazol-4-yl]diazenyl-kN1]-2-(hydroxy-kO)-5-nitrobenzenesulfonato(3-)]-,sodium (1:2) | 70209-87-9 | C32H21 Cr N10 O11 S . 2 Na | 0 | Chromate(2-), 2,4-dihydro-4-2-(hydroxy-.kappa.O)-4-nitrophenylazo-.kappa.N1-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)-.kappa.O33-4,5-dihydro-3-methyl-5-(oxo-.kappa.O)-1-phenyl-1H-pyrazol-4-ylazo-.kappa.N1-2-(hydroxy-.kappa.O)-5-nitrobenzenesulfonato(3-)-, |
Chromane-2-carboxylic acid | 51939-71-0 | C10H10O3 | 178.18 | CHROMANE-2-CARBOXYLIC ACID; IFLAB-BB F2108-0136; 2H-1-BENZOPYRAN-2-CARBOXYLIC ACID, 3,4-DIHYDRO-; Chroman-2-carboxylic acid |
Chroman 1 | 1273579-40-0 | C24H28N4O4 | 436.50 | (3S)-N-[2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2H-chromene-3-carboxamide;chroman1;1273579-40-0;CHEMBL3221807;3543AH;CS-0775 |
Chromafenozide | 143807-66-3 | C24H30N2O3 | 394.51 | N'-tert-butyl-N'-(3,5-dimethylbenzoyl)-5-methyl-3,4-dihydro-2H-chromene-6-carbohydrazide chromafenozide 143807-66-3 UNII-2ODM465D5M CHEBI:38450 Chromafenoside Matric Chromafenozide [ISO] SCHEMBL73335 2ODM465D5M CHEMBL227020 DTXSID4057976 ANS 1 |
Chrodrimanin B | 132196-54-4 | C27H32O8 | 484.54 | Thailandolide B |
CHR-6494 | 1333377-65-3 | C16H16N6 | 292.34 | CHR-6494;1333377-65-3;3-(1H-indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine;QCR-8;C16H16N6;3199AH |
CHR-3996 | 1235859-13-8 | C21H20FN5O2 | 393.422 | CHR-3996; CHR3996; CHR 3996. |
CHR 6494 trifluoroacetate | 1458630-17-5 | C16H16N6.CF3CO2H | 406.36 | 3-(1H-Indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine trifluoroacetate |
CHPG Sodium salt | 1303993-73-8 | C8H7ClNNaO3 | 223.59 | (RS)-2-Chloro-5-hydroxyphenylglycine sodium salt |
CHPG | 170846-74-9 | C8H8NO3Cl | 201.61 | (RS)-2-Chloro-5-hydroxyphenylglycine; 2-chloro-5-hydroxyphenylglycine; 2-Amino-2-(2-chloro-5-hydroxyphenyl)acetic acid |
CHORISMIC ACID BARIUM SALT | 55508-12-8 | C10H8BaO6 | 361.49 | CHORISMIC ACID BARIUM SALT; TRANS-3-[(1-CARBOXYETHENYL)OXY]-4-HYDROXY-1,5-CYCLOHEXADIENE-1-CARBOXYLIC ACID BARIUM SALT; chorismic acid barium; Chorismic acid barium salt from Enterobacter aerogenes |